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1 Introduction 
In Lewis base catalysis, an electron pair donor (Lewis base) interacts with an acceptor (Lewis 
acid), forms a binding adduct that possesses an enhanced nucleophilic, electrophilic or ambiphilic 
character and therefore increases the rate of the catalyzed reactions. [1]  As a requirement for all 
catalytic reactions, the Lewis base should be recovered unchanged at the end of the reaction.  
Three Lewis base-Lewis acid interactions are considered relevant for catalysis, namely n–π* 
interactions, n–σ* interactions and n–n* interactions.[2] The type of n– π* interactions includes the 
largest and most common form of Lewis base catalysis where the nonbonding electron pair of a 
Lewis base (n donor orbital) interacts with an unsaturated functional group of the acceptor (π* 
acceptor orbital), such as carbonyl[3-9], alkene[10-17] or alkyne[18-24]. Comparatively, n–σ* interactions 
and n–n* interactions involve the electron-pair acceptors whose coordination sphere could be 
expanded to a “hypervalent” state, such as organometallic reagents and boranes. [25] 
Although a variety of processes can be catalyzed by Lewis bases, in comparison to Lewis 
acid catalysis, Lewis base catalyzed reactions are underexploited in organic synthesis. [26] This can be 
attributed to the limitations of valence expansion at carbon centers. Nevertheless, a variety of Lewis 
base catalysts were developed and evaluated in reactions of organic molecules. [1] Lewis bases 
containing electron-pair donor atoms from group 15, such as nitrogen and phosphorus, have attracted 
the most attention because of their strong nucleophilic properties and versatile character easy to 
modify through different substituents.[16-17, 23-24]   
Amines and phosphines were used as Lewis base catalysts in reactions with unsaturated 
organic functional groups early in the development of the field. [27-30] These usually generate reactive 
zwitterionic intermediates via the most common n-π* interactions. The enhanced reactivity of the 
zwitterionic intermediates enables these species to form new bond in the presence of other reaction 
partners. For example, via the nucleophilic addition of a tertiary amine or phosphine to the Michael 
acceptor α,β-unsaturated carbonyl compounds are transformed to zwitterionic enolates that have 
enhanced nucleophilic character at C2 (Scheme 1-1, A).[24] With a suitable substituent at C3 position 
the collapse of the zwitterionic enolate produces the intermediate with enhanced electrophilic 
characteristics at C3 (Scheme 1-1, B). If a secondary amine is used, intramolecular proton transfer of 
the zwitterionic intermediate (Scheme 1-1, A) would occur and lead to the formation of a neutral 
tertiary amine.[31-32]  
Similar process also takes place in substitutions of Morita−Baylis−Hillman (MBH) adducts in 
the presence of Lewis base catalysts and (pro)nucleophiles. Despite the reports of formation of C-
C,[33] C-O,[34] C-N,[35] C-S[36] and C-P[37] bonds to produce the SN2 products in substitution of MBH 
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adducts (Scheme 1-2, Path A), these processes are not truly general and they depend on the acidity 
and nucleophilicity of the pronucleophiles.[20, 38-40] Especially for N-centered nucleophiles, the scope 
is limited to substrates that are fairly N-H acidic. In addition to this limitation, their nucleophilicity 
can set a competition with the Lewis base catalysts, and result in the formation of SN2’ product (Path 
B) or a mixture of SN2 and SN2’ products.[31-32, 41]  
 
Scheme 1-1 Amine or phosphine catalyzed reaction of α,β-unsaturated carbonyl compounds . 
 
 
Scheme 1-2 Substitutions of Morita-Baylis-Hillman (MBH) adducts . 
This thesis aims to address the limitations related to the requirement of N-H acidity of the N-
centered nucleophiles and explores the Lewis base catalyzed reactions of anilines with MBH 
carbonates. Furthermore, this work addresses the detrimental competition of the nucleophilic reaction 
partner and the Lewis base catalyst by developing the concept of latent silylated nucleophiles in 
allylations of N- and C-centered nucleophiles (N-heterocycles and (diethoxyphosphoryl)-
difluoromethyl nucleophile). The details are included in Chapter 2. 
In contrast to substitutions of MBH adducts, a suitable substituent at C3 position enables the 
collapse of the zwitterionic enolate to produce the vinyl onium (phosphonium or ammonium) 
intermediate with enhanced electrophilic characteristics at C3 (Scheme 1-1, B). Similar vinyl 
phosphonium intermediates can be produced in phosphine catalyzed reactions with electron deficient 
alkynes in the presence of Lewis or Brønsted acids. This thesis also explores the selective 
transformations of such vinyl phosphonium intermediates in catalysis and in the reactions that rely on 
the use of stoichiometric quantities of Lewis base as a promotor or a reagent. The work on selective 
reductive transformations of electron deficient alkynes catalyzed by phosphines and the related C-H 
functionalizations via aryl phosphonium ion intermediates are described in Chapter 3. 
Chapter 2. Latent nucleophiles in Lewis base catalysis  
11         
 
2 Latent nucleophiles in Lewis base catalysis  
Parts of this chapter have been published in P1) Y. Zi, M. Lange, P. Schüler, S. Krieck, M. 
Westerhausen, I. Vilotijevic, Synlett 2020, 31, 575–580; P2) Y. Zi, M. Lange, C. Schultz, I. 
Vilotijevic, Angew. Chem. Int. Ed. 2019, 58, 10727–10731; P3) M. Lange, Y. Zi, I. Vilotijevic, J. 
Org. Chem. 2020, 85, 1259-1269; P4) M. Lange, Y. Zi, I. Vilotijevic, Synlett 2020, accepted; P5) Y. 
Zi, M. Lange, I. Vilotijevic, Chem. Commun. 2020, accepted, DOI: 10.1039/D0CC01815E. 
Allylic substitution reactions are of major interest in modern organic chemistry. They have 
been utilized in C-C[33], C-O[34], C-N[35], C-S[36], C-P[37] bond formation. The selective formation of C-
N bonds is of great interest in medicinal chemistry and, in allylic substitution reactions, is also the 
most challenging. The preparation of allylic amines by metal-catalyzed reactions has been studied 
extensively resulting in numerous protocols and methods.[42-45] Yet each of the reported methods 
struggles to address the selectivity issues which exist on level of regio, chemo and enantioselectivity. 
The regioselectivity cannot be controlled in many cases since the intrinsic reactivity of both coupling 
partners is determined by steric effects, normally leading to selectivity for the product with less steric 
clashing.[46] Chemoselectivity issues are often observed when ambident nucleophiles are employed 
yielding isomeric compounds or products of multiple allylation. [47] As with other stereoselective 
transformations, the search for the optimal chiral ligands that affords the products with high 
enantioselectivity is always a laborious process. Lewis base catalyzed allylic substitutions may offer 
alternative to the existing transition metal catalyzed processes.[1] The Morita Baylis Hillman (MBH) 
adducts have emerged as prime electrophiles in these reactions. [41, 48-50] Part of the appeal of MBH 
adducts is that they are synthesized by Lewis base induced addition of a Michael acceptor to an 
aldehyde or related species (Scheme 2-1) which offers high atom economy, easy reaction setup and 
high selectivity.[51-54] 
 
Scheme 2-1 Morita Baylis Hillman reaction. 
 
2.1 Synthesis of β- lactams via enantioselective allylation of anilines with Morita–Baylis–
Hillman carbonates 
* Markus Lange has worked on this section as part of his PhD thesis. 
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To enhance the utility of MBH alcohols in synthesis, the hydroxyl group must be converted 
to a better leaving group like an ester or a carbonate. The carbonates have been the most utilized 
substrates in enantioselective Lewis base catalyzed substitutions. Lewis base catalyzed allylations of 
N-centered nucleophiles with MBH carbonates have been pursued by many research groups. [46, 55-59] 
Another approach for the same scaffold would be a direct aza-MBH reaction but this transformation 
comes with severe drawbacks like unstable starting materials or protecting groups which must be 
cleaved under rather harsh condition not allowing for a broad substrate scope or sensitive moieties. [60]  
 
Scheme 2-2 N-centered nucleophiles applied with MBH carbonates. 
The allylic amines produced via substitution reaction of either MBH acetates or carbonates 
have been used for the synthesis of N-heterocycles, such as pyridines,[61] quinolines,[62] 
pyrimidines,[63] pyrroles,[64] as well as complex pharmaceutical reagents or natural products [65]. The 
reported methods showed that the acidity of N-H plays an important role during the processes.[66] 
Hence, MBH carbonates are better suited due to the in situ release of the tert-butoxide anion which 
could deprotonate N-H with higher pKa (Scheme 2-2). A survey of literature indicated that the N-
centered nucleophiles with highest pKa that can be utilized in Lewis base catalyzed substitutions are 
sulfoximines (pKa~24). Less acidic N-centered nucleophiles have not been reported and they are 
considered not reactive in these reactions with MBH adducts. 
 
Scheme 2-3 Bio-active β-lactam analogues. 
Chapter 2. Latent nucleophiles in Lewis base catalysis 
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Our focus were the reactions of aniline (pKa = 30.6) and Morita-Bayliss-Hillman (MBH) 
adducts. The products of these reactions could be applied in synthesis of β-amino acids and their 
derivatives, β-lactams. 
 
Scheme 2-4 Proposed route for asymmetric synthesis of β-lactams from aldehydes, acrylate and aniline. 
β-Lactams are a central motif in modern medicinal chemistry due to the wide presence in 
antibiotics like penicillins and cephalosporins (A and B, Scheme 2-3).[67] β-lactam containing are not 
only inhibitors of the bacterial cell wall biosynthesis, but they also exhibit a set of other biological 
activities such as neuroprotective, antioxidant, analgesic or immunomodulatory capabilities. Certain 
β-lactams (C and D, Scheme 2-3)[68-70] have been treated as potent tubulin binders and therefore 
potential anti-cancer agents.  
A suitable route for asymmetric synthesis of β-lactams originating from aldehydes, acrylate 
and aniline was proposed (Scheme 2-4). In the presence of Lewis base catalyst, allylation of anilines 
utilizing MBH adducts would produce 3 which can be cyclized directly to form β-lactams 5, 
derivatives of biologically active compounds C and D. In addition, the exo-methylene in the resulting 
lactams, 4 provided an opportunity to further modify the scaffold diastereoselectively. 
Several reactions of anilines and MBH adducts have been disclosed to provide racemic N-
allyl anilines,[71] catalyzed or promoted with DABCO. Development of an enantioselective coupling 
of anilines and MBH carbonates prompted us to commence our study with the chiral Lewis base 
catalyzed allylation of aniline 2a with MBH carbonate 1a (Table 2-1). The use of DABCO resulted in 
52% yield for the product after 2 hours. Further optimization studies were carried out to explore how 
the identity of the Lewis base catalyst influences the reaction outcomes. A set of cinchona alkaloid 
based catalysts were utilized because of their documented performance in similar transformations.[35, 
58-59, 72-77] Monomeric cinchona catalysts did initiate the reactions, albeit in lower yields and with poor 
enantioselectivity (Table 2-1, entries 2-3). Dimeric catalysts, such as (DHQD)2AQN, (DHQD)2PHAL 
and (DHQD)2PYR showed distinct activities and gave high enantioselectivity (entry 4 with 
(DHQD)2AQN, 67% yield, 92:8 er). Cyclohexane was identified as a suitable solvent (entries 7-11). 
By investigations on catalyst loading (entries 12-13), ratio of reaction partners (entries 14-15), 
concentration (entries 17-18) and temperature (entries 19-20) the optimized conditions include 
2.1 Synthesis of β-lactams via enantioselective allylation of anilines with Morita–Baylis–Hillman carbonates 
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cyclohexane as a solvent with 10 mol% of (DHQD)2AQN as the catalysts at room temperature, with 
0.4 M concentration for the electrophile. The process can be seen as a kinetic resolution 1, but only 
slight excess of aniline (2, 1.1 equiv.) was adequate to drive complete conversion which makes this 
process greener and more efficient. 
Table 2-1 Optimization of conditions for asymmetric allylation of anilines . 
 
Entry Cat. (10 mol%) Sol. t (h) Yield (%)[a] ee (%)[b] 
1 DABCO Toluene 2 52 / 
2 Quinine Toluene 56 24 -30 
3 Cinchonidine Toluene 56 30 25 
4 (DHQD)2AQN Toluene 56 67 84 
5 (DHQD)2PHAL Toluene 56 27 9 
6 (DHQD)2PYR Toluene 56 21 -18 
7 (DHQD)2AQN THF 56 46 79 
8 (DHQD)2AQN Dioxane 56 46 84 
9 (DHQD)2AQN DCM 56 86 75 
10 (DHQD)2AQN PhCF3 56 64 88 
11 (DHQD)2AQN Cyclohexane 56 81 82 
12 (DHQD)2AQN Cyclohexane 56 67 86[c] 
13 (DHQD)2AQN Cyclohexane 56 74 86[d] 
14 (DHQD)2AQN Cyclohexane 56 76 87[e] 
15 (DHQD)2AQN Cyclohexane 56 79 87[f] 
16 (DHQD)AQN C6H12/PhCF3 56 66 89 
17 (DHQD)2AQN Cyclohexane 56 94 (94) 87[g] 
18 (DHQD)2AQN Cyclohexane 56 50 88[h] 
19 (DHQD)2AQN Cyclohexane 40 94 84[i] 
20 (DHQD)2AQN PhCF3 40 88 88[i] 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard and isolated yield in parentheses; [b] 
Determined by HPLC of purified product; [c] 5 mol% of catalyst was used; [d] 15 mol% catalyst was used; [e] 1.0 equiv. of 
4-Cl-aniline was used; [f] 1.3 equiv. of 4-Cl-aniline was used; [g] The concentration was 0.4 M; [h] The concentration was 
0.1 M; [i] The reaction was heated to 40 °C. 
With the optimal conditions in hand, the following studies of the reaction scopes  for anilines 
and MBH carbonates were carried out (Scheme 2-5). For anilines featuring halogen substitutions, the 
desired allylation products (3a-3f) were obtained in excellent yields (up to 94%) and high 
enantioselectivities (up to 94:6 er). Both electron rich anilines (3h-3j) and electron poor anilines (3k) 
gave the allylation products in good yields (57% - 85%) with high enantioselectivities (89:11 - 94:6 
er). Besides halogens, ethers and nitrile, extended π-systems (3l-3m) within anilines were also well 
tolerated. Sterically hindered anilines can be utilized using this method, but the corresponding 
products are generated in lower yields with decreased enantioselectivity (3f and 3l).  
Subsequently, a set of MBH carbonates were evaluated. MBH carbonates featuring halide 
substituents performed well, giving good yields and enantioselectivity (3n-3s , up to 96% yield and 
98:2 er, Scheme 2-5). Despite the generally good yields, steric bulk on the MBH carbonates resulted 
in lower enantioselectivity (2r, 77%, 84:16 er). Electron donating and electron withdrawing groups 
Chapter 2. Latent nucleophiles in Lewis base catalysis 
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were all tolerated well, with yields of up to 97% and enantiomeric ratios up to 98:2 (3t-3x). To assign 
the absolute stereochemistry optical rotation experiments were conducted and comparison of the data 
for 3d, ([α]D20 = -115.8) with previously reported for the same compound ([α ]D20 = +115.0) 
confirmed the configuration of the major enantiomer in current reactions catalyzed by 
(DHQD)2AQN.[44] 
 
Scheme 2-5 Enantioselective Lewis base catalyzed allylation of anilines using MBH carbonates . 
Further investigations were focused on the cyclization of the obtained allylated anilines to 
form the exo-methylene containing β-lactams. Sn(HMDS)2 was chosen as suitable base to effect the 
cyclization and afford the desired four-membered rings. Gratifyingly, a variety of substituted β-
lactams were obtained in good yields (Scheme 2-6, 43% - 95%) by treating the allylated anilines with 
Sn(HMDS)2 and even allylation products bearing bulky substituents underwent the desired 
cyclization with good yields  (4j, 89%). 
With access to a range of β-lactams, we turned our attention to the enantiomeric ratios for the 
products. As shown in Scheme 2-6, the enantiomeric ratios remained stable and matched with those 
of the starting allylated anilines, demonstrating that the stereogenic center is not affected during the 
cyclization processes. 
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Scheme 2-6 Cyclization to exo-methylene containing β-lactams. 
To access analogues of 5 from β-lactams 4, 1,4-reduction is required and to simplify the 
operation, we opted for the general hydrogenation over a Pd/C catalyst in the presence of hydrogen. 
Excellent yields were achieved for the reduction of numerous β-lactams 4 (Scheme 2-7) and the major 
reaction product was identified as the cis-diastereomer being also the thermodynamically favored 
form which was tested by standard equilibration tests using strong base. The configuration was 
determined based on 3JH-H coupling constants which are consistent with the dihedral angles in the low 
energy conformations for these two isomers (5.9 Hz for cis-5a and 2.4 Hz for trans-5a). The 
enantiomeric ratios of the final β-lactams 5 matched those of the starting materials indicating that the 
stereogenic center adjacent to the nitrogen atom is not affected during the two-step sequence. 
 
Scheme 2-7 Diastereoselective hydrogenation of exo-methylene containing β-lactams. 
Due to the low acidity of aniline, the occurrence of the process with MBH adduct was 
attributed to its nucleophilicity which promoted the reaction with the intermediate i (Scheme 2-8). 
The formed cation ii has an enhanced N-H acidity which was then deprotonated by the in situ formed 
tert-butoxide. We hypothesized that the difference of nucleophilicity between N-centered 
Chapter 2. Latent nucleophiles in Lewis base catalysis 
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nucleophiles and the catalyst is the crucial point. The relative lower nucleophilicity of aniline 
compared to Lewis base catalyst resulted in the selective process with enhanced electrophile i. A 
competitive nucleophilic addition to MBH carbonate would happen between N-centered nucleophile 
and the catalyst if a higher nucleophilic amine was used. Alkyl amines were subsequently 
investigated and only direct SN2’ products, without a stereogenic center, were obtained. These 
observations are in line with previous results of the Mayr group. [78-81]  
 
Scheme 2-8 Proposed pathway of anilines with MBH carbonates . 
 
2.2 Enantioselective N-allylation of N-heterocycles 
* Markus Lange has worked on this section as part of his PhD thesis and Constanze Schultz has worked on this section for 
her Master thesis. 
Due to the possible competition between the nucleophile and the catalyst, the nucleophile 
must be less nucleophilic than the catalysts in Lewis base catalyzed allylic substitutions. If this 
requirement is not met, a mixture of SN2 and SN2’ products is obtained and/or the reaction proceeds in 
the absence of catalyst which precludes the development of enantioselective catalytic reactions. [41] It 
was proposed that latent nucleophiles, which are derivatives of nucleophilic molecules that are not 
nucleophilic but can be activated to participate in the reaction, can address this problem. [82-83] The 
latency of the starting nucleophile would prevent its reaction with electrophilic species present in the 
reaction mixture and thus reduce the rates of side reactions (Scheme 2-9). Activation of the latent 
nucleophile can occur via a mediator that is generated as a leaving group in the process of electrophile 
activation. The activated nucleophile would then be produced in the reaction mixture only when the 
activated electrophile is already present thus enabling the reaction between the two activated species 
to kinetically outcompete other possible reaction pathways. This concept could be utilized to improve 
the substrate scope for Lewis base catalyzed reactions, control their chemo- and regioselectivity and 
ultimately enable enantioselective transformations to occur under mild conditions when chiral Lewis 
base catalysts are used. 
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A review of the literature indicated that pyrrole derivatives have been utilized in reactions 
with MBH adducts but electron withdrawing groups or stoichiometric amount of Lewis base were 
required for efficient reactions.[35, 84-85] Nucleophilic properties of pyrrole derivatives are well 
documented [78-79, 81, 86] and pyrrole can act as N-, C2- and C3-nucleophile.[80, 84-85, 87] We hypothesized 
that introducing a silyl group attached to nitrogen would attenuate the nucleophilicity of pyrroles and 
turn them into latent nucleophiles.[78-81] In this case, a fluoride ion could be used to activate the N-silyl 
latent nucleophile indicating that the allylic fluorides derived from MBH adducts could be suitable 
coupling partners.  
 
Scheme 2-9 Latent nucleophiles in Lewis base catalysis . 
Shibata and co-workers have used allylic fluoride derived from MBH adducts to form C-C 
bond with C-silyl substituted compounds in the presence of chiral cinchona alkaloid based 
catalysts.[88-91] For C-centered nucleophiles, it is likely that only stabilized carbanions could be 
utilized as nucleophiles in these reactions.[88, 90] For N-centered nucleophiles, by virtue of all N-
centered anions being significantly less basic than the corresponding alkyl groups from the N-
trialkylsilyl, virtually any N-centered nucleophile could be accommodated in the proposed Lewis base 
catalyzed reactions of latent N-centered nucleophiles. 
To determine the feasibility of the approach with N-centered latent nucleophiles, we focused 
on the allylic fluorides to enable a regio and enantioselective allylation of N-heterocycles (Scheme 
2-10). This approach would address the problems of the activation the N-latent nucleophiles, the 
regioselectivity for the pyrrole nucleophile (N, C2, C3) and the regioselectivity of the substitution 
reaction (SN2 and SN2’). 
Chapter 2. Latent nucleophiles in Lewis base catalysis 
19         
 
 
Scheme 2-10 Possible products in N-allylation of pyrrole derivatives . 
N-TBS-pyrrole (7a) was chosen for reaction optimization whereas 1.1 equivalent of 7a was 
enough for the transformation and no better results were obtained when excess 7a was present (Table 
2-2. entries 1-4). A series of catalysts were tested in which N-centered Lewis base catalysts performed 
generally with better efficacy than the corresponding P-centered catalysts which failed to catalyze the 
allylic amination with the latent N-nucleophile (entries 7-8). No reaction occurred in the absence of 
DABCO while even 1 mol% of DABCO provided good yield (79%, entry 10). Increasing the catalyst 
loading does not affect the yield albeit a faster reaction was observed. The examination of solvents 
showed that 1,2-dichloroethane and toluene could provide good yields (96% and 91%, entries 13-14). 
Increasing temperature showed no apparent effect other than rate acceleration (entry 17). 
Table 2-2 Optimization of allylic amination. 
 
With the optimal conditions in hand, the scope of the reaction was evaluated. Good to very 
good yields for primary (83%, 8ra) and secondary (up to 99%) allylic fluorides were observed which 
demonstrates the generality of the transformation. For substituted aryl allylic fluorides featuring either 
electron donating groups (Scheme 2-11a, 8aa-8fa) or electron withdrawing groups (8ga-8la) the 
Entry 7a (equiv.) Cat. (X mol%) Sol. Tem. (oC) Yield (%)[a] 
1 1 DABCO (5) DCM 25 90 
2 1.1 DABCO (5) DCM 25 96 
3 1.25 DABCO (5) DCM 25 93 
4 1.5 DABCO (5) DCM 25 92 
5 1.1 DBU (5) DCM 25 / 
6 1.1 TEA (15) DCM 25 73 
7 1.1 PBu3 (5) DCM 25 / 
8 1.1 PPh3 (5) DCM 25 / 
9 1.1 DABCO (0) DCM 25 / 
10 1.1 DABCO (1) DCM 25 79 
11 1.1 DABCO (2.5) DCM 25 82 
12 1.1 DABCO (10) DCM 25 93 
13 1.1 DABCO (5) DCE 25 96 
14 1.1 DABCO (5) Toluene 25 91 
15 1.1 DABCO (5) THF 25 58 
16 1.1 DABCO (5) DMF 25 71 
17 1.1 DABCO (5) DCE 60 91 
[a]  NMR yields based on crude mixtures with triphenylmethane as the internal standard. 
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substitutions performed well to afford the desired allylation products (75% - 96%). In addition to 
ethers, esters, nitriles and nitro groups, halogen and alkyl substituents were also well tolerated (8ma-
8qa, 68% - 99%). Extended conjugate systems like the substrates naphthyl (86%, 8sa) and 3-indolyl 
(71%, 8ta) substituents were also reactive under the described conditions. Aliphatic allylic fluorides 
were also reactive with good product yields (84% yield for 8ua and 55% yield for 8va). The product 
of SN2’ substitution was not observed in any case indicating excellent regioselectivity. Under the 
optimized conditions, scalability was tested with 6a (1.00 g) and 8a (1.03 g) which proceeded with 
equal efficiency (8aa, 88%) indicating a practical and promising prospect of this process for 
application in medicinal chemistry (Scheme 2-11b). 
Evaluation of the scope for latent nucleophiles, N-TBS-pyrrole and indole derivatives, was 
subsequently carried out (Scheme 2-11b). Simple N-TBS-pyrrole as well as 2- or 3-substituted N-
TBS-pyrroles all performed well as nucleophiles in good yields (8ae-8ah, 67% - 86%). Numerous 
substituted indoles, bearing electron donating groups and electron withdrawing groups, were then 
tested in the reactions which performed well and lead to the desired products in good yields (8ai-8am, 
77% - 96%). Electron withdrawing groups (8aj) resulted in a slight decrease in yields. However, the 
reaction showed sensitivity to steric bulk resulting in lower yield for 2-methylindole (8an, 47%). 
Subsequently, N-silyl carbazole was also tested as a suitable substrate in the reaction (8ao, 82%).  
To further evaluate the scope of this process, a series of experiments with electronically 
matching and mismatching electrophiles and substituted latent nucleophiles were carried out (Scheme 
2-11c). Under the optimized conditions, pyrrole derivatives were smoothly introduced to primary and 
secondary allylic fluorides in good yields (44% - 88%) although some detrimental effects of steric 
crowding close to the reactive centers were observed (8wl, 8xl).  
Further investigations were carried out by treating a series of other silylated N-nucleophiles, 
including phthalimide, tosylamide and diphenylamine, with allylic fluoride under the optimized 
conditions and the moderate to excellent yields (up to 99%) showed the generality of the concept of 
Latent nucleophiles in Lewis base catalyzed allylic substitutions.  
Initial attempts to achieve enantioselective allylic substitutions relied on the use of catalysts 
based on cinchona alkaloids, such as (DHQD)2PHAL, (DHQD)2AQN and (DHQD)2PYR, which are 
often used in similar allylic substitutions.[35, 58-59, 72-77] With (DHQD)2PHAL (5 mol%) as the Lewis 
base catalyst in DCM with 0.2 M concentration of the fluoride at room temperature (Table 2-3, entry 
1) 91:9 er was observed after 40 hours although only 23% of the product 8aa’ was isolated. Repeated 
optimization of several variables followed. Switching the solvent to toluene with 10 mol% of 
(DHQD)2PHAL provided slightly higher yield (36%) and enantioselectivity (97:3). A set of N-
centered catalysts were tested in this process (entries 3-9) but (DHQD)2PHAL provided the best 
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outcomes. The screening of solvent (entr ies 10-15) revealed PhCF3 as the better choice that 60% yield 
and 96:4 er.  
 
Scheme 2-11 Scope study. 
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Lower catalyst loading diminished the yield while and further increase from 10 mol% in 
catalyst loading did not improve the yields while enantioselectivity remained similar (entries 16-21). 
To increase the conversion, various ratios of reacting partners were considered.  Due to the dynamic 
kinetic resolution scenario[88-91] as well as the low rate for these reactions, an excess of the allylic 
fluoride was required (entries 22-26). Further investigation of the influence of the reaction time, 
temperature and concentration led to the optimal reaction conditions: 2 equivalents of the allylic 
fluoride in the presence of 10 mol% of (DHQD)2PHAL in trifluorotoluene at ambient temperature. 
Table 2-3 Screening results of asymmetric N-allylic alkylation. 
 
Entry Cat. (X mol %) Sol. Ratio Concentration Tem. (°C) t (h) Yield (%)[a] er[b] 
1 (DHQ D)2PHAL (5) DCM 1:1.3 0.2M rt 40 23 91:9 
2 (DHQD)2PHAL (10) Toluene 1:1.3 0.2M rt 40 36 97:3 
3 (DHQ D)2AQN (10) Toluene 1:1.3 0.2M rt 40 31 90:10 
4 (DHQ D)2PYR (10) Toluene 1:1.3 0.2M rt 40 11 94:6 
5 Q uinine (10) Toluene 1:1.3 0.2M rt 40 11 / 
6 Q uinidine (10) Toluene 1:1.3 0.2M rt 40 16 / 
7 Cinchonine (10) Toluene 1:1.3 0.2M rt 40 12 65:35 
8 Cinchonidine (10) Toluene 1:1.3 0.2M rt 40 10 / 
9 Nicotine (10) Toluene 1:1.3 0.2M rt 40 / / 
10 (DHQD)2PHAL (10) DCE 1:1.3 0.2M rt 40 60 89:11 
11 (DHQD)2PHAL (10) PhCF3 1:1.3 0.2M rt 40 60 96:4 
12 (DHQD)2PHAL (10) THF 1:1.3 0.2M rt 40 33 89:11 
13 (DHQD)2PHAL (10) Hexane 1:1.3 0.2M rt 40 47 89:11 
14 (DHQD)2PHAL (10) Mesitylene 1:1.3 0.2M rt 40 28 97:3 
15 (DHQD)2PHAL (10) Dioxane 1:1.3 0.2M rt 40 45 97:3 
16 (DHQD)2PHAL (1) PhCF3 1:1.3 0.2M rt 40 20 96:4 
17 (DHQD)2PHAL (2) PhCF3 1:1.3 0.2M rt 40 35 96:4 
18 (DHQD)2PHAL (5) PhCF3 1:1.3 0.2M rt 40 44 95:5 
19 (DHQD)2PHAL (15) PhCF3 1:1.3 0.2M rt 40 50 95:5 
20 (DHQD)2PHAL (20) PhCF3 1:1.3 0.2M rt 40 52 95:5 
21 (DHQD)2PHAL (30) PhCF3 1:1.3 0.2M rt 40 45 95:5 
22 (DHQD)2PHAL (10) PhCF3 1:1.1 0.2M rt 40 51 96:4 
23 (DHQD)2PHAL (10) PhCF3 1:1.0 0.2M rt 40 47 95:5 
24 (DHQD)2PHAL (10) PhCF3 1.5:1 0.2M rt 40 65 97:3 
25 (DHQD)2PHAL (10) PhCF3 2:1 0.2M rt 40 77 (73[c]) 97:3 
26 (DHQD)2PHAL (10) PhCF3 2.2:1 0.2M rt 0 70 97:3 
27 (DHQD)2PHAL (10) PhCF3 2:1 0.2M rt 24 61 96:4 
28 (DHQD)2PHAL (10) PhCF3 2:1 0.2M rt 64 50 95:5 
29 (DHQD)2PHAL (10) PhCF3 2:1 0.2M rt 88 53 97:3 
30 (DHQD)2PHAL (10) PhCF3 2:1 0.5M rt 40 77 95:5 
31 (DHQD)2PHAL (10) PhCF3 2:1 0.1M rt 40 66 95:5 
32 (DHQD)2PHAL (10) PhCF3 2:1 0.05M rt 40 50 95:5 
33 (DHQD)2PHAL (10) PhCF3 2:1 0.2M 0 48 46 98:2 
34 (DHQD)2PHAL (10) PhCF3 2:1 0.2M 40 40 50 97:3 
35 (DHQD)2PHAL (10) PhCF3 2:1 0.2M 60 40 57 95:5 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] Determined by HPLC analysis 
using a chiral column; [c] Isolated yield. 
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 Scheme 2-12 Scope of allylic fluorides and N-latent nucleophiles. 
The scope for the enantioselective process was examined starting with N-silyl pyrroles 
providing good yields and enantioselectivities ( Scheme 2-12). Aryl fluorides featuring electron rich 
and poor substituents were well tolerated and produced the desired products with N-silyl pyrroles in 
good yields (45% - 83%) with enantiomeric ratios higher than 90:10. Lower reaction rates for the 
reactions with chiral catalysts led to competitive decomposition of aliphatic allylic fluorides, likely 
due to competitive elimination of HF, which led to lower yields although the enantiomeric ratios 
remained high (8ua’, 19%, 89:11 er). Indoles bearing both electron-donating and electron-
withdrawing groups provided the products in yields as high as 98% and with 99:1 er demonstrating 
that the electronic effects had little influence on the reactions. In some cases, low stereoselectivity 
was observed but this could be improved by focused optimization. As shown in  Scheme 2-12, a 
simple change of reaction solvent was sufficient to increase the enantiomeric ratios for 8ai’ and 8al’ 
from 92:8 to 95:5 and from 83:17 to 94:6 respectively. Carbazole nucleophiles are also competent 
substrates for this process affording satisfactory yield and enantioselectivity (8ao’, 66%, 88:12 er). 
The absolute configuration of the new stereogenic center in the products was assigned by comparison 
of optical rotation for 8am’ ([α ]D20 = +144.6) to the previously reported data for the same 
enantioenriched material ([α]D20 = +135.9) which confirms the configuration to be S. 
A set of control experiments were carried out to study the mechanistic features (Scheme 
2-13). Two possible pathways, which involve either the intermolecular addition of the nucleophile to 
the allyl ammonium intermediate or the simultaneous intramolecular delivery of the nucleophile and 
the silyl assisted cleavage of C-F bond, were proposed for this process (Scheme 2-13a).[33, 35, 58, 75, 88-93] 
2.2 Enantioselective N-allylation of N-heterocycles 
        24 
 
Formation of the ammonium salt 9 was observed by NMR when allylic fluoride 6a was treated with 
DABCO in the absence of latent nucleophile (Scheme 2-13b)[94] suggesting that the first pathway is 
feasible and that the silyl assistance is not required for C-F cleavage. When deuterium labeled indole 
7i-D was used together with N-TBS-indole 7i as an equimolar mixture, the reaction gave both the 
products with and without the deuterium label (82%, 8i-D:8i = 52:48) which was attributed to the 
equilibrium of indolide anions (Scheme 2-13c). Additional control experiments, which showed that 
no reaction occurs between indole and allylic fluoride under the standard conditions and no transfer of 
TBS group happens between N-TBS-indole 7i and deuterium labeled indole 7i-D excluded other 
possible explanations for this observation. In the presence of externally added fluoride catalysts, such 
as TBAF, exclusive SN2’ product 10 was observed (Scheme 2-13d) indicating the high nucleophilicity 
of the activated latent nucleophile as well as the requirement for sequential activation of the 
electrophile and then the nucleophile in these reactions.  
 
Scheme 2-13 Control experiments and proposed mechanism. 
The mechanism as shown in Scheme 2-13e) can be proposed. Nucleophilic addition of the 
Lewis base catalyst to the allylic fluoride results in the elimination of fluoride ion, via E1cb 
mechanism and affords the allylic ammonium intermediate i. The formation of silyl fluoride 
facilitates the cleavage of silyl group of N-latent nucleophile, namely the activation of the latent 
nucleophile, to give the anionic N-nucleophile which preferred to undergo the conjugate addition to 
activated electrophile, ammonium intermediate i, to from the zwitterionic intermediate ii. The 
increased rate for the reaction between activated nucleophile and activated electrophile compared to 
that of the activated nucleophile and the starting fluoride is highlighted by the control experiments in 
the presence of DABCO and in the presence of TBAF as the catalyst (Scheme 2-13d)).[95] This 
demonstrates the importance of simultaneous presence of activated electrophile and nucleophile pair 
in the reaction mixture and the importance of the latent character of the starting silylated nucleophile. 
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Subsequently, the final product was obtained via the elimination of the Lewis base catalyst. Good 
regioselectivity and stereocontrol were observed in the presence of chiral Lewis base catalysts.  
 
Scheme 2-14 Enantioselective approach to pyrrolizin-1-ones. 
To illustrate the utility of the developed enantioselective allylation of N-heterocycles, we 
focused on application of this method to enantioselective synthesis of biologically active pyrrolizin-1-
ones. 2,3-dihydro-1H-pyrrolizin-1-ones (E) (Scheme 2-14) exert anti-amyloid properties making 
them potential candidates for the treatment of Alzheimer disease.[96] Despite the previous synthetic 
work on pyrrolizin-1-one derivatives,[97-98] there are no reports of their stereoselective synthesis which 
prompted us to develop a new approach to these molecules starting from the enantioenriched N-
allylpyrroles prepared in our previous study (Scheme 2-14). 
 
Scheme 2-15 Hydrogenation and diastereoselective cyclization to pyrrolizin-1-ones; [a] Isolated yields. 
Our investigation started with the reduction of the alkene in 8’ to provide inseparable 
mixtures of products 12 in excellent yield but with low diastereoselectivity ranging from 1.3:1 to 
3.5:1 (Scheme 2-15). Friedel-Crafts-type cyclization was subsequently utilized to realize the 
cyclization of 12 to afford the corresponding pyrrolizin-1-ones in the presence of BBr3.[99-100] The 
relative configuration of the products was assigned as trans based on the 3JH-H coupling constants for 
C2 and C3 protons. Independent cyclization of both syn-12 and anti-12 with BBr3 afforded trans-11 
as the major cyclization product (Scheme 2-15). Unreacted starting material isolated when the 
reactions were stopped at around 50% conversion was unchanged indicating that the isomerization 
happened upon cyclization. Due to the three sp2 atoms in the pyrrolidinone ring, we expected the low 
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energy conformations to be rather flat, causing significant gauche interactions between C2 and C3 
substituents in the cis-isomer of 11 which makes the trans-isomer more stable than the cis-isomer as 
the substituents become larger. 
BBr3 promoted cyclization using mixtures of diastereomers of a series of 12 was carried out. 
The desired pyrrolizin-1-ones (11) were isolated in moderate yields (the major diastereomers) with 
diastereoselectivity between 5:1 and >25:1 in which the trans-isomer was the major product in all 
cases. The moderated yields are supposed to be the consequence of the harsh conditions which could 
result in side reactions, such as the degradation of ether, ester, trifluoromethyl and nitrile substituents. 
Another possible reaction pathway is the intramolecular electrophilic aromatic substitution on the C3-
aryl substituent, explaining the much better performance of 11ua and 11va which don’t have an aryl 
substituent at C3.  
The measurements for enantiomeric ratios for products trans-11aa and trans-11da showed it 
to be constant through the two-step sequence demonstrating that the stereogenic center set in the 
allylation is not changed during synthesis. This easy handling as well as the enantioselectivity 
provides a powerful tool for the synthesis of enantioenriched pyrrolizin-1-ones via the three-step 
sequence. 
 
2.3 Asymmetric allylic phosphonyl difluoromethylation 
* Markus Lange has worked on this section as part of his PhD thesis. 
The promising study on the enantioselective allylation of N-centered nucleophiles directed 
our attention to C-centered nucleophiles. Shibata has pioneered the work by using silylated C-
nucleophiles in Lewis base catalyzed substitution of allylic fluorides and the results indicated that the 
delivered substituent should be the least basic nucleophile,[88-91] which is also in accordance for a 
mechanism involving an Si-ate complex.[101]  To enhance the performance of silylated C-center 
reagent to form a less basic or a more stable C-nucleophile, stabilized anionic species were 
considered and due to recent relevance, phosphonates were chosen as a model system. The latency of 
the C-centered pronucleophiles could still be preserved by the introduction of silyl group as well as 
the sequential activation of electrophile and nucleophile which allows control of selectivity. In 
addition, the reaction site should also be restricted at the α position of phosphonate. 
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Scheme 2-16 Biologically active molecules bearing a phosphonyldifluoromethyl group. 
Difluoromethylphosphonates are present in many metabolically stable and bioactive 
molecules,[102-105] especially nucleoside analogues.[106-109] Important examples include protein tyrosine 
phosphatase (PTP) inhibitors F[110], mimics of sugar phosphates (G)[111] as well as phosphorylation 
inhibitors H[105] and I[112] (Scheme 2-16). As an oxygen bioisostere and a lipophilic hydrogen-bond 
donor, difluoromethyl group is used to increase the activity of pharmaceutical molecules via 
replacement of hydroxyl, amino and thiol groups. Among the species featuring a difluoromethyl 
group, difluoromethyl phosphonates are of particular interest because they mimic the tetrahedral 
transition state in peptide hydrolysis and act as phosphatase inhibitors. [113] 
 
Scheme 2-17 Approaches for the introduction of phosphonyldifluoromethyl group. 
Numerous methods to introduce a phosphonyldifluoromethyl group have been recently 
reported and they include addition/substitution reactions with phosphonyldifluoromethyl nucleophiles, 
processes that involve the phosphonyldifluoromethyl radical and the transitional metal catalyzed 
methods (Scheme 2-17).[114-125] In spite of the apparent need for enantioenriched biologically active 
difluoromethyl phosphonates, there are no enantioselective methods to introduce this moiety. With 
the goal of developing an enantioselective reaction for allylic phosphonyldifluoromethylation, our 
initial work commenced with the optimization of the reaction conditions for silyl difluoromethyl 
phosphonate 13 with MBH derived allylic fluoride 6a in the presence of chiral Lewis base catalyst 
(Table 2-4). 
Focus for the optimization was initially on cinchona alkaloid derived catalysts, including 
(DHQD)2AQN, (DHQD)2PHAL and (DHQD)2PYR. In the early optimization, (DHQD)2PHAL gave 
the best yield of the desired product 14a (37%, Table 2-4, entry 2) and it was chosen for focused 
optimization that focused on the identity of solvent, temperature, concentration and ratio of reaction 
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partners. DME, THF and dioxane (entr ies 5-6, 9) gave good yields at ambient temperature. Reactions 
at 0 °C resulted in slightly lower yields but higher enantiomeric ratios. Solvent mixtures of dioxane 
with DME or THF were subsequently tested, resulting in better enantioselectivity. Reaction with the 
mixture of dioxane and THF as the solvent performed the best with respect to both yield and 
enantioselectivity (47% yield, up to 98:2 er, entry 15) when two equivalents of 13 were used at 0 °C 
for 51 hours (entry 14). Further increase in the amount of the pronucleophile 13 did not improve the 
reaction outcomes (entries 16-18). 
Despite the excellent enantioselectivity, the moderate yields were a signal that kinetic 
resolution of the allylic fluoride (6a) is taking place in the presence of chiral Lewis base catalyst 
(Table 2-5). The reactions conditions were therefore optimized for the kinetic resolution of 6a and 
enantioenrichment and yields of both the starting material and the products were monitored by chiral-
HPLC and NMR. 
 
Table 2-4 Optimization for the reaction conditions . 
 
Entry Cat. (10 mol%) Sol. Ratio Concentration Tem. (°C) t (h) Yield (%)[a] er[b] 
1 (DHQD)2AQN PhCF3 1:1.3 0.2M rt 60 18 94:6 
2 (DHQD)2PHAL PhCF3 1:1.3 0.2M rt 60 37 94:6 
3 (DHQD)2PYR PhCF3 1:1.3 0.2M rt 60 30 92:8 
4 (DHQD)2PHAL DCE 1:1.3 0.2M rt 60 12 93:7 
5 (DHQD)2PHAL DME 1:1.3 0.2M rt 60 42 94:6 
6 (DHQD)2PHAL THF 1:1.3 0.2M rt 60 41 94:6 
7 (DHQD)2PHAL CycloHexane 1:1.3 0.2M rt 60 31 91:9 
8 (DHQD)2PHAL Toluene 1:1.3 0.2M rt 60 7 91:9 
9 (DHQD)2PHAL Dioxane 1:1.3 0.2M rt 60 40 93:7 
10 (DHQD) 2PHAL DME 1:1.3 0.2M 0 40 31 96:4 
16 (DHQD)2PHAL THF 1:1 0.2M 0 60 36 95:5 
11 (DHQD)2PHAL 
Dioxane:DME 
(5:1) 1:1.3 0.2M 0 40 32 97:3 
12 (DHQD) 2PHAL 
Dioxane:THF 
(5:1) 1:1.3 0.2M 0 40 35 96:4 
13 (DHQD)2PHAL Dioxane:THF (5:1) 1:1.3 0.5M 0 40 45 95:5 
14 (DHQD)2PHAL Dioxane:THF (5:1) 1:1 0.5M 0 40 44 95:5 
15 (DHQD)2PHAL Dioxane:THF (5:1) 1:1 0.2M 0 51 47
[c] 98:2 
16 (DHQD)2PHAL Dioxane:THF (5:1) 1:2 0.2M 0 88 45 96:4 
17 (DHQD)2PHAL Dioxane:THF (5:1) 1:3 0.2M 0 88 43 95:5 
18 (DHQD)2PHAL Dioxane:THF (5:1) 1:4 0.2M 0 88 38 96:4 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] Determined by HPLC analysis 
using a chiral column; [c] Isolated yield. 
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Table 2-5 Kinetic resolution of 6a and enantioselective formation of S-14. 
 
Entry t (h) Yield of S-14a[a] ee of S-14a[b] Yield of R-6a[a] ee of R-6a[b] 
1 3h  99%  10% 
2 6h  99%  22% 
3 8h  99%  29% 
4 21h  98%  68% 
5 24h  98%  73% 
6 28h 33% 98% 60% 82% 
7 31h  97%  92% 
8 46h 46% 96% 45% 96% 
9 51h 47%[c] 95% 45% 97% 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] Determined by HPLC analysis 
using a chiral column; [c] Isolated yield. 
 
 
Scheme 2-18 Kinetic resolution of allylic fluorides 6 by enantioselective phosphonyl difluoromethylation. 
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After reacting for 3 hours, small amount of S-6a was consumed, resulting in 10% ee for the 
reioslated starting material (entry 1) and excellent enantioselectivity for S-14a with 99% ee. Obvious 
increase in ee for 6a enantiomers were observed over time (10% - 97% ee) indicating that S-6a was 
continuously consumed. Only slight decrease of the enantioselectivity of the product S-14a was 
observed. The conversion of 6a and the yield of S-14a were both detected based on the monitoring by 
1H NMR in the presence of internal standard which also demonstrated that the S-6a was smoothly 
converted to the corresponding S-14a and the residual amount of R-6a (45%) and the final yield of S-
14a (47%) both maintained at around 50%.  
Upon optimization of the reaction conditions and the study of kinetic resolution, the scope of 
this reaction was evaluated for a range of allylic fluorides (6) in the presence of catalytic amount of 
chiral Lewis base (DHQD)2PHAL in dioxane/THF (5:1; 0.2M) as the solvent at 0 °C (Scheme 2-18). 
For each reaction, allylic fluoride 6 was consumed slowly to give the corresponding enantioenriched 
allylic fluoride R-6 and product S-14 which was detected by chiral HPLC and reactions were stopped 
based on the enantiomeric ratio of the residue allylic fluoride R-6. A range of esters, such as methyl, 
ethyl, n-butyl, benzyl and t-butyl esters (6a-6e), were investigated and converted to the corresponding 
products smoothly providing good yields with good selectivity (S-14a-14e , 34%-47%, 95:5 - 98:2 er). 
The allylic fluorides R-6a-6e were detected with excellent enantioselectivities (up to 99:1 er) while 
allylic fluoride with t-butyl ester group 6e  showed slightly worse enantiomeric ratio (82:18) due to the 
bulky group and lower reactivity.  
Under the optimized conditions, a series of allylic fluorides 6f-6t with electron poor aromatic 
ring were converted to the corresponding products with good yields (42% - 55%) and 
enantioselectivities (90:10 - 96:4 er). The electron withdrawing groups accelerated the reaction rates 
which shortens their reaction times. Almost every residue allylic fluoride (6f-6k) showed over 99:1 
enantiomeric ratio. Allylic fluorides featuring halogen substituents, which were also well tolerated 
under the optimal conditions, gave the products in good yields (S-14l-14n, 42% - 49%) with excellent 
degrees of stereocontrol (95:5 - 97:3 er). The remaining unreacted allylic fluorides with over 99:1 
enantiomeric ratio indicated the full conversion of the favored enantiomer of S-6. The reaction of 6p 
with a sterically demanding naphthyl moiety also provided the corresponding product in good yield 
and selectivity. The reactions with allylic fluorides bearing electron rich aromatic ring were 
subsequently carried out, however, the reaction time was longer (6q-6t) due to the inactivation by the 
electron donating groups. Nevertheless, good yields and good enantiomeric ratios (96:4 - 97:3 er) 
were obtained. Aliphatic allylic fluorides produced only trace amount of the corresponding product S-
14u and there was no conversion in the reaction of 6v even after one week. 
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Scheme 2-19 Control experiments. 
To further examine the kinetic resolution scenario of allyl fluorides 6a, (DHQ)2PHAL was 
utilized for the reaction instead of (DHQD)2PHAL under the optimized conditions (Scheme 2-19a). 
The corresponding product, the opposite set of enantiomers, R-14a was obtained in 31% yield with 
4:96 enantiomeric ratio while enantioenriched allylic fluoride, S-6a, was observed (82:12 er). 
Furthermore, enantioenriched allylic fluoride R-6j (>99:1 er) was recovered and immediately 
subjected to the standard reaction conditions in the presence of (DHQ)2PHAL as the catalyst (Scheme 
2-19b). The corresponding product R-14j was detected in 36% yield with good enantioselectivity 
(8:92 er). The deterioration of the enantiomeric ratio for the residue R-6j was also observed. 
 
Scheme 2-20 Proposed mechanism. 
The proposed mechanism is shown in Scheme 2-20. Nucleophilic addition of the Lewis base 
catalyst to the allylic fluoride results in the formation of the corresponding allylic ammonium 
intermediate i and the free fluoride ion. The favored formation of silyl fluoride facilitates the cleavage 
of silyl group to give difluoromethyl phosphonate ion which undergoes the conjugate addition to the 
ammonium intermediate i. Subsequently, the final product was obtained via the elimination of the 
Lewis base catalyst. 
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3 Lewis base catalyzed or promoted reactions with phosphonium 
intermediates 
Parts of this chapter have been published in P6) F. Schömberg, Y. Zi, I. Vilotijevic, Chem. 
Commun. 2018, 54, 3266–3269; P7) Y. Zi, F. Schömberg, F. Seifert, H. Görls, I. Vilotijevic, Org. 
Biomol. Chem. 2018, 16, 6341–6349; P8) Y. Zi, F. Schömberg, K. Wagner, I. Vilotijevic, Org. 
Lett. 2020, 22, 3407-3411; P9) Y. Zi, K. Wagner, F. Schömberg, I. Vilotijevic, 2020, submitted. 
3.1 Selective reduction of ynones 
* Fritz Schömberg has worked on this section as part of his Master and now PhD thesis. 
Pinacolborane (pinBH) is a mild hydride donor often used in catalytic reduction and 
hydroboration reactions because it’s low reactivity prevents non-catalyzed background reactions to 
occur.[126] Metal catalysts[127-129], Brønsted or Lewis acids[130-131] and Lewis bases[132] are the common 
strategies for the activation of the pinBH to act as the reducing agent. We have determined that 
pinacolborane does not produce stable Lewis adducts with common triaryl and trialkyl phosphines 
which means that these compounds constitute a non-traditional frustrated Lewis pair. This could 
allow the combination of the two to be used in simultaneous activation of small molecules with a 
Lewis base and a Lewis acid which inspired us to examine the reactions of ynones as the typical 
substrates in Lewis base catalysis, with phosphines and pinacolborane. 
We have determined that pinacolborane does not readily form Lewis adducts with 
phosphines.[133] Since pinacolborane itself is not a strong reducing agent[134] and it is not activated by 
a phosphine, we hypothesized that a nucleophilic phosphine could be used as a Lewis base catalyst 
that activates the other reacting partner in reactions involving pinacolborane. For our first trials we 
selected ynones, the quintessential substrates in Lewis base catalysis, as the starting materials. We 
anticipated that reduction (possible 1,2-, 1,4- and over-reduction products) and hydroboration (both 
alkyne and carbonyl with various regioselectivity) reactions may occur in addition to the typical 
dimerization, oligomerization and polymerization processes that ynones undergo in the presence of 
phosphines.  
To initiate our study, ynone 15a was treated with pinBH in the presence of phosphines. 
Dichloromethane was used as a non-coordinating solvent to avoid activation of pinBH by formation 
of Lewis adducts between the solvent and pinBH. With 5% PBu3 as the catalyst, the desired product 
of 1,2-reduction 16a was obtained with 62% yield while 14% of the product of 1,4-reduction 17a was 
also formed (Table 3-1, entry 1). Higher catalyst loading (20%) leads to diminished yields (Table 3-1, 
entry 2). The major products isolated from the reaction mixture were propargylic alcohol 16a, enone 
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17a and allylic alcohol together with a complex mixture of oligomers of 15a. The screen of various 
additives in the reaction mixture revealed that protic additives like water and alcohols promote the 
1,2-reductions and decrease the amount of overreduction and oligomerization products. i-PrOH and t-
BuOH proved to be the best additives affording 16a in yields of 94% and 90% respectively when 1.5 
equiv. of the additive was used.  
Table 3-1 Effects of additives on reaction selectivity and isolated yield of the 1,2-reduction product. 
 
 
Entry t-BuOH (X equiv.) 16a (%)[a] 17a (%)[a] 15a (%)[a] 
1 - 62 14 24 
2[b] - 39 13 7 
3 0.5 81 12 3 
4 1.1 89 0 0 
5 1.5 90 0 0 
6 2.1 86 0 0 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] 20 mol% of Pbu3 was used. 
 A set of commercially available phosphines were tested as the catalysts to reduce the ynones 
(Table 3-2). PPh3 and PMePh2 failed to reach full conversion even after longer reaction times (entries 
1-2). Trialkyl phosphines proved more efficient with both PBu3 and PMe3 effecting the complete 
consumption of ynones within 10 minutes and affording the desired products in high yields (entries 5-
6). PCy3 and P(t-Bu)3 showed decreased activity (entries 3-4). These results suggest that the 
nucleophilicity of the phosphine plays an important role in these reactions making the more 
nucleophilic, not sterically hindered trialkyl phosphines ideal for this application.  
Table 3-2 Optimization of the phosphine catalyst. 
 
Entry PR3 Reaction time 
Yield (%)[a] 
16a 15a 
1 PPh3 24 h 55 28 
2 PMePh2 24 h 68 10 
3 PCy3 24 h 14 23 
4 P(t-Bu)3 24 h 3 89 
5 PMe3 10 min 89 0 
6 PBu3 10 min 89 0 
[a] Yield determined by 1H NMR spectroscopy of crude product mixtures after quenching reactions at designated time point 
using triphenylmethane as internal standard.  
Under the optimized conditions various propargylic alcohols were obtained in good yields 
(Scheme 3-1). The scalability was tested with a gram-scale reduction of 15a which proceeded 
efficiently with no deterioration of the yield. Both aryl and alkyl substituents in the α’-position of the 
ynone were well tolerated (16a-16f). The increasing steric bulk at the α’-carbon led to decrease in 
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reaction rates (16g). Ynones with both aryl and alkyl groups in α-position gave the propargylic 
alcohols in good yields. With the increase of the steric demand for the α-substituent, the reaction rates 
dropped. Although 16c afforded the desired product in 80%, the reaction rate for the substrate 16d 
with the t-butyl substituent in α-position was too low for the reaction to be synthetically useful. The 
diastereoselectivity of the reduction reaction was tested with ynones containing a stereogenic center 
in the α-position. 15r produced the desired propargylic alcohol, a 1.6:1 mixture of diastereomers, with 
a combined yield of 96% while 15s  and 15t gave a 1.5:1 mixture and 2.1:1 mixture respectively.  
Electron rich (16h) and electron deficient ynones (16i-16m) provided the desired alcohol 
products with high rates and good yields (74% - 93%). The different in reaction rate for electron rich 
and electron poor ynones was noticeable and showed that the more electrophilic substrates react faster 
presumably due to the higher rate of the reaction with the nucleophilic phosphine. Various 
heterocycles, including furan, thiophene and protected indole (16n-16q), gave the desired products 
with good yields too (83% - 91%).  
 
Scheme 3-1 Reaction scope for the phosphine catalyzed ynone reduction with pinacolborane . 
As shown in Scheme 3-1, alkene, nitro, carbamate, amide, ester and nitrile substituents in the 
ynone did not undergo reduction or hydroboration. When ynones containing other ketones in the 
molecule were used, the ynones were selectively reduced although minor quantities of the 
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corresponding diol were also observed (16v-16x, 74% - 91%). When benzylic aldehydes were present 
in the starting ynone, chemoselective reduction of the aldehyde was observed.  
 Further intermolecular competition experiments were conducted with ketones and ynones 
(Scheme 3-2a). Ynone 15a undergoes 1,2-reduction in the presence of phosphine and pinacolborane. 
When phosphine is not present, ynone did not undergo reduction or hydroboration with pinacolborane. 
Simple ketones, like acetophenone and cyclohexane, also did not undergo reduction of hydroboration 
in the presence of phosphine and pinacolborane. In the competition experiments, when ynone and 
ketone are present in equimolar amounts ynones (Scheme 3-2b), however, the ynone undergoes 
reduction but reduction of the ketone is seen too, although in minor quantities. The deuterium labeling 
experiments ynones (Scheme 3-2c) demonstrated that the reducing hydride originates entirely from 
the pinacolborane. Together, these experiments are an indication that pinacolborane itself is not the 
active reducing agent in the reaction. The more likely reductant would be an activated borohydride 
that is only produced when the ynone is present in the reaction mixture.  
Scheme 3-2 a) Evaluation of the intramolecular competition experiment; b) Evaluation of Lewis base catalyzed 
reduction of ketones and ynones with mild  hydride donors ; c) Labelling and product studies of 1,2-reduction of 
ynones. 
We proposed two mechanistic scenarios outlined in Scheme 3-3. Zwitterionic intermediate iii 
could be formed from ynone 15a in the presence of phosphine.[1, 135] The nucleophilic addition of 
phosphine catalyst to ynone followed by protonation by the protic additive provides vinyl-
phosphonium salt v and tert-butoxide anion iv (Scheme 3-3, cycle A). The coordination of tert-
butoxide to pinBH could then generate the activated hydride vi which could reduce the carbonyl 
group of vinyl-phosphonium salt to produce allylic alcoholate vii.[132] Proton transfer could occur in 
the presence of protic additive subsequently to form the intermediate viii which could provide the 
desired propargylic alcohol via the liberation of the phosphine to start another catalytic cycle. 
Phosphonium cation results in the higher reactivity of vinyl-phosphonium salt intermediate. It makes 
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the vinyl-phosphonium salt more prone to accept the hydride which could explain the high selectivity 
for 1,2-reduction while the 1,4-reduction could be hindered by the steric phosphonium ion. 
Considering the activated hydride vi could also reduce the starting ynone directly which was 
confirmed by a simple experiment where t-BuOK was used as the catalyst instead of the phosphine, a 
simpler mechanism was proposed (Scheme 3-3, cycle B). The hydride source vi could simply reduce 
the ynone and produce a new alcoholate ix which could activate pinBH subsequently or get 
deprotonated by the protic additive to generate the final propargylic alcohol. Both pathways are 
possible and maybe operate in parallel. And the activation of pinBH via alcoholate anion is clearly 
required in this kind of 1,2-reduction of ynones.  
 
Scheme 3-3 Proposed mechanisms for the phosphine catalyzed 1,2-reduction of ynones to propargyl alcohols . 
The quenching of the zwitterionic intermediate iii plays a key role in suppressing the 
oligomerization and overreduction pathways that take place in the absence of an additive (Scheme 
3-4). In the presence of alcohols, this intermediate is protonated and the alkoxide coordinates to 
pinacolborane to produce the proposed activated hydride donor vi. The intermediate iii, as an O-
centered Lewis base, may directly interact with pinBH to provide intermediate x. As a base, iii could 
also deprotonate starting ynone if acidic protons are present in α-position. This generates enolate xi 
and vinyl-phosphonium ion v with increased electrophilicity owing to its cationic character. The 
different selectivity for reduction observed in reactions carried out in the presence and without protic 
additive may originate from the differences in reactivity of the activated hydride donor (vi vs. x or 
xii).  
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Scheme 3-4 Possible Lewis bases to activate the pinBH. 
 
3.2 Lewis-base catalyzed trans-hydroboration of ynoates with pinacolborane 
* Fritz Schömberg has worked on this section as part of his Master and now PhD thesis. 
To understand the differences between the selectivity observed in reactions carried out with 
and without the protic additive, we turned our attention to the reactions without additives. In the 
absence of protic additive, pinBH could potentially be activated by two different enolates iii and xi. 
To simplify the model system, we looked into the reaction of diaryl ynone 15b that can only produce 
enolate of type iii because it lacks acidic protons in α and α’ positions. 
Table 3-3 Phosphine-catalyzed reactions of ynone 15b with pinBH. 
 
Entry Conditions 16b (%)[a] 17b (%)[a] 21 (%)[a] 
1 DCM, rt, t-BuOH (1.5 euiv.) 87 - - 
2 DCM, rt < 3 - - 
3 DCE, reflux - 77[b] - 
4 THF, reflux < 3 56[b] 23[b] 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] Isolated yields. 
Ynone 15b could be selectively reduced to the corresponding propargyl alcohol 16b in 87% 
yield in the presence of t-BuOH as the protic additive (Table 3-3, entry 1). However, only trace 
amount of 16b was observed in the absence of protic additive even prolonging the reaction time to 4 
hours. At elevated temperature, in refluxing DCE, only enone 17b, the product of 1,4-reduction, was 
obtained. When the reaction was carried out in refluxing THF, enone 17b was isolated as the major 
product in 56% yield. The product of hydroboration, 21, was observed in both reactions as a minor 
component.  
Knowing that the esters are less prone to reductions with pinacolborane in the presence of 
phosphines, we hypothesized that ynoates may be suitable substrates for the development of 
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phosphine catalyzed hydroboration protocols. Ethyl phenyl propiolate 22a underwent hydroboration 
with pinBH in the presence of PBu3 as the catalyst. The characterization data for vinyl boronate 23a 
did not match the presumed Z-configuration of the double bond that would arise via the typical syn-
hydroboration. Instead, the NOESY spectra of 23a (Scheme 3-5) showed a cross peak between the 
vinylic proton and aryl protons establishing suggesting that E-olefin 23a has been produced via an 
unusual trans-hydroboration process. This assignment was later confirmed via X-ray crystallography 
for a heavier analog of 23a (23j, Scheme 3-6). 
 
 
Scheme 3-5 Initial experiments on phosphine catalyzed trans-hydroboration of 22a and the NOESY spectrum of 23a. 
Several transition metal catalyzed approached to trans-selective hydroboration of terminal 
alkynes have been reported. [136-139] This type of transformation on internal alkynes were limited to 
ruthenium (II) catalyzed hydroborations[140-141] that suffer from low regioselectivity and those that are 
directed by a pyridyl-group or an alkene.[142-144] Since these approaches cannot be applied to electron 
deficient alkynes, such as ynones or ynoates, we further developed the phosphine catalyzed trans-
hydroboration of ynoates. 
Initial screening of solvents showed that the reaction performed the best in DCM and DCE 
(Table 3-4, entries 1-2) while the use of Et2O, THF and toluene resulted lower yields (entr ies 3-5). 
Notably, higher temperature accelerated the reaction rate to generate the product in comparable yield 
as the reaction at room temperature (entry 6). Increasing the amount of pinBH did not further improve 
the yield. 
As the catalyst is crucial (Table 3-4, entry 17), a variety of Lewis bases were investigated as 
the catalysts to conduct the trans-hydroboration of ynoates. Trialkyl phosphines proved to be the most 
efficient. PBu3 and PMe3 generated 23a as the only product with comparable yields and excellent E/Z 
selectivity (>99:1, determined by 1H NMR). Furthermore, by using PBu3 as the catalyst, the loading 
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could be reduced to 2 mol% without significantly affecting the yield (entry 9). Less nucleophilic 
phosphines, like methyl diphenyl phosphine, provided the product in lower yield (12%) and lower 
selectivity (E/Z = 81:18). Bulky and significantly less nucleophilic phosphines, such as 
triphenylphosphine and tri-tert-butyl phosphine, failed to afford the desired product (Table 3-4, 
entries 11-12). Comparison of phosphines demonstrated the important role of catalyst’s 
nucleophilicity in this reaction. Other types of catalysts, such as O- and N-centered Lewis bases, were 
also tested (entries 13-16) but no reaction was observed, presumably because of the formation of 
Lewis adducts between the O- and N-centered Lewis bases and pinBH. 
Table 3-4 Optimization for phosphine catalyzed trans-hydroboration of ynoate 22a. 
 
Entry Cat. (5 mol%) Sol. Tem. (°C) t (h) Yield (%)[a] 
1 PBu3 DCM rt 4 92 (83[b]) 
2 PBu3 DCE rt 4 93 
3 PBu3 Et2O rt 4 45 
4 PBu3 THF rt 4 66 
5 PBu3 PhMe rt 4 64 
6 PBu3 DCE reflux 2 94 
7 PMe3 DCM rt 4 90 
8 PBu3 DCM rt 4 92 (83[b]) 
9[c] PBu3 DCM rt 8 88 
10 PMePh2 DCM rt 4 12 (E/Z = 82:18) 
11 PPh3 DCM rt 4 NR 
12 P(t-Bu)3 DCM rt 4 NR 
13 DABCO DCM rt 4 NR 
14 DBU DCM rt 4 NR 
15 N-methyl pyrrolidine DCM rt 4 NR 
16 t-BuOK DCM rt 4 NR 
17 none DCM rt 24 NR 
[a] NMR yields with triphenylmethane as the internal standard; [b] Isolated yields; [c] 2 mol% of PBu3 was used. 
A series of aryl ynonates was used to evaluate the reaction scope (Scheme 3-6). Electron rich 
substrates reacted well to produce the corresponding vinyl boronates in yields between 70% and 96% 
(23a-23d). Lower yield observed for 23e (40%) indicated that the reaction is sensitive to steric 
hindrance by the ortho-methoxy group. Aryl halides were tolerated well (23g-23k, up to 86% yield). 
Electron deficient ynoates showed lower reactivity and gave lower yields although E/Z selectivity 
remained high (22m–22n, E/Z > 99:1). Strongly electron withdrawing substituents reduced the 
reactivity of the ynoates to the level where no reaction was observed. Lower reaction rates of electron 
deficient ynoates prompted further optimization of the conditions. The use of DCE allowed increase 
of the reaction temperature which increased the reaction rates and, in most cases, resulted in higher 
yields while maintaining high selectivity (>99:1). Disappointingly, the products 23o and 23p could 
not be observed at elevated temperatures either. 
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Scheme 3-6 trans-Hydroboration of ynonates. [a] NMR yields with Ph3CH as the internal standard and isolated 
yields (in brackets) for react ions in DCM at rt; [b ] NMR yields and isolated yields (in brackets) for reactions in 
DCE at reflux; [c] 4,4,6-trimethyl-1,3,2-dioxaborinane was used instead of pinacol borane.  
 
Table 3-5 Influence of protic additive on yield and selectivity. 
 
Entry t-BuOH (Y equiv.) PBu3 (X mol%) t (h) Yield 23a (%)[a] Yield 24a (%)[a] 
1 0 5 4 92 - 
2 1.25 5 4 68 10 
3 2 5 4 <1 5 
4 1.25 20 4 62 8 
5 2 20 4 53 7 
6 10 20 4 <1 6 
7 10 100 4 <1 7 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard. 
Ynoates 22q and 22r also underwent the hydroboration, although with lower yields (64% and 
49%) and decreased E/Z selectivity, despite featuring the acidic protons in γ position. This prompted a 
closer inspection of the reaction sensitivity to protic additive. Control experiments demonstrated that 
the reaction outcome is affected by the amount of protic additive in the mixture (Table 3-5). As the 
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amount of t-BuOH in the reaction mixture increased, yields became lower. This effect could be off-
set to a certain extent by increasing the amount of PBu3 (entries 4-7). The common side product in 
these reactions was 24a, the product of simple 1,4-reducton. The trans-hydroboration was suppressed 
by the protic additive presumably due to the quenching of the enolate intermediate and formation of a 
stable vinyl phosphonium salt. 
The proposed mechanism features an intramolecular hydride transfer in intermediate xiv 
which is formed via the activation of pinBH by the zwitterionic intermediate xiii, generated from the 
nucleophilic addition of phosphine to ynoate (Scheme 3-7a). The hydride transfer is made possible by 
the presence of a vinyl phosphonium motif which leads to the formation of the phosphorus ylide xv. 
Allylic anion resonance allows isomerization of the double bond to form the E-configured 
intermediate xvi. Intramolecular boronate transfer to C3 position occurs via intermediate xvii 
followed by the E1cb elimination of phosphine to liberate the product. The strong interaction between 
the boronate and carbonyl oxygen in xvii is crucial for high selectivity and if disrupted, for example 
by protic additives, it leads to deterioration of selectivity. 
 
Scheme 3-7 Proposed mechanism, labeling and product studies of trans-hydroboration of ynoates . 
This mechanistic proposal is further supported by a series of control experiments. These 
experiments confirmed that the hydride from pinacolborane is exclusively incorporated at the C2 of 
the product (Scheme 3-7b). Furthermore, enoates do not undergo hydroboration likely because of the 
inability of the hydride transfer within the saturated analog of the vinyl phosphonium ion xiv (Scheme 
3-7b). The 1,4-reduction product 24a, does not originate from proteodeborylation of the vinyl 
boronate product 23a (Scheme 3-7c) and it is more likely formed via the direct 1,4-reduction of the 
ynoate 22a.  
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3.3  Z-selective reduction of ynoates with phosphine and water  
Knowing that 1,4-reduction occurs with ynoates in the presence of protic additives, called for 
a closer inspection of these reactions and suggested that this pathway may be controlled by the protic 
additive. We have determined that 1,4-reduction pathway depends on the amount of phosphine 
present in the reaction mixture and that water further promotes these reactions. We have further 
evaluated the reactions of ynoate 22b in various solvents and in the presence of different phosphine 
and discovered that the reactions are, in fact, stoichiometric in phosphine and Z-selective (Table 3-6).  
Table 3-6 Screening of solvents . 
 
Entry Sol. PR3 (X equiv.) Yield (%)[a] E/Z 
1 MeCN PBu3 (1.1) 0 - 
2 Isopropanol PBu3 (1.1) 0 - 
3 DMF PBu3 (1.1) 5 1:4 
4 DMSO PBu3 (1.1) 2 1:20 
5 THF PBu3 (1.1) 12 1:2 
6 1,4-Dioxane PBu3 (1.1) 18 1:5 
7 1,4-Dioxane PBu3 (2) 8 1:0 
8 1,4-Dioxane PBu3 (3) 8 1:0 
9 1,4-Dioxane PPh3 (1.1) 55 1:2 
10 1,4-Dioxane PPh3 (2.2) 57 1:2 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard. 
Further optimization of these reactions was carried out by other group members and their 
work resulted in the development of highly Z-selective method for reduction of ynoates that use 
equimolar amounts of ynoate, tributyl phosphine and water.  
The mechanistic proposal for the reduction reactions placed vinyl phosphonium hydroxide in 
the spotlight and highlighted the possibility that these reactions proceed via pentavalent phosphorus 
intermediates that result from nucleophilic attack of the hydroxide on the phosphonium ion. While 
other group members focused on the reactivity of such vinyl phosphonium ions, my attention was 
directed to reactivity of the aryl phosphonium ions. 
 
Scheme 3-8 Examples for selective reduction of activated alkynes to Z-olefins.  
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3.4 C-H functionalization of (benzo)thiazoles via aryl-phosphonium salt 
*The work of this section was completed together with Konrad Wagner and Fritz Schömberg by equal contribution. 
Benzothiazole-2-phosphonium salts were prepared by Konrad Wagner. 
The pioneering work on the synthesis and use of heteroaryl phosphonium salts has been 
published by Anders and revisited by the recent work of McNally and coworkers. [145-157] Their work 
has focused almost exclusively on azines. Our attention was, in contrast, directed towards azoles and 
the possibility to develop a metal free method for C-H functionalization of thiazoles, in particular.  
 
Scheme 3-9 Examples for thiazole containing molecules . 
Thiazoles have attracted much attention due to the wide application in biological,[158-164] 
material fields[165] and organic synthesis[166-168]. As the most common 5-membered aromatic nitrogen 
heterocycle in FDA approved drugs,[169] thiazoles are omnipresent in mandersedicinal chemistry. For 
example, they are a part of Abafungin (antifungal drug), sulfathiazole (antimicrobial drug) and 
Tiazofurin (antineoplastic drug).[170] Their derivatives exhibit a wide range of biological activities  
including the nicotinic-acetylcholine-receptor ligand J[171], the inhibitor of all trans-retinoic acid 
metabolism K[172], aldolase reductase inhibitor L[173], the potent and selective ACC2 (acetyl-CoA -
carboxylases) inhibitor M[174], Cathepsin-D inhibitor N and PPAR receptor activator O[175-178]. 
Although most of these molecules feature a heteroatom substituent at C2, the methods to perform C2-
H functionalization of thiazoles and benzothiazoles remain limited mostly to those that proceed under 
extremely high temperature and are therefore not suitable for use in more complex settings like 
medicinal chemistry. 
Considering the ease of synthesis of thiazolyl-phosphonium salts,[179-180] we hypothesized that, 
similar to what we have observed with vinyl phosphonium salts, such salts can be useful 
intermediates on the path for overall C-H functionalization of thiazoles and benzothiazoles. Upon 
preparing the benzothiazole-2-phosphonium salt 25a following the protocol by Anders, initial 
optimization of the reaction conditions was carried out with focus on the reactions with benzyl 
alcohol (Table 3-7). Base activation of the nucleophile was required for the synthesis of the 
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corresponding ether. A screen of different bases used for activation of the alcohol revealed that 
sodium hydride performs well in THF and generates the least amount of waste. Optimization of 
solvent showed that the reaction in THF, Et2O and toluene performed the best (entries 13-20). Higher 
yield was obtained when the amount of benzyl alcohol, as well as NaH as the base, increased to 1.5 
equivalents while 2 equivalents resulted in a slightly diminished yield (entries 21-23).  
Table 3-7 Simple optimization. 
 
Entry Base (X equiv.) 26m (equiv.) Sol. Tem. (°C) Yield (%)[a] 
1 NaH (1.0) 1.0 THF 0 °C - rt 55 
2 n-BuLi (1.0) 1.0 THF -78 °C - rt 44 
3 LDA (1.0) 1.0 THF -78 °C - rt 29 
4 i-PrMgBr (1.0) 1.0 THF -78 °C - rt Trace 
5 t-BuOK (1.0) 1.0 THF -78 °C - rt Trace 
6 Et3N (1.0) 1.0 THF rt Trace 
7 DBU (1.0) 1.0 THF rt 34 
8 DMAP (1.0) 1.0 THF rt Trace 
9 DABCO (1.0) 1.0 THF rt Trace 
10 NaH (1.0) 1.0 Et2O 0 °C - rt 55 
11 NaH (1.0) 1.0 Dioxane 0 °C - rt 29 
12 NaH (1.0) 1.0 n-Hexane 0 °C - rt 16 
13 NaH (1.0) 1.0 Toluene 0 °C - rt 56 
14 NaH (1.0) 1.0 DCE 0 °C - rt Trace 
15 NaH (1.0) 1.0 MTBE 0 °C - rt 11 
16 NaH (1.0) 1.0 Chlorobenzene 0 °C - rt 37 
17 NaH (1.0) 1.0 PhCF3 0 °C - rt 40 
18 NaH (1.25) 1.25 THF 0 °C - rt 55 
19 NaH (1.5) 1.5 THF 0 °C - rt 80[b] 
20 NaH (2.0) 2 THF 0 °C - rt 75 
[a] NMR yields based on crude mixtures with triphenylmethane as the internal standard; [b] Isolated yields 
Under the optimal conditions, a range of alcohol nucleophiles were efficiently introduced to 
the benzothiazole-2-phosphonium salt (25a) (Scheme 3-10). Aliphatic alcohols, including primary, 
secondary and tertiary alcohols were investigated first under the optimal conditions producing 
moderate to good yie lds (27a-27l, 34% - 91%). Lower yields were seen with long alkyl chain primary 
alcohols and allylic alcohols. Benzyl alcohol performed well to convert to the corresponding product 
in 80% yield (27m). Halogen groups or extended conjugation system were well tolerated (27n-27o) 
and gave up to 99% yields while electron withdrawing substituents decreased the yield (27p, 42%) 
which was attributed to the lower nucleophilicity of the alcohol. Secondary benzyl alcohols showed 
comparable yields (27q-27r, 72% and 73%). Phenols bearing electron donating and electron 
withdrawing substituents produced the desired products under the standard conditions in good yields 
(59-99%) which were not affected by the steric variations (27s-27af). Halogens and cyano groups 
were tolerated well under these conditions even for multi substituted substrates (27ac-27af, 59% - 
66%). As to demonstrate the utility of this protocol, menthol and cholesterol were also tested which 
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also gave the corresponding products in moderate yields (42% for 27ag and 64% for 27ah). When 
hydroquinone was used, the product of mono substitution was produced in 75% yield (27ai). 
 
Scheme 3-10 Scope study of 25a with alcohol nucleophile. 
 
Scheme 3-11 Scope study of 25a with N-centered nucleophile. 
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Scheme 3-12 Scope study of 25a with S-centered nucleophile. 
N-nucleophiles, including anilines and heterocycles, proved to be reactive under similar 
conditions. The products were isolated in moderated to good yields (29b-29o) under the optimized 
conditions using NaHMDS instead of NaH (Scheme 3-11). A range of reactive groups, such as cyano 
(29i, 85%), nitro (29j, 90%) and halogen (29k, 82%), were well tolerated in these processes. 
Deprotection happened partially to acetyl aniline and benzoyl methyl amine under the basic 
conditions to give the corresponding products or the deprotected ones (29a, 29p). Steric effect played 
a role in lowering the yields when imidazole derivatives with substitution at position 2 were utilized 
(29l-29m, 24% and 14%). Phenyl group in imidazole motif diminished the yield dramatically. 1-H-
Pyrazole was also used as a competent reagent for this process and provided moderate yield (29o, 
54%). 
 
Scheme 3-13 Scope study of 25a with diselenide. 
Thiols were subsequently taken into consideration (Scheme 3-12). Excellent yields (up to 
99%) were achieved from primary, secondary and tertiary alkyl thiols (31a-31h) while only 21% 
yield of 31d was obtained due to its self-assembling reaction. Thiophenols featuring electron rich and 
electron poor groups provided the product in good to excellent yields (31i-31u, 65% - 99%). Halogen 
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substituted thiophenols showed good performance and all para-, meta- and ortho- substitutions (31n-
31p) resulted in comparable yields which indicated the slight influence of steric effect on this process. 
Despite the hindered groups of 2,6-dimethylthiphenol, 93% yield was still achieved (31l). 
Thiophenols featuring heteroaryl substitution or extended conjugation system were well tolerated (65% 
for 31t and 90% for 31u). Two benzothiazoles were introduced to 30v generating 31v in 66% yield. 
Gratifyingly, diselenide, treated with NaH, could afford the corresponding product in good yield as 
well (32, Scheme 3-13, 77%). 
 
Scheme 3-14 Extended scope for C-hetero atom bond formation. 
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Besides the investigation of commonly used nucleophiles, a series of substituted thiazole-2-
phosphonium salts were also evaluated to assess the versatility of the method (Scheme 3-14). 4-MeO-
phenol, 5-NO2-indole and octanethiol were then selected as model nucleophiles to further investigate 
this protocol. It was found that both thiazole-2-phosphonium salt and substituted benzothiazole-2-
phosphonium salts with electron donating groups, halogen or electron withdrawing groups were 
suitable for this transformation in the presence of alcohols (Scheme 3-14a, 39% - 99%), amines 
(Scheme 3-14b, 51% - 99%) and thiols (Scheme 3-14, 80% - 99%), and the corresponding products 
were obtained in good to excellent yields.  
Iminophosphorane (33) was obtained (56% yield) while aniline was treated in the presence of 
NaHMDS which promoted us to consider about the preliminary mechanism. As shown in Scheme 3-
15, the first step of the nucleophilic attack occurred when the phosphonium salt was added to the 
aniline anion system to produce the phosphorane 34. The other proton of aniline was deprotonated 
under the basic conditions after which, the second nucleophilic attack happened to release the 
iminophosphorane. 
 
Scheme 3-15 Iminophophorane from the reaction of 99a with aniline and the proposed pathway. 
Inspired by the result, we hypothesized that the use of water as the nucleophile (as hydroxide 
ion) would result in reduction of the thiazole and the formation of phosphine oxide. Experiments 
using only slight excess of sodium deuteride demonstrated that this indeed is the case. The specific 
C2 deuterium labeling with 97% yield and higher than 98% deuterium incorporation was observed 
when salt 25a was used (Scheme 3-16). The process also appears general as benzothiazoles with both 
electron-donating and withdrawing substituents undergo efficient C2 labeling (35b-35d). 
 
Scheme 3-16 Synthesis of deuterated heterocycles . 
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4 Summary and conclusion 
The aim of this thesis was to develop solutions to overcome the common problem related to 
nucleophile scope in Lewis base catalyzed reactions and, by doing so, develop new synthetic methods 
and generate new knowledge and deeper understanding of these processes and reactivity of the 
involved molecular species.  
Relying on the strategies used in previous reports of Lewis base catalyzed allylic substitutions 
using N-H acidic nucleophiles, we have expanded the scope for these reactions to allylation of 
anilines that have been considered insufficiently N-H acidic for applications in such reactions.[66] The 
enantioenriched products obtained in reactions that use chiral cinchona alkaloid based catalysts, have 
been used in enantio- and diastereoselective synthesis of β-lactams (Scheme 4-1a) structurally similar 
to those determined to be low nM binders of tubulin[68-70] and therefore considered potential treatment 
for cancer (Scheme 2-3).  
 
Scheme 4 -1 Lewis base catalyzed allylic substitutions with latent (pro)nucleophiles and examples of application 
of the newly developed methods in stereoselective synthesis of biologically relevant molecules.  
The analogous strategy was not applicable for N-allylation of pyrroles which highlighted the 
need for a new approach to further expand the scope of Lewis base catalyzed reactions. The solution 
came in the form of the concept of latent nucleophiles, the molecules that are not (or not strongly) 
nucleophilic but can be activated to act as a nucleophile at an opportune time during the reaction. We 
have focused on the development of this concept for N-centered nucleophiles and the use of N-silyl 
compounds, where the silyl group attenuates the nucleophilicity of the parent N-H compound, as 
latent nucleophiles in Lewis base catalyzed reactions. The necessity for activation of such latent 
nucleophiles during the reaction made the molecules that feature fluoride as a leaving group their 
logical reaction partners in Lewis base catalyzed reactions.  
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The proof of principle study for the concept of latent nucleophiles was the development of 
enantioselective N-allylation of N-silyl pyrroles, indoles and carbazoles using allylic fluorides. These 
reactions proceed with excellent regioselectivity with respect to both reaction partners and expand the 
scope of Lewis base catalyzed allylic substitutions to otherwise problematic nucleophiles (Scheme 2-
11). This new method for enantioselective synthesis of N-allyl pyrroles enabled the first enantio- and 
diastereoselective synthesis of substituted pyrrolizin-1-ones (Scheme 4-1b) that have been shown to 
exert anti-amyloid and radical scavenging effects.  
Further application of the concept of latent nucleophiles in Lewis base catalysis was pursued 
with C-centered nucleophiles and in particular the diethyl (difluoro(trimethylsilyl)-methyl) 
phosphonate as a reagent for introduction of difluoromethyl phosphonate moiety to organic molecules 
(Scheme 1c). Lewis base catalyzed reactions of this reagent with allylic fluorides resulted in the first 
enantioselective phosphonyldifluoromethylation and synthesis of molecules that are considered 
bioisosteres of organic phosphates. The presence of difluoromethyl group allowed for improved 
diastereoselectivity in the subsequent reactions of the enantioenriched difluoromethyl phosphonate 
products.  
In contrast to the work with N-centered Lewis base catalysts, the work presented in this thesis 
on reactions catalyzed by P-centered Lewis bases was focused on the possibility of simultaneous dual 
activation of small organic molecules with Lewis acids and Lewis bases that do not form stable Lewis 
adducts and constitute non-traditional frustrated Lewis pairs.  
Pinacolborane and tributyl phosphine, the two materials that do not form stable Lewis 
adducts, have been used in selective transformation of ynones and ynoates, the common substrates in 
lewis base catalyzed reactions. We have discovered that, in the presence of protic additive, ynones 
undergo highly selective 1,2-reduction reactions to produce the corresponding allylic alcohols 
(Scheme 4-2a). Mechanistic investigation of these reactions highlighted that the formation of vinyl 
phosphonium intermediate and the activation of pinacolborane with the O-centered Lewis base 
derived from the protic additive play important roles in control of selectivity in these reactions.  
Despite the apparent similarities of ynones and ynoates, they show diverse reactivity with 
pinacolborane in the presence of phosphine catalysts. We have discovered and developed the atypical 
trans-hydroboration of alkynes in ynoates that is catalyzed by phosphines (Scheme 4-2b). These 
reactions proceed with high regio and diastereoselectivity and the mechanistic studies have shown 
that the vinyl phosphonium intermediates play an important role in these reactions too.  
The work on the development of 1,2-reduction of ynones and trans-hydroboration of ynoates 
highlighted the versatile reactivity of vinyl phosphonium salts and inspired further studies involving 
these types of intermediates. The first in line were the 1,4-reductions of ynoates using stoichiometric 
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quantities of phosphines and water which were shown to be highly Z-selective (Scheme 4-2c) which 
contradicted the previous reports that these types of reactions produce E-alkenes.[181] 
 
Scheme 4-2 Newly developed phosphine catalyzed  or phosphine promoted reactions involving viny l- or aryl 
phosphonium ions as catalytic or synthetic intermediates.  
Interest in reactivity of vinyl phosphonium ions informed the interest in reactivity of aryl 
phosphonium ions. In this area, we have shown that thiazoles and benzothiazoles undergo 
regioselective C2-H functionalization with triphenylphosphine to form thiazol-2-yl-
triphenylphosphonium salts and that these salts undergo efficient substitution reactions with N-, O-, S- 
and Se-centered nucleophiles to introduce various heteroatom substituents in the C2 position of 
thiazoles and benzothiazoles (Scheme 4-2d, e). The two-step sequence features a truly broad scope 
for various nucleophiles including secondary amines, amides, pyrroles, indoles, imidazoles, pyrazoles 
and related N-heterocycles, alcohols, phenols, thiols, thiophenols and selenides, and it constitutes an 
effective method for C-H functionalization of the parent thiazoles and benzothiazoles, the most 
common five membered N-heterocycles in FDA approved drugs.[169]  
The newly developed synthetic methods presented in this thesis have already found 
application in synthesis of biologically relevant molecules, but, more importantly, they set the 
foundation for further applications of similar ideas and concepts in a variety of other Lewis base 
catalyzed or Lewis acid promoted reactions.  
 
Chapter 5. Zusammenfassung und Schlussfolgerungen 
        52 
 
5 Zusammenfassung und Schlussfolgerungen 
Im Rahmen dieser Arbeit sollten Lösungsansätze entworfen und etabliert werden, um 
Probleme bezüglich nukleophiler Reaktanden bei Lewis-Base-katalysierten Reaktionen zu umgehen. 
Ausgehend davon sollten neue synthetische Strategien entwickelt werden, um ein tieferes Verständnis 
der Prozesse zu erlangen, welche sich auf molekularer Ebene ereignen.  
Basierend auf bereits etablierten Protokollen für die Allylierung von N-H-aciden 
Nukleophilen in der Lewis-Base-Katalyse konnten im Rahmen dieser Arbeit Nukleophile verwendet 
werden, welche zuvor als unreaktiv eingestuft worden sind. [66]  Unter Verwendung wurden die 
Allylierungsprodukte in enantioselektiver Weise erhalten und anschließend diastereoselektiv in β-
Lactam-Derivate überführt (Schema 5-1a). Analoge Verbindungen zeigten in bereits veröffentlichten 
Studien eine hohe Affinität zu Tubulin[68-70] weshalb sie potenziell zur Behandlung von Krebs 
eingesetzt werden könnten. (Schema 2-3).  
 
Schema 5-1 Lewis-Base-katalysierte, ally lische Substitution mit latenten (Pro) -Nukleophilen und Beispiele für 
die Anwendungen dieses Konzeptes für die stereoselektiven Synthesen von biologisch relevanten Molekülen.  
Eine analoge Strategie ließ sich nicht in dieser Arbeit für die N-Allylierung von Pyrrolen 
entwickeln. Dies unterstreicht die Notwendigkeit einer neuen Reaktionsmethodik für die Lewis-Base-
katalysierte Reaktionen, um deren Anwendbarkeit zu steigern. Als Lösungsansatz wurde hierbei das 
Konzept der latenten Nukleophile entwickelt und angewendet. Dies basiert auf Molekülen, die selbst 
nicht (oder schwach) nukleophilen Charakter zeigen, aber in Gegenwart eines geeigneten Stimulus im 
Verlaufe der Reaktion aktiviert werden können (sog. Latente Nukleophile).  Der Fokus lag hierbei auf 
der Entwicklung des Konzeptes bezüglich N-zentrierter Nukleophile, wobei die Latenz durch eine 
siliziumbasierte Schutzgruppe induziert werden sollte.  Die Notwendigkeit einer Aktivierung 
prädestiniert Moleküle, welche Fluorid als Abgangsgruppe tragen, zu geeigneten Reaktionspartnern 
für Lewis-Base-katalysierte Reaktionen.  
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Zur Demonstration des Konzeptes der latenten Nukleophile wurde die enantioselektive N-
Allylierung von Silylpyrrolen, -Indolen und -Carbazolen mit allylischen Fluoriden untersucht. Diese 
Reaktionen zeigten exzellente Regioselektivitäten bezüglich beider Reaktionspartner und erweitern 
drastisch die Anwendbarkeit allylischer Substitutionen unter Lewis-Base-Katalyse besonders für jene 
Nukleophile die zuvor als nicht verwendbar angesehen worden sind. (Schema 2-11). Diese neue 
Methode für die enantioselektive N-Allylierung von Pyrrolen erlaubte auch die erste enantio- und 
diastereoselektive Synthese von substituierten Pyrrolizin-1-onen (Schema 5-1b), einer Substratklasse 
die sich durch ihre anti-amyloide und radikalfangenden Eigenschaften auszeichnet.   
Weiterhin wurden latente Nukleophile für C-zentrierte  Nukleophile, in diesem Fall das 
Diethyl(difluoro(trimethylsilyl)methyl)phosphonate, als Reagenz benutzt, um die 
Difluormethylphosphonat-Gruppe mittels Lewis-Base-Katalyse einzuführen (Schema 5-1c). Die 
Reaktion dieses Reagenzes mit den Allylfluoriden beschreibt die erste enantioselektive 
Phosphonyldifluormethylierung, wobei die Produkte als Bioisostere organischer Phosphate angesehen 
werden können. Durch die Anwesenheit des Difluormethyl-Strukturmotivs verliefen nachfolgende 
Reaktionen diastereoselektiv.  
Neben den Untersuchungen von N-zentrierten Lewis-Base-Katalysatoren wurden im Rahmen 
dieser Arbeit auch Studien für P-zentrierte Katalysatoren angefertigt. Der Aspekt der dualen 
Aktivierung von kleinen organischen Molekülen unter Verwendung von Lewis-Säuren und -Basen 
stand hierbei im Vordergrund. Da diese keine stabilen Addukte ausbilden, können sie im weitesten 
Sinne als frustrierte Lewis-Paare angesehen werden.  
Pinakolboran und Tributylphosphin, welche kein stabilen Lewis-Addukt bilden, wurden für 
Transformationen von Alkinonen und Alkinoaten verwendet. Es wurde gefunden, dass protische 
Additive Alkinone selektiv einer 1,2-Reduktion untergehen ließen, sodass Allylalkohole gebildet 
wurden (Schema 5-2a). Mechanistische Studien dieser Reaktion zeigten, dass die Bildung von 
Vinylphosphoniumsalzen als Intermediat und die Aktivierung von Pinakolboran durch eine vom 
Additiv gebildete O-zentrierte Lewis-Base essenziell für die Selektivität dieser Reaktion ist.   
Obwohl Alkinone und Alkinoate chemisch sehr ähnlich sind, zeigten sie verschiedene 
Reaktivitäten unter Einwirkung von Pinakolboran und Tributylphosphin als Katalysator. Dies 
resultierte in der Entwicklung einer untypischen trans-Hydroborierung der Dreifachbindung von 
Alkinoaten unter Phosphin-Katalyse (Schema 5-2b). Die Reaktionen zeigten hohe Regio- und 
Diastereoselektivitäten und mechanistische Experimente offenbarten, dass auch hier das 
Vinylphosphonium-Salz das Schlüsselintermediat ist.  
Die Untersuchungen der 1,2-Reduktion der Alkinone und die trans-Hydroborierung von 
Alkinoaten demonstrierten die mannigfaltige Reaktivität von Vinylphosphonium-Salzen und waren 
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somit Anstoß für weitere Untersuchungen ähnlicher Intermediate. Zunächst wurden 1,4-Reduktionen 
von Alkinoaten mittels stöchiometrischer Mengen von Phosphinen und Wasser untersucht, welche 
eine hohe Z-Selektivität zeigten (Schema 5-2c). Dies widerspricht den bisherigen Ergebnissen anderer 
Forscher, welche fast ausschließlich E-Selektivität beschrieben.[181] 
 
Schema 5-2 Neue Phosphine-katalysierte oder -induzierte Reaktionen mit Viny l oder Arylphosphoniumionen 
als katalytisches beziehungsweise isolierbares Intermediat.  
Aufgrund der interessanten Reaktivität von Vinylphosphoniumionen wurden zudem auch 
Arylanaloga untersucht. In dieser Arbeit konnte gezeigt werden, dass Thiazole und Benzothiazole 
einer selektiven C2-Funktionalisierung unterworfen werden können, wenn Triphenylphosphin zur 
Synthese der entsprechenden Thiazol-2-yl-triphenylphosphonium-Salze verwendet wird. Diese Salze 
lassen sich anschließend gemäß einer Substitutionsreaktion mit diversen N-, O-, S-, und Se-zentrierten 
Nukleophilen umsetzen, sodass die in 2-Position-manipulierten Verbindungen erhalten werden 
(Schema 5-2d, e). Die aus zwei synthetischen Schritten bestehende Sequenz zeigte ein breites 
Anwendungsspektrum bezüglich der Nukleophile, wobei sekundäre Amine, Amide, Pyrrole, Indole, 
Imidazole, Pyrazole und verwandte Heterozyklen sowie Alkohole, Phenole, Thiole, Thiophenole und 
Selenide untersucht wurden. Somit bildet diese synthetische Strategie eine effektive Methode für die 
C-H-Funktionalisierung von Thiazolen und Benzothiazolen. Das Thiazolmotiv ist eines der von der 
FDA am häufigsten zugelassenen Medikamente.[169] 
Die in dieser Arbeit neu entwickelten, synthetischen Methoden wurden dann für die Synthese 
von biologisch relevanten Molekülen wie -Lactame und Pyrrolizinone verwendet. Darüber hinaus 
sind die hier präsentierten Ergebnisse der Grundstein für weitere Anwendungen von ähnlichen Ideen 
und Konzepten in Lewis-Base-katalysierten oder Lewis-Säure-induzierten Reaktionen.  
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Abbreviations 
Cat.  catalyst 
DABCO  1,4-diazabicyclo[2.2. 2]octane 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCE  1,2-dichloroethane 
DCM  dichloromethane 
DME  dimethoxyethane 
DMF  dimethylformamide  
DMSO  dimethyl sulfoxide 
ee  Enantiomeric excess 
er  Enantiomeric ratio 
HMDS  bis(trimethylsilyl)amine 
LDA  lithium diisopropylamide 
MBH  Morita-Baylis-Hillman 
pinBH  Pinacolboran 
Sol.  solvent 
TBS  tert-butyldimethylsilyl 
Tem.  temperature 
THF  tetrahydrofuran  
TMS  trimethylsilyl 
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Abstract Enantioenriched -lactams are accessed via enantioselective
allylation of anilines with Morita–Baylis–Hillman carbonates followed by
a base-promoted cyclization. The resulting 3-methyleneazetidin-2-ones
are amenable to diastereoselective functionalization to produce ana-
logues of biologically active -lactams. The use of nearly equimolar
quantities of the starting materials make this method efficient and
straightforward.
Key words -lactams, allylic substitution, allylation, Lewis base catal-
ysis
-Lactams remain a central structural motif in modern
medicinal chemistry due to the widespread use of penicil-
lins, cephalosporins, carbapenems and monobactams (1
and 2) (Scheme 1, a).1 In addition to -lactam antibiotics
which inhibit bacterial cell wall biosynthesis, molecules
containing this structural motif exhibit a range of other bi-
ological activities including neuroprotective, antioxidant,
analgesic or immunomodulatory capabilities.2 For example,
a new class of -lactams (3 and 4) (Scheme 1, a) has been
identified as potent tubulin binders and therefore potential
anticancer agents.3 Although numerous synthetic ap-
proaches to -lactams have been reported,4 the continuing
cycle of discovery of new biological activities for -lactams
creates the need for the synthesis of molecules with new
substitution patterns and makes the development of new
methods and the improvement of known processes a wor-
thy endeavor.
While developing the concept of latent nucleophiles in
Lewis base catalysis as a general method for enantioselec-
tive allylation of N-centered nucleophiles using cheap and
widely available Morita–Baylis–Hillman (MBH) adducts 7,5,6
we became interested in applying such reactions to the syn-
thesis of -amino acids and their derivatives, -lactams. We
were particularly interested in the allylation of anilines,
which would allow access to structures of type 11, being
derivatives of biologically active compounds 3 and 4. The
products of N-allylations using MBH adducts 9 (Scheme 1,
b) appear to be perfectly equipped for this as they are a sin-
gle cyclization step away from the desired -lactams. The
presence of an exo-methylene in the resulting lactam 10
was seen as an excellent opportunity for further modifica-
tions of the scaffold in a diastereoselective manner, which
highlights the importance of efficiently constructing the
Scheme 1  (a) Bioactive -lactam analogues. (b) Proposed route for the 
asymmetric synthesis of -lactams from aldehydes, acrylate and anilines.
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lines similar to 9 have been previously prepared via metal-
catalyzed allylic substitutions that are often burdened with
the issue of SN2 vs SN2′ selectivity,7 and via aza-MBH reac-
tions where the scope for the imine is usually very limited.8
An efficient organocatalytic method that circumvents these
problems would certainly be of interest in small-scale ex-
ploratory medicinal chemistry work.
Lewis base catalyzed allylations of N-centered nucleo-
philes are normally limited in scope to those nucleophiles
that feature an acidic N–H that can be activated by a leaving
group released from a typical MBH adduct, usually a car-
boxylate or a carbonate/alcoholate.7g,9 Imides/carba-
mates,7g,9b,d sulfonamides9c,e and sulfoximines,9h,i for exam-
ple, perform well in allylations using MBH carbonates. The
N-centered nucleophile in these reactions should also be
less nucleophilic than the catalyst in order to avoid compet-
ing reactivity with the catalyst itself. With these restric-
tions in mind and considering their low N–H acidity (pKa of
around 30 compared to a pKa of around 18 for the butoxide
generated upon degradation of a carbonate), predicting the
reactivity of anilines in (chiral) Lewis base catalyzed allyla-
tions is not straightforward.10
Reactions of anilines and MBH adducts, catalyzed or
promoted with DABCO, produce racemic N-allyl anilines.11
These products easily undergo 3,3-sigmatropic rearrange-
ments, which proved useful in synthesis of N-heterocycles
such as quinolines and uracils.12 With the goal of develop-
ing an enantioselective coupling of anilines and MBH car-
bonates, our work commenced with the optimization of the
reaction conditions for the chiral Lewis base catalyzed al-
lylation of aniline 8a with MBH carbonate 7a (Table 1). Fo-
cus was placed on cinchona-alkaloid-based catalysts that
are often used for similar transformations.6c,13 The chiral
catalysts required significantly longer reaction times than
the reactions with DABCO. In our hands, the monomeric
cinchona catalysts failed to produce the desired products
with high enantioselectivity. Dimeric catalysts such as (DH-
QD)2AQN, (DHQD)2PHAL and (DHQD)2PYR were tested and
surprisingly showed distinctly divergent activities and en-
antioselectivities. (DHQD)2AQN was identified as a suitable
catalyst as it provided the desired product in good yield
with an enantiomeric ratio of 92:8. Further optimization
was focused on the catalyst loading and identification of
the optimum reaction solvent, reaction time, concentration
and temperature. The optimized conditions included reac-
tions in cyclohexane with 10 mol% of (DHQD)2AQN as the
catalyst at room temperature, with a 0.4 M concentration of
the electrophile.14
It is apparent that these reactions fit the kinetic resolu-
tion scenario where the two enantiomers of the racemic
MBH carbonate 7 react in an enantioconvergent manner to
produce one enantiomer of the substitution product 9 pre-
dominantly. It is noteworthy that only a slight excess of ani-
line (1.1 equiv) was sufficient to drive the reactions to com-
pletion after 56 hours, allowing us to avoid the commonly
seen use of superstoichiometric quantities of electrophile.
The reactions reported here are thus greener and more effi-
cient.
Optimization studies were followed by an investigation
of the reaction scope for substituted anilines and MBH car-
bonates (Scheme 2). Halogen-substituted anilines gave the
corresponding allylation products 9a–f in excellent yields
and high enantioselectivities. The reactions showed gener-
ally broad tolerance for substituents on the aniline. Sub-
Table 1  Optimization of the Conditions for the Asymmetric Allylation 
of Anilinesa
Entry Catalyst Solvent Time (h) Yield (%)b ee (%)c
 1 DABCO toluene  2 52   –
 2 quinine toluene 56 24 –30
 3 cinchonidine toluene 56 30 25
 4 (DHQD)2AQN toluene 56 67 84
 5 (DHQD)2PHAL toluene 56 27 9
 6 (DHQD)2PYR toluene 56 21 –18
 7 (DHQD)2AQN THF 56 46 79
 8 (DHQD)2AQN dioxane 56 46 84
 9 (DHQD)2AQN CH2Cl2 56 86 75
10 (DHQD)2AQN PhCF3 56 64 88
11 (DHQD)2AQN cyclohexane 56 81 82
12d (DHQD)2AQN cyclohexane 56 67 86
13e (DHQD)2AQN cyclohexane 56 74 86
14f (DHQD)2AQN cyclohexane 56 76 87
15g (DHQD)2AQN cyclohexane 56 79 87
16 (DHQD)2AQN cyclohexane/PhCF3 56 66 89
17h (DHQD)2AQN cyclohexane 56 94 (94) 87
18i (DHQD)2AQN cyclohexane 56 50 88
19j (DHQD)2AQN cyclohexane 40 94 84
20j (DHQD)2AQN PhCF3 40 88 88
a Reaction conditions: Carbonate 7a (1 equiv), 4-chloroaniline (8a) (1.1 
equiv), catalyst (10 mol%), rt, 0.2 M.
b NMR yield based on triphenylmethane as the internal standard, yield of iso-
lated product in parentheses.
c Determined by HPLC of the purified product.
d (DHQD)2AQN (5 mol%) was used.
e (DHQD)2AQN (15 mol%) was used.
f 4-Chloroaniline (1.0 equiv) was used.
g 4-Chloroaniline (1.3 equiv) was used.
h The concentration was 0.4 M.
i The concentration was 0.1 M.
j The reaction was heated to 40 °C.
OBoc
COOMe NH
COOMe
Cat. (10 mol%)
+
7a 8a 9a
Cl
NH2
Cl
Solvent© 2020. Thieme. All rights reserved. Synlett 2020, 31, 575–580
577
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drawing (9k) substituents gave the desired products in
good yields.
Extended -systems within the nucleophile were also
well tolerated (9l and 9m). The enantiomeric ratios re-
mained good for various combinations of reaction partners
with values of up to 94:6. The enantioselectivities observed
with bulkier nucleophiles like 2-naphthylamine and an or-
tho-substituted aniline were slightly lower (9f and 9l). The
steric bulk of the nucleophile also affected the yield when
an ortho-substituted nucleophile was used (9f). A series of
substituted MBH carbonates was used to assess the reaction
scope for the electrophilic partner. MBH carbonates carry-
ing halide substituents all performed well with respect to
both yield and enantioselectivity (9n–s) (Scheme 2). Even
an electrophile with an ortho-substituent performed well,
albeit with lower enantioselectivity (9r, 77%, 84:16 er).
Substrates with electron-donating and electron-withdraw-
ing substituents performed equally well in these reactions,
showing generally good functional group tolerance with
yields of up to 97% and enantiomeric ratios of up to 98:2.
The configuration of the major enantiomer in reactions cat-
alyzed by (DHQD)2AQN was assigned by comparison of
the optical rotations to those of the previously reported
material.7c With access to a variety of allylated anilines, we
turned our attention to the cyclization to form the exo-
methylene-containing -lactams, substituted 3-methylene-
azetidin-2-ones 10.
The focus was placed on activation of the nucleophiles
with a strong base to effect cyclization. A brief optimization
of the reaction conditions corroborated the previous re-
ports that Sn(HMDS)2 gives the desired four-membered
rings with the highest yields. Cyclizations using Sn(HMDS)2
provided a small library of compounds with various N- and
C4-substituents, which included alkyl, halide and ether
substituents (including methyl ethers often present in the
tubulin-binding -lactams) (Scheme 3, a). Gratifyingly, the
cyclization reactions provided a variety of substituted -
lactams in good yields (43–95%) and were even able to ac-
commodate an ortho-substituted substrate carrying addi-
tional steric bulk close to the reactive center (10j, 89%). A
brief survey of the enantiomeric ratios for the products
showed that they matched those of the starting materials,
confirming that the stereogenic centers are not affected
during the cyclization process.
The final synthetic step to access analogues 11 was 1,4-
reduction. With a variety of methods to choose from,15 we
opted for simple hydrogenation over a palladium catalyst.
The reactions confidently produced the reduced products in
excellent yields across the set of substrates used to test the
Scheme 2  Enantioselective Lewis base catalyzed allylations of anilines using MBH carbonates
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Y. Zi et al. ClusterSyn lettreaction scope (Scheme 3, b). Furthermore, the hydrogena-
tion reactions proceeded with good control of the diastere-
oselectivity. Attempts to isomerize the reaction product un-
der basic conditions produced only minor quantities of the
trans-isomers, suggesting that the cis-diastereomer was
more stable, a fact that could be used to control otherwise
less diastereoselective transformations involving the exo-
methylene group in the resulting -lactams. The assign-
ment of the structures of the two diastereomers was based
on 3JH–H coupling constants, which are consistent with the
dihedral angles in the low energy conformations for the
two isomers (5.9 Hz for cis-11a and 2.4 Hz for trans-11a).
The enantiomeric ratios of the isolated -lactams matched
those of the starting materials, showing that the stereogen-
ic center  to the nitrogen atom was not affected by the
two-step sequence.
In conclusion, we have presented an efficient route for
the asymmetric synthesis of biologically relevant -lactams
that relies on enantioselective Lewis base catalyzed allyla-
tion of anilines to set the stereogenic centers.16 Considering
the high atom economy in the synthesis of MBH adducts,
the efficiency of the catalytic substitution reactions which
require nearly equimolar quantities of starting materials
and the simplicity of the cyclization/reduction se-
quence,17,18 this route represents an economical and green
tool for the synthesis of -lactams. The library of prepared
compounds will be evaluated for biological activity in due
course.
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was evacuated and refilled with nitrogen 3 times. The reaction
mixture was then stirred at room temperature after adding
cyclohexane (0.4 M). After completion of the reaction, the
solvent was removed under reduced pressure. The crude
residue was purified by column chromatography (eluent: 5%
ethyl acetate in petroleum ether).
Methyl 2-{[(4-Chlorophenyl)amino](phenyl)methyl}acry-
late (9a)
Yield: 28 mg (94%); pale yellow oil; 93:7 er (determined by
HPLC analysis) [Phenomenex Lux Cellulose-1, n-hexane/i-
PrOH = 95:5, 1.0 mL/min,  = 253 nm, tR (major) = 18.73 min, tR
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5.92 (s, 1 H), 5.39 (s, 1 H), 4.24 (s, 1 H), 3.72 (s, 3 H). 13C NMR (75
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fied by flash column chromatography (eluent: 5% ethyl acetate
in petroleum ether).
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Yield: 25 mg (98%); white solid. IR (ATR): 2974, 1728, 1597,
1492, 1381, 1365, 1161, 1091, 813, 744 cm–1. 1H NMR (300© 2020. Thieme. All rights reserved. Synlett 2020, 31, 575–580
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Latent Nucleophiles in Lewis Base Catalyzed Enantioselective
N-Allylations of N-Heterocycles
You Zi, Markus Lange, Constanze Schultz, and Ivan Vilotijevic*
Abstract: Latent nucleophiles are compounds that are them-
selves not nucleophilic but can produce a strong nucleophile
when activated. Such nucleophiles can expand the scope of
Lewis base catalyzed reactions. As a proof of concept, we
report that N-silyl pyrroles, indoles, and carbazoles serve as
latent N-centered nucleophiles in substitution reactions of
allylic fluorides catalyzed by Lewis bases. The reactions feature
broad scopes for both reaction partners, excellent regioselec-
tivities, and produce enantioenriched N-allyl pyrroles, indoles,
and carbazoles when chiral cinchona alkaloid catalysts are
used.
Lewis base catalysts can serve to increase both the electro-
philicity and nucleophilicity of reactants, which allows them
to trigger a surprisingly diverse set of reactivity patterns.[1]
Most Lewis base catalyzed reactions involve an interaction
between a nucleophile and an electrophile. The fact that many
of these reactions feature a narrow scope with respect to the
nucleophilic reaction partner is often underappreciated. For
example, in Lewis base catalyzed allylic substitution reactions,
the nucleophilic reaction partner should be less nucleophilic
than the catalyst and it should match the catalystQs Lewis base
affinity.[2] If these criteria are not met, mixtures of products of
SN2 and SN2’ substitution reactions will be observed and/or the
reactions may proceed without involvement of the catalyst,
which precludes the development of enantioselective catalytic
processes.[3] A potential solution could be provided by latent
nucleophiles, which are derivatives of otherwise nucleophilic
molecules that are not (or not markedly) nucleophilic but can
be activated to participate in the reaction.[4] When activation
of a latent nucleophile is dependent on activation of the
electrophilic partner, the reaction between the activated
nucleophile and the activated electrophile may outperform
other competing pathways and enable selective transforma-
tions (Scheme 1a). This concept should allow us to expand
the reactivity range and the type of catalysts to be utilized in
Lewis base catalysis.
The nucleophilic properties of pyrroles and indoles have
been studied and quantified.[5] Both pyrroles and indoles can
serve as N-, C2-, and C3-nucleophiles, and the issues with
regioselectivity in their functionalization are well docu-
mented.[6] We hypothesized that an N-silyl substituent
would attenuate the nucleophilicity of pyrroles and indoles,
turning them into latent nucleophiles. Activation of N-silyl
latent nucleophiles could be mediated by fluoride ions. If
activation of the nucleophile is to be dependent on activation
of the electrophile, the fluoride ions should be generated
during activation of the electrophilic reaction partner. For this
reason, allylic fluorides were chosen as suitable coupling
partners.[7] We focused on fluorides derived from Morita–
Baylis–Hillman (MBH) adducts to enable a regio- and
enantioselective allylation of N-heterocycles.[8] We envisioned
that both 1) the problem of activating pyrroles, indoles, and
carbazoles as nucleophiles and 2) the problems related to the
regioselectivity in their functionalization (N, C2, or C3) and
substitution of allylic fluorides (SN2 vs. SN2’) can be addressed
by using latent N-silyl nucleophiles (Scheme 1b). Herein, we
report that N-silyl pyrroles, indoles, and carbazoles serve as
latent N-nucleophiles in substitutions of allylic fluorides and
enable enantioselective allylations of N-heterocycles.
Our initial studies of different silyl groups in the latent
nucleophiles revealed that the commonly used silyl protecting
groups all afforded the products ofN-allylation in good yields
when allylic fluoride 1a (Scheme 2) was used in combination
with the N-silyl pyrrole (see the Supporting Information for
details on the optimization studies). In order to preempt
Scheme 1. a) The concept of using latent nucleophiles in Lewis base
catalysis. b) Latent nucleophiles in the N-allylation of pyrroles and
indoles and the possible products.
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interactions of the Lewis base catalyst with the silyl group of
the latent nucleophile and avoid this type of nucleophile
activation,[9] the bulky 1-(tert-butyldimethylsilyl)pyrrole was
chosen for further reaction optimization, which explored how
the identity of the Lewis base catalyst, solvent, catalyst
loading, ratio of reaction partners, and temperature influ-
enced the reactions outcome. N-centered Lewis base catalysts
generally showed better efficacy than the corresponding
P-centered Lewis bases. A slight excess of the latent
nucleophile in combination with 5 mol% of DABCO as the
catalyst afforded the desired products in high yields.
Upon optimization of the reaction conditions, the scope of
the reaction was evaluated, first for the allylic fluorides and
then for the N-silyl nucleophiles. In reactions of fluorides
1 with 2a, good yields were observed across the board
regardless of the electronic properties of the MBH fluoride
(Scheme 2a). Both electron-rich (3e–3 f) and electron-poor
(3 i–3 l) allylic fluorides afforded the desired products in good
yields with short reaction times (< 5 min). Alkyl fluorides also
proved to be reactive but lower yields were observed for
primary alkyl substituents (3c, 3d). Aryl halides, good
substrates for further functionalizations of the reaction
products, were all well tolerated (3g and 3h) as were alkyl/
aryl ethers, esters, benzylic methylene groups, nitriles, and
nitro compounds. Gratifyingly, no products of SN2’ substitu-
tion were observed with any of the tested substrates.
The investigation of the scope for latent nucleophiles
started with a series ofN-TBS pyrroles, which performed well
and demonstrated the generality of the process (Scheme 2b).
Simple N-silyl pyrrole and 2-substituted pyrroles all per-
formed well as nucleophiles. Increasing the steric demands of
the nucleophile, as with 2,5-dimethylpyrrole, rendered the
substitution reaction prohibitively slow. Further evaluation of
the reaction scope included indoles and carbazoles. Various
substituted indoles performed well in the reaction, giving the
desired products of substitution in good yields regardless of
the electronic influences of the substituents (3p–3u).
2-Methylindole (3u) indicated the sensitivity of this reaction
to steric bulk. Despite this limitation, the desired product was
obtained in a yield of 47%, which could be improved by
increasing catalyst loading. N-Silyl carbazole performed even
better, with the product being isolated in 82% yield (3o).
Importantly, these reactions were highly regioselective with
respect to both coupling partners. Neither products of C2/C3
allylation of the pyrrole/indole nor of SN2’ substitution were
observed in any of these experiments.
A series of experiments where various combinations of
substituted nucleophilic and substituted electrophilic partners
were subjected to the optimized reaction conditions further
established the generality of this process (Scheme 2c) and
demonstrated that even MBH fluorides with ortho substitu-
ents are competent substrates in these reactions (products 3x
and 3y). With selected examples, the catalyst loading could be
lowered to as little as 1 mol% of DABCO without deterio-
ration of the yields, although the reaction times generally had
to be extended for these reactions. Scalability was tested for
the reaction of 1a (1.00 g) and 2a (1.03 g), which proceeded
with equal efficiency and no changes in selectivity. Good
scalability together with a plethora of methods for further
product functionalization[10] make this method attractive for
applications in target-oriented synthesis.
Having confirmed that the reactions with latent nucleo-
philes are highly regioselective and feature broad scope for
both reactive partners with DABCO as the catalyst, we
commenced our investigation of an enantioselective variant
using chiral Lewis base catalysts. Our studies had confirmed
Scheme 2. a) Scope of allylic fluoride 1 in the Lewis base catalyzed
allylation of 1-(tert-butyldimethylsilyl)pyrrole 2a. b) Scope of N-silyl
pyrroles, indoles, and carbazoles in the N-allylation with allylic fluoride
1a. c) Various combinations of substituted N-silyl nucleophiles and
substituted allylic fluorides. [a] The reaction of 1 with 2 (1.1 equiv) and
DABCO (5 mol%) was carried out in DCM at room temperature.
[b] NMR yield with Ph3CH as the internal standard. [c] With 1.5 equiv
of 2 and 10 mol% of DABCO.
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that N-centered Lewis base catalysts performed better in
these reactions and highlighted the efficacy of DABCO,
which directed our optimization efforts towards cinchona
alkaloid based catalysts. We investigated how the identity of
the chiral Lewis base catalyst, the reaction temperature,
concentration, solvent, and the ratio of the reaction partners
influenced the reaction outcome (see the Supporting Infor-
mation for details). The optimized conditions included the use
of 10 mol% of (DHQD)2PHAL as the chiral Lewis base
catalyst in trifluorotoluene at room temperature. A clear
difference in the rates of the reactions catalyzed by chiral
cinchona alkaloids compared to those catalyzed by DABCO
resulted in slightly lower yields (Scheme 3). N-Silyl pyrroles,
indoles, and carbazoles all gave the products ofN-allylation in
good yields and with a good degrees of stereocontrol (3a’, 3p’,
3o’). A series of experiments showed that both electron-rich
and electron-poor allylic fluorides performed well in these
reactions (3ab’, 3ac’, 3ad’, 3h’, and 3k’), with yields of
approximately 80% and enantiomeric ratios exceeding 90:10.
Reactions with alkyl-substituted fluorides proved to be too
slow, which allowed for competitive decomposition of the
alkyl fluorides leading to lower yields, although the enantio-
meric ratios for the isolated substitution products remained
high. Modifying the latent nucleophiles with electron-with-
drawing or -donating groups had a moderate effect on the
yields and enantioselectivities, which were, in some cases, as
high as 99:1 er (3ae’, 3w’, 3t’, 3s’). Other regioisomers were
not observed in any of the tested reactions. The enantiose-
lectivities could be further improved by focused optimization
for individual cases, as demonstrated for 3p’ and 3s’where the
enantiomeric ratios could be increased from 92:8 to 95:5 and
from 83:17 to 94:6, respectively, simply by changing the
reaction solvent. The configuration of the stereogenic center
of the major enantiomer was assigned as S by comparison to
previously reported data for 3t’,[11] and the absolute config-
uration of other products was assigned by analogy.[12]
A substitution product containing a pyrrole moiety (3a)
proved to be useful in a short synthesis of pyrrolizinones
shown to exert anti-amyloid and radical-scavenging effects
(Scheme 4a).[13] Hydrogenation followed by cyclization pro-
moted by BBr3 afforded trans-7 in 56% yield (the cis isomer,
isolated in minor quantities, could be separated and isomer-
ized to increase the yield of trans-7). To further demonstrate
the generality and utility of the concept of using latent
nucleophiles in Lewis base catalysis, a broader range of
silylated N-nucleophiles, including phthalimide, tosylamide,
and diphenylamine, were tested and shown to be competent
in reactions with allylic fluorides (3af, 3ag, 3ah ; Scheme 4b).
Our attention then turned to the mechanistic features of
these processes. The reactions could proceed via allyl
ammonium intermediates often evoked in substitutions of
MBH acetates and carbonates (Scheme 5a).[11, 14] Alterna-
tively, a silyl-assisted cleavage of the C@F bond with simulta-
neous intramolecular delivery of the nucleophile (Sche-
me 5a) could take place.[15] When allylic fluoride 1a was
treated with DABCO in the absence of N-TBS pyrrole, the
Scheme 4. a) Synthesis of pyrrolizinones that are potentially useful in
the treatment of Alzheimer’s disease. b) Expanded scope of N-nucleo-
philes: Phthalimide, tosylamide, and diphenylamine can also be
introduced as latent nucleophile.
Scheme 3. Enantioselective Lewis base catalyzed allylic substitutions of
allylic fluorides with N-silyl nucleophiles. [a] The reaction of 1 (2 equiv)
with 2 and (DHQD)2PHAL (10 mol%) was carried out in PhCF3 at
room temperature under N2 atmosphere. [b] 1,4-Dioxane was used as
the solvent. [c] Dimethoxyethane was used as solvent.
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formation of ammonium salt 4 was observed by NMR
spectroscopy in situ (Scheme 5b).[16] In a crossover experi-
ment where deuterium-labeled indole 2af was used in an
equimolar mixture with N-TBS indole 2p, both indole
moieties were incorporated into the reaction product (Sche-
me 5c), suggesting that they may equilibrate through an
indolide anion. To scrutinize other reasonable pathways that
would result in the same outcome, two control experiments
were carried out to confirm that 1) the indole itself does not
react with the allylic fluoride under the reaction conditions
and 2) the TBS group is not transferred between 2af and 2p in
the presence of DABCO. Finally, when TBAF was used as the
catalyst, the reaction proceeds with high rates (reaction time
< 20 min) and only the products of SN2’ substitution were
observed (Scheme 5d). Based on these experiments, we
propose the mechanism outlined in Scheme 5e. The allylic
fluoride undergoes conjugate addition of the catalyst, which,
after E1cb elimination of the fluoride ion, results in the allylic
ammonium intermediate 4’. The fluoride ion then adds to the
silyl group of the N-silyl pyrrole/indole and after elimination
forms the silyl fluoride (observed in the reaction mixture by
NMR analysis) and the anionic N-nucleophile 6. The acti-
vated electrophile, allyl ammonium intermediate 4’, under-
goes conjugate addition of 6 to form the product after
elimination of the catalyst. The observed selectivity for the
product of direct substitution of the fluoride is the conse-
quence of two consecutive conjugate additions/eliminations.
The addition rates of anion 6 to electrophile 4’ are proposed
to be high because the products of SN2’ substitution were not
observed in DABCO-catalyzed reactions even though com-
peting addition of 6 to 1, resulting in the formation of SN2’
products, occurs with high rates when TBAF is used as the
catalyst.[17] This highlights the importance of the simultaneous
presence of activated electrophile/nucleophile pairs in the
reaction mixture and demonstrates the importance of the
latent character of the nucleophile. Finally, the excellent
regioselectivities and good stereocontrol observed in the
presence of chiral Lewis base catalysts suggest that addition of
the activated nucleophile to a non-activated electrophile does
not occur.
In conclusion, the use of N-silyl pyrroles, indoles, and
carbazoles as latent nucleophiles enables the highly regiose-
lective N-allylation of these heterocycles by using allylic
fluorides. When widely available chiral cinchona alkaloid
based catalysts were used, the allylation products were
isolated with high degrees of enantioselectivity. This is the
first general enantioselective method to introduce pyrroles in
Lewis base catalyzed substitution reactions. The mechanistic
details of this process suggest that the concept of using latent
nucleophiles in Lewis base catalysis hinges on the concurrent
activation of both reaction partners, which allows for
expanded reaction scope and improved selectivities. This
concept may be generally applicable in a variety of reactions
that depend on the use of heteroatom-centered nucleophiles.
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ABSTRACT: Pyrrolizidine alkaloids and their derivatives often
feature interesting biological activities. A class of substituted 2,3-
dihydro-1H-pyrrolizin-1-one derivatives has been explored as a
potential treatment for Alzheimer’s disease, but enantioselective
synthesis of these molecules is still elusive. We report that
enantioselective N-allylation of N-silyl pyrrole latent nucleo-
philes with allylic fluorides followed by hydrogenation and diastereoselective Friedel−Crafts cyclization constitute an efficient
synthetic route to access enantioenriched substituted 2,3-dihydro-1H-pyrrolizin-1-ones.
Pyrrolizidine alkaloids are a large group of plant naturalproducts with a 1-azabicyclo[3.3.0]octane core.1 Many of
these are toxic to humans and livestock and pose a significant
threat to food safety. Other members of the group exhibit
medicinally relevant biological activity such as pochonicine (1,
Scheme 1a) which has been identified as a potent β-N-
acetylglucosaminidase inhibitor.2 Among synthetic derivatives
with different levels of unsaturation and oxidation of the
pyrrolizidine core, the derivatives with 2,3-dihydro-1H-
pyrrolizine, such as the dual COX/LOX inhibitor licofelone
(2),3 have been under intense investigation and clinical
development. The ease of access to 1,2-dihydro-3H-pyrroli-
zin-3-ones (3) has prompted numerous SAR studies of this
scaffold.4 In contrast to this, synthetic approaches to 2,3-
dihydro-1H-pyrrolizin-1-ones (4) remain scarce despite the
fact that this scaffold, due to its radical scavenging and
antiamyloid properties, has recently been identified as a
promising platform for treatment of Alzheimer’s disease.5 The
reported synthetic approaches to this scaffold lack the control
of stereoselectivity; the reactions proceed with low diaster-
eoselectivity, and the products have not been prepared in
enantioenriched form.5,6
Considering the possibility of easy epimerization at C2, we
presumed that a successful enantioselective approach to
substituted 2,3-dihydro-1H-pyrrolizin-1-ones would have to
effectively construct the C3 stereogenic center and allow for
good control of diastereoselectivity at the C2 center. We have
recently reported a Lewis base catalyzed enantioselective N-
allylation of pyrroles, indoles, and carbazoles which benefits
from the concept of latent nucleophiles in Lewis base
catalysis.7 As these reactions construct a stereogenic center α
to the nitrogen of the pyrrole and install the carbonyl group of
the ester in an appropriate position, we saw this as an
opportunity to develop a short enantioselective synthesis of
substituted 2,3-dihydro-1H-pyrrolizin-1-ones. Here, we report
the development of a short route to this scaffold that consists
of enantioselective N-allylation of N-silyl pyrroles followed by
reduction and diastereoselective cyclization (Scheme 1b).
Our work on Lewis base catalyzed N-allylation commenced
as a proof of concept study for the use of latent nucleophiles in
Lewis base catalysis. This concept is aimed at expanding the
scope for nucleophiles and allowing for better control of
chemo-, regio-, and stereoselectivity in Lewis base catalyzed
reactions.8 It is a common occurrence that heteroatom
Received: October 22, 2019
Published: December 5, 2019
Scheme 1. (a) Some Biologically Active Molecules/Scaffolds
Derived from Pyrrolizidine; (b) Outline of Our Approach to
Enantioselective Synthesis of Substituted 2,3-Dihydro-1H-
pyrrolizin-1-ones
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nucleophiles compete and outperform the Lewis base catalyst
thus preventing the development of enantioselective Lewis
base catalyzed reactions.9 We hypothesized that lowering the
nucleophilicity of the nucleophilic reaction partner would
increase the reaction selectivity and allow flexibility in the
choice of catalyst. For N-centered nucleophiles, introducing a
silyl group at the nitrogen atom lowers the nucleophilicity of
the derivative (compared to the corresponding N−H
nucleophile).10 Such latent nucleophiles require an appropriate
trigger to participate in the reaction. If activation of the
nucleophile depends on the activation of the electrophile, by
mediacy of the leaving group from the electrophile, the
activated nucleophile is produced only when the activated
electrophile is already present in the reaction mixture allowing
for the bimolecular reaction of the two activated reactants to
outcompete other possible pathways.7 If activation of a N-silyl
Scheme 2. N-Allylation of N-Silyl Latent Nucleophiles 6 with Various Allylic Fluorides 5 in the Presence of DABCOa
aIsolated yields of the N-allyl pyrroles, indoles, and carbazoles are shown. Conditions: 5 mol % DABCO, 1.1 equiv of 6, CH2Cl2 (0.1 M).
Numbering scheme follows the following formula: 5x + 6y gives 8xy.
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latent nucleophile is to be dependent on activation of an
electrophile, mediacy of a fluoride ion as a leaving group would
be a suitable trigger which makes Morita−Baylis−Hillman
derived allylic fluorides a fitting reaction partner.
The reactions of various substituted allylic fluorides with N-
TBS pyrrole have been evaluated in the presence of catalytic
amounts of DABCO (Scheme 2). This exercise demonstrated
a broad electrophile scope with reactions proceeding with good
yields for both primary (8aa) and secondary allylic fluorides
regardless of their electronic properties (8ba−8va). The same
is true for a variety of substituted pyrroles, indoles, and
carbazoles (8ba−8bl). Electronically matched and mismatched
sets of nucleophiles and electrophiles performed equally well in
these reactions with generally good yields (8kc, 8if, 8wi, 8jl,
8om, 8xi). Even sterically demanding nucleophiles/electro-
philes, previously reported not to be reactive in related
reactions, performed reasonably well with yields of around 50%
(8bk and 8wi).11 The reactions proceeded with excellent
regioselectivity: C2/C3 allylation of N-heterocycles and SN2′
type products were not observed in any of the reactions.
The comprehensive study of the reaction scope led to
investigation of enantioselective N-allylation of pyrrole in the
presence of a chiral Lewis base catalyst (Scheme 3). The
cinchona alkaloid based catalysts, well-established in similar
Scheme 3. Enantioselective Allylic Substitution with N-TBS Pyrrole 6aa
aIsolated yields and enantiomeric ratios determined by HPLC on chiral stationary phase are shown. The absolute configuration of the N-allyl
pyrroles 8 is assigned based on analogy to previously reported material. Conditions: 10 mol % DHQD2(PHAL), 2 equiv of 5, PhCF3 (0.2 M).
Scheme 4. Hydrogenation of N-allyl Pyrroles 8a
aIsolated yields for the inseparable mixtures of anti and syn diastereomers and the diastereomeric ratio determined by 1H NMR are shown. Relative
stereochemistry is tentatively assigned based on 1H NMR and the results of cyclization experiments. Reactions were performed with both racemic
material and enantioenriched material (for 8ba and 8ea). Conditions: 10 mol % Pd/C, 1 atm. H2, MeOH.
bIsolated yields of anti-9sa and syn-9sa
which do not account for losses of each isomer during purification.
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allylic substitutions,12 performed well in these reactions too.
(DHQD)2PHAL, (DHQD)2AQN, and (DHQ)2PHAL all gave
the desired products in good yields and good enantioselectiv-
ities. The reactions proceed as kinetic resolutions of the
racemic allylic fluorides,13 which is why the optimized
conditions included an excess of the allylic fluoride in the
presence of 10 mol % of (DHQD)2PHAL in trifluorotoluene at
ambient temperature. The excess of allylic fluoride was
required to offset the low reaction rates caused by the
significantly lower reactivity of the chiral catalysts and not to
increase the enantioselectivities suggesting that the reactions of
the two enantiomeric allylic fluorides are enantioconvergent.
The enantiomeric ratios for pyrrole nucleophiles were
generally higher than 90:10, and a short, focused optimization
of the reaction conditions for a specific substrate can be
conducted to improve enantioselectivity.7 The yields remained
good regardless of the electronic properties of the allylic
fluoride (45−83%, Scheme 3). The lowered reactivity of the
catalyst also allowed for competitive elimination of the fluoride
from alkyl substituted allylic fluorides which led to lower yields
(8ta′).
Further investigation was focused on the alkene reduction
and the cyclization to produce the desired pyrrolizinones. The
main concerns while developing the two-step procedure were
the preservation of the C3 stereogenic center, the control of
diastereoselectivity at C2, and the operational simplicity of the
sequence. Attempts to carry out cyclization followed by
reduction failed due to the lability of the Michael acceptor
under acidic conditions. This prompted exploration of the
reverse sequence: reduction followed by cyclization.
Scheme 5. (a) Evaluation of the Diastereoselectivity for Cyclizations of anti-9sa and syn-9sa and Plausible Mechanism for the
Isomerization; (b) Proposed Mechanism for Cyclization and Isomerization of 9
Scheme 6. Diastereoselective Cyclization of Mixtures of anti-9 and syn-9 to Pyrrolizinones 7a
aIsolated yields for the major diastereomer and the diastereomeric ratio are shown. Conditions: 1.05 equiv of BBr3, CH2Cl2 (0.1 M).
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With a large pool of methods for 1,4-reduction to choose
from,14 we opted for the simplest heterogeneous hydro-
genation of 8 over the palladium catalyst which provided the
desired reduction product in excellent yield but with low
diastereoselectivity (Scheme 4). This was not seen as a setback,
as it allowed access to both diastereomers of the reduced
products which were of interest in subsequent cyclization
attempts. The difficulties in separating the two diastereomers,
however, brought about the search for a substrate that would
allow the easier separation of the two isomers. All attempted
reductions proceeded with good yields and low diastereose-
lectivities ranging from 1.3:1 to 3.5:1 without an obvious trend
(Scheme 4).4 It was only the syn- and anti-isomers of naphthyl
substituted ester 9sa that could be separated by column
chromatography.
Having access to both syn- and anti-diastereomers of 9sa, the
conditions for cyclization reactions became a focal point. In the
presence of a pyrrole and an aryl substituent at C3, Friedel−
Crafts-type cyclization was a logical choice for cyclization, as
we expected the electron-rich pyrrole to outperform the aryl
substituent. On the other hand, mild reaction conditions were
desired in order to minimize the epimerization at C2. To
reconcile these requirements, numerous Lewis and Brønsted
acids (AlCl3, Ti(O
iPr)4, BF3, TMSOTf, and TfOH among
others) were tested as potential promotors of the cyclization to
no avail. Only the treatment with BBr3 afforded the desired
cyclization product, albeit in moderate yield.15 This suggested
the in situ formation of an acyl bromide which further reacts to
form the pyrrolizinone (see Scheme 5). To test this, the ester
was hydrolyzed, and the corresponding acid was treated with
PBr3 to form the cyclization product although in lower yields.
Independent cyclization of syn-9sa and anti-9sa, somewhat
surprisingly, afforded the same isomer of 7sa as the major
cyclization product tentatively assigned as trans-7sa based on
the 3JH−H coupling constants for C2 and C3 protons. When
these reactions were stopped at ∼50% conversion, the
reisolated starting material was unchanged suggesting that
isomerization happens upon cyclization. With three sp2 atoms
in the pyrrolidinone ring, we expected the low energy
conformations to be rather flat which would cause significant
gauche interactions between C2 and C3 substituents in the cis
isomer of 7 making the trans isomer increasingly more stable
than the cis as the substituents become larger (as in the case of
naphthyl derivative 7sa).
Since the configuration of 9 does not appear to significantly
influence the diastereoselectivity in the cyclization to form cis-
and trans-7 (although it may influence the reaction rates and
overall yield), we carried out BBr3 promoted cyclization using
mixtures of diastereomers for a series of N-allyl pyrroles 9
(Scheme 6). The desired pyrrolizinones (Scheme 6) were
isolated with good to excellent diastereoselectivity between 5:1
and >25:1. The diastereomers could be separated in each case
with the trans-isomer being the major product in all attempted
cyclizations. Assignment of the cis and trans isomers was made
based on 1H NMR spectra and the 3JH−H coupling constants
for C2 and C3 protons which were consistent across the series
with values of around 4.8 Hz for the trans-7 and around 7.7 Hz
for cis-7, the latter being indicative of the close to syn-
periplanar arrangement of these protons in cis-7. The isolated
yields for the major diastereomers range from 22% to 62%
(Scheme 6). These moderate yields are likely a consequence of
the rather harsh reaction conditions and the side reactions
which include competitive degradation of ether, ester,
trifluoromethyl, and nitrile substituents (7fa, 7ka, 7ia, and
7ja),16 and intramolecular electrophilic aromatic substitution
on the C3-aryl substituent. The substrates with alkyl
substituents, and therefore with no opportunity for the
competing Friedel−Crafts involving the C3 substituent,
performed much better in the cyclization reactions to produce
7ua and 7ta. Finally, when enantioenriched N-allyl pyrroles 8
were used in the two-step sequence, the yields and
diastereoselectivity in both hydrogenation and cyclization
reactions remained unaffected. The same is true for the
configuration at C3 and therefore the enantiomeric ratios of
the trans-7 products. Products trans-7ba and trans-7ea, for
example, were isolated with enantiomeric ratios of 97:3 and
93:7, respectively, which matches that of the of starting
materials 8ba′ and 8ea′.
In conclusion, the three-step sequence of pyrrole N-
allylation followed by simple Pd-catalyzed hydrogenation and
BBr3 promoted cyclization is an effective route for the
synthesis of substituted 2,3-dihydro-1H-pyrrolizin-1-ones.
The concept of latent nucleophiles in the Lewis base catalysis
is a powerful tool for the development of enantioselective
allylic substitutions with a broad scope for both reaction
partners. The use of N-TBS pyrrole as a latent nucleophile in
combination with allylic fluorides and common chiral Lewis
base catalysts allows for the enantioselective N-allylation of
pyrrole and, for the first time, enables the synthesis of
enantioenriched pyrrolizin-1-ones via the said three-step
sequence. These enantioenriched materials are required for
further biological evaluation of their radical scavenging and
antiamyloid properties which will be reported in due course.
■ EXPERIMENTAL SECTION
General Remarks. All the chemicals that are not mentioned in the
subsequent parts were purchased from Merck, Alfa Aesar, Acros
Organics, ABCR, Fluorochem or TCI and used without further
purification. The solvents if needed were dried according to standard
laboratory practices. For column chromatography and TLC (SiO2,
60M, pore size 0.04−0.063 mm), products of Machery-Nagel were
used. The TLC-glass-plates DURASIL consisted of a 0.25 mm layer of
silica 60 with Fluorescence indicator UV254. TLCs were checked
under UV light (254 or 365 nm) and stained with an aq. KMnO4
solution, PMA-stain, or DNP or PAA solution. Reaction monitoring
using GC-MS was performed using HP 6890, capillary column DB5-
MS, and Agilent 5973 MSD. The default method was 70 °C (2 min),
ramp 20 °C/min to 270 °C, hold 10 min. Injector temperature 250
°C, Aux temperature 275 °C. All 1H, 13C, and 19F NMR spectra were
measured with a BRUKER 250 (13C), BRUKER Fourier 300 (1H,
13C), or a BRUKER Avance 400 spectrometer (1H, 13C, 19F). The
chemical shift of each signal was registered in ppm. For 1H and 13C
measurements, the chemical shift refers to TMS, showing a signal at 0
ppm. As an internal standard, the remaining protons or respectively
the carbons of the corresponding deuterated solvent were used
(CDCl3, 7.26 ppm (
1H NMR), 77.16 ppm (13C NMR)). The
chemical shift of the fluorine NMR was determined indirectly. For
carbon spectra, a broad-band decoupling was performed. Enantio-
meric excess was determined by HPLC analysis on Phenomenex Lux
Cellulose-1 columns. High-resolution mass spectra (HRMS) were
measured with EI or ESI ionization by the MS platform. A
chromatographic purification was performed before each measure-
ment. The Thermo Q-Exactive plus device for ESI-mass spectra was
coupled to a binary UHPLC system using orbitrap as the mass
analyzer. For EI-measurement, a GC system was coupled to the
Thermo Q-Exactive (quadrupole) GC Orbitrap device. All the IR
spectra were measured using the Shimadzu IR-Affinity-1 (FTIR)
device.
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Synthesis of Morita−Baylis−Hillman (MBH) Fluorides 5. DAST
(1.1 or 1.2 equiv) was added to CH2Cl2 at −78 °C. To this, a
precooled solution of MBH adduct (1 equiv) in CH2Cl2 was added
slowly (overall concentration MBH 0.25 M in CH2Cl2). The mixture
was stirred for 30 min and then quenched with sat. NaHCO3 solution.
The mixture was extracted twice with CH2Cl2. The combined organic
layers were dried over Na2SO4 and concentrated under reduced
pressure. The crude product was purified by flash column
chromatography using either ethyl acetate in petroleum ether or
ether in petroleum ether. The data for the known compounds 5a,17
5b, 5c, 5g, 5k, 5l, 5m, 5n, 5o, 5p, 5q, 5s, 5t, 5v13 and 5d, 5e, 5f, 5h,
5i, 5j, 5u7 are consistent with previous reports.
Methyl 2-((4-Iodophenyl)fluoromethyl)acrylate (5r). 4-iodo-ben-
zaldehyde (2.00 g, 8.60 mmol mmol) was treated with DABCO (0.48
g, 4.30 mmol) in methyl acrylate (1.48 g, 17.2 mmol) and stirred at
ambient temperature until judged completed by TLC. The crude
mixture was directly subjected to column chromatography (silica)
using ethyl acetate and petroleum ether (15:85) as solvent system to
give the corresponding alcohol, methyl 2-(hydroxy(4-iodo)methyl)-
acrylate as a colorless solid. Yield: 1.34 g, 4.21 mmol, 49%. 1H NMR
(400 MHz, CDCl3) δ 7.71−7.67 (d, J = 8.8 Hz, 2H), 7.19−7.10 (d, J
= 8.8 Hz, 2H), 6.36 (s, 1H), 5.85 (s, 1 H), 5.51 (d, J = 4.5 Hz, 1H),
3.75 (s, 3H), 3.16 (s. 1H). 13C{1H} NMR (63 MHz, CDCl3) δ 167.5,
142.4, 141.9, 138.4, 129.4, 127.4, 94.4, 73.8, 53.0. HRMS [EI]: m/z
calculated for C11H11IO3 [M]
+ 317.9747; found 317.9746. IR (ATR):
ν = 3441 (br, w), 1709, (vs), 1420 (m), 1146 (vs), 1138 (s), 1007
(vs) cm−1. The corresponding MBH fluoride was prepared by general
procedure for synthesis of Morita−Baylis−Hillman fluorides. Yield:
colorless solid, 434 mg, 1.36 mmol, 44%. 1H NMR (400 MHz,
CDCl3) δ 7.74 (d, J = 7.8 Hz, 2H), 7.16 (d,
3JH,H = 9.4 Hz, 2H), 6.48
(d, J = 2.8 Hz, 1H), 6.24 (d, J = 45.8 Hz, 1H), 6.05 (s, 1H), 3.74 (s,
3H). 13C{1H} NMR (101 MHz, CDCl3) δ 165.0 (d, J = 6.4 Hz),
138.9 (d, J = 22.9 Hz), 137.7, 137.1 (d, J = 20.8 Hz), 128.9 (d, i = 5.6
Hz), 126.2 (d, J = 8.8 Hz), 90.2 (d, J = 174.9 Hz), 52.1.19F NMR
(377 MHz, CDCl3) δ −172.54 (d, J = 45.8 Hz). HRMS [EI]: m/z
calculated for C11H10FIO2 [M]
+ 319.9704, found 319.9702. IR
(ATR): ν = 2959(w), 1713 (s), 1273 (s) 1165 (m), 964 (s), 806 (s)
cm−1.
Synthesis of N-Silyl-N-heterocycles 6.7 Under a nitrogen
atmosphere, the heterocycle (1 equiv) was dissolved in THF cooled
to −78 °C, and then n-BuLi (1.1 equiv) or NaH (1.1 equiv) was
added and stirred at this temperature for 15 min. TBS-chloride (1.2
equiv) was added portionwise. The reaction mixture was allowed to
warm to room temperature. The reaction was quenched with water
and then extracted with diethyl ether. The combined organic layers
were dried over Na2SO4, and the solvent was removed under reduced
pressure. The crude mixtures were either distilled or subjected to
column chromatography using ethyl acetate in petroleum ether. The
analytical data for known compounds 6b, 6c, 6h, 6l,7 6f, 6k,18 and
6j19 matched the previously reported data. Compounds 6a, 6d (TIPS
derivative), 6e (TIPC derivative), 6g, and 6i are commercially
available.
Substitution of Allylic Fluorides. The TBS protected pyrrole,
indole, or carbazole 6 (for 6a: 1.04 g, 5.67 mmol) and DABCO (28.9
mg, 0.26 mmol) were dissolved in CH2Cl2 (15 mL). To this, a
solution of allylic fluoride (for 5b: 1.00 g, 5.15 mmol) in CH2Cl2 (15
mL) was added slowly. After the completion of the reaction
(monitored by TLC), the mixture was concentrated and purified by
flash column chromatography using ethyl acetate in petroleum ether.
Menzyl 2-((1H-Pyrrol-1-yl)methyl)acrylate (8aa). Yield: colorless
oil, 23.8 mg, 0.100 mmol, 83%. Chromatography: ethyl acetate/
petroleum ether 10:90. 1H NMR (250 MHz, CDCl3) δ 7.41 (s, 5H),
6.69 (t, J = 2.1 Hz, 2H), 6.36 (d, J = 1.1 Hz, 1H), 6.22 (t, J = 2.1 Hz,
2H), 5.35 (d, J = 0.9 Hz, 1H), 5.26 (s, 2H), 4.80 (s, 2H). 13C{1H}
NMR (63 MHz, CDCl3) δ 166.2, 138.8, 136.5, 129.5, M29.3, 129.1,
127.5, 122.1, 109.5, 67.7, 50.9. HRMS [ESI]: m/z calculated for
C15H15NO2 [M]
+ 241.1097, found 241.1097. IR (ATR): ν = 2924
(w), 1713 (s), 1288 (m), 1134 (m), 1088 (m), 725 (s) cm−1.
Methyl 2-(Phenyl(1H-pyrrol-1-yl)methyl)acrylate (8ba).7 Yield:
colorless solid, 1.09 g, 5.15 mmol, 88%. Chromatography: ethyl
acetate/petroleum ether 5:95.
Methyl 2-((1H-Pyrrol-1-yl)(p-tolyl)methyl)acrylate (8ca). Yield:
colorless oil, 65.2 mg, 0.255 mmol, 83%. Chromatography: ethyl
acetate/petroleum ether 5:95. 1H NMR (400 MHz, CDCl3) δ 7.07
(d, J = 7.9 Hz, 2H), 6.99 (d, J = 8.2 Hz, 2H), 6.51 (t, J = 2.1 Hz, 2H),
6.37 (d, J = 1.0 Hz, 1H), 6.23 (s, 1H), 6.07 (t, J = 2.2 Hz, 2H), 5.13
(dd, J = 1.6, 0.8 Hz, 1H), 3.63 (s, 3H), 2.26 (s, 3H). 13C{1H} NMR
(101 MHz, CDCl3) δ 166.1, 141.2, 138.0, 135.1, 129.4, 127.9, 127.5,
120.7, 108.3, 62.6, 52.2, 21.1. HRMS [ESI]: m/z calculated for
C16H17NO2 [M]
+ 255.1254, found 255.1255. IR (ATR): ν = 2951
(w), 1721 (vs), 1435 (m), 1273 (s), 1138 (vs), 721 (vs) cm−1.
Methyl 2-((4-(tert-Butyl)phenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8da).7 Yield: colorless oil, 63.3 mg, 0.210 mmol, 79%. Chromatog-
raphy: ethyl acetate/petroleum ether 7.5:92.5.
Methyl 2-((3,5-Dimethylphenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8ea).7 Yield: colorless oil, 77.0 mg, 0.29 mmol, 84%. Chromatog-
raphy: diethyl ether/petroleum ether 5:95
Methyl 2-((4-Methoxyphenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8fa).7 Yield: colorless solid, 35.7 mg, 0.130 mmol, 77%.
Chromatography: ethyl acetate/petroleum ether 10:90
Methyl 2-((3-Methoxyphenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8ga).7 Yield: colorless oil, 49.0 mg, 0.18 mmol, 84%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90
Methyl 2-((1H-Pyrrol-1-yl)(4-(((trifluoromethyl)sulfonyl)oxy)-
phenyl)methyl)acrylate (8ha).7 Yield: colorless oil, 65.5 mg, 0.17
mmol, 80%. Chromatography: ethyl acetate/petroleum ether 20:80
Methyl 4-(2-(Methoxycarbonyl)-1-(1H-pyrrol-1-yl)allyl)benzoate
(8ia).7 Yield: colorless solid, 88.2 mg, 0.29 mmol, 92%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85.
Methyl 2-((4-Cyanophenyl)(1H-pyrrol-1-yl)methyl)acrylate (8ja).
Yield: colorless oil, 41.0 mg, 0.15 mmol, 92%. Chromatography: ethyl
acetate/petroleum ether 10:90 1H NMR (250 MHz, CDCl3) δ 7.73−
7.60 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 6.61 (t, J = 2.1 Hz,
1H), 6.57 (s, 1H), 6.42 (s, 1H), 6.23 (t, J = 2.2 Hz) 5.30 (s, 1H), 3.77
(s, 3H). 13C{1H} NMR (63 MHz, CDCl3) δ 166.5, 144.8, 140.8,
133.5, 130.0, 129.4, 121.5, 119.3, 113.1, 110.1, 63.1, 53.4. HRMS
[EI]: m/z calculated for C16H14N2O2 [M]
+ 266.1050, found
266.1052. IR (ATR): ν = 2955 (w), 2230 (w), 1721 (s), 1273
(m), 1142 (s), 725 (vs) cm−1.
Methyl 2-((4-(Trifluormethyl)-phenyl)(1H-pyrrol-1-yl)methyl)-
acrylate (8ka).7 Yield: colorless solid, 60.5 mg, 0.20 mmol, 82%. %.
Chromatography: ethyl acetate/petroleum ether 10:90
Methyl 2-((4-Nitrophenyl)(1H-pyrrol-1-yl)methyl)acrylate (8la).7
Yield: colorless oil, 30.6 mg, 0.11 mmol, 79%. Chromatography:
diethyl ether: petroleum ether 30:70
Methyl 4-((3-Nitrophenyl)(1H-pyrrol-1-yl)allyl)benzoate (8ma).
Yield: colorless oil, 30.0 mg, 0.10 mmol, 71%. Chromatography: ethyl
acetate/petroleum ether 10:90 1H NMR (250 MHz, CDCl3) δ 8.22
(dd, J = 8.0, 1.9 Hz, 1H), 8.06 (d, J = 2.0 Hz, 1H), 7.68−7.39 (m,
2H), 6.62 (dd, J = 5.0, 2.7 Hz, 3H), 6.47 (s, 1H), 6.24 (d, J = 2.1 Hz,
2H), 5.33 (s, 1H), 3.77 (d, J = 1.6 Hz, 3H). 13C{1H} NMR (63 MHz,
CDCl3) δ 166.4, 149.5, 141.6, 140.8, 134.8, 130.8, 123.0, 124.2, 123.7,
121.5, 110.2, 62.9, 53.4. HRMS [ESI]: m/z calculated for
C15H14N2O4 [M]
+ 286.0954, found 286.0948. IR (ATR): ν = 2955
(w), 1721 (s), 1528 (vs), 1346 (vs), 1273 (s), 725 (vs) cm−1.
Methyl 2-((4-Fluorophenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8na). Yield: colorless solid, 62.1 mg, 0.24 mmol, 68%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90. 1H NMR (400 MHz,
CDCl3) δ 7.18 (dd, J = 8.6, 5.3 Hz, 2H), 7.07 (t, J = 8.6 Hz, 2H), 6.61
(t, J = 2.1 Hz, 2H), 6.50 (s, 1H), 6.36 (s, 1H), 6.20 (t, J = 2.1 Hz,
2H), 5.25 (d, J = 2.0 Hz, 1H), 3.75 (s, 3H). 13C{1H} NMR (101
MHz,) δ 165.9, 162.5 (d, JC−F = 247.2 Hz), 141.0, 134.0 (d, JC−F = 3.3
Hz), 129.7 (d, JC−F = 8.2 Hz), 127.9, 120.6, 115.7 (d, JC−F = 21.7 Hz),
108.6, 62.1, 52.3. 19F NMR (377 MHz, CDCl3) δ −113.82. HRMS
[ESI]: m/z calculated for C15H14FNO2 [M]
+ 259.1003, found
259.1007. IR (ATR): ν = 2951 (w), 1717 (s), 1508 (s), 1265 (m),
1219 (m) 1134 (m), 733 (vs) cm−1.
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Methyl 2-((4-Chlorophenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8oa).7 Yield: colorless oil, 40.0 mg, 0.14 mmol, >99%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85.
Methyl 2-((4-Bromophenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8pa). Yield: colorless solid, 61.7 mg, 0.19 mmol, 84%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90 1H NMR (250 MHz,
CDCl3) δ 7.48 (d, J = 8.4 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 6.58 (t, J
= 2.2 Hz, 2H), 6.49 (s, 1H), 6.30 (s, 1H), 6.17 (t, J = 2.2 Hz, 2H),
5.23 (s, 1H), 3.72 (s, 3H). 13C{1H} NMR (63 MHz, CDCl3) δ 166.7,
141.5, 138.3, 132.8, 130.5, 129.1, 123.2, 121.5, 109.6, 63.1, 53.2.
HRMS [EI]: m/z calculated for C15H14NO2BrNa [M + Na]
+
342.0106, found 342.0106. IR (ATR): ν = 2951 (w), 1721 (vs),
1489 (m), 1273 (s), 1142 (s), 1072 (m), 725 (vs) cm−1.
Methyl 2-((3-Bromophenyl)(1H-pyrrol-1-yl)methyl)acrylate
(8qa).7 Yield: colorless oil, 58.0 mg, 0.18 mmol, 82%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90.
Methyl 2-((4-Iodophenyl)(1H-pyrrol-1-yl)methyl)acrylate (8ra).
Yield: colorless solid, 69.0 mg, 0.19 mmol, 82%. Chromatography:
diethyl ether/petroleum ether 10:90 1H NMR (300 MHz, CDCl3) δ
7.77−7.50 (m, 2H), 6.96−6.80 (m, 2H), 6.57 (t, J = 2.1 Hz, 2H),
6.48 (t, J = 0.8 Hz, 1H), 6.29 (s, 1H), 6.17 (t, J = 2.2 Hz, 2H), 5.24
(d, J = 1.5 Hz, 1H), 3.72 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3) δ
165.8, 140.6, 138.1, 137.9, 129.9, 128.3, 120.7, 108.8, 94.1, 62.3, 52.4.
HRMS [ESI]: m/z calculated for C15H14INO2 [M]
+ 367.0064, found
367.0066. IR (ATR): ν = 2947 (w), 1697 (vs), 1481 (m), 1439 (m),
1269 (m), 1142 (s), 1084 (s), 737 (vs) cm−1.
Methyl 2-(Naphthalen-2-yl(1H-pyrrol-1-yl)methyl)acrylate
(8sa).7 Yield: yellow solid, 61.4 mg, 0.21 mmol, 88%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90.
Methyl 2-(Cyclohexyl(1H-pyrrol-1-yl)methyl)acrylate (8ta).7
Yield: colorless oil, 26.5 mg, 0.11 mmol, 84%. Chromatography:
diethyl ether/petroleum ether 5:95.
Methyl 2-Methylene-5-phenyl-3-(1H-pyrrol-1-yl)pentanoate
(8ua).7 Yield: colorless oil, 45.5 mg, 0.169 mmol, 55%. Chromatog-
raphy: ethyl acetate/petroleum ether 2.5:97.5.
Methyl 2-((1H-Pyrrol-1-yl)(1-((trifluoromethyl)sulfonyl)-1H-indol-
3-yl)methyl)acrylate (8va).7 Yield: colorless wax, 38.3 mg, 0.09
mmol, 71%. Chromatography: diethyl ether/petroleum ether 5:95.
Methyl 2-((2-Cyano-1H-pyrrol-1-yl)(phenyl)methyl)acrylate
(8bb).7 Yield: colorless oil, 26.6 mg, 0.100 mmol, 67%. Chromatog-
raphy: ethyl acetate/petroleum ether 10:90.
Methyl 1-(2-(Methoxycarbonyl)-1-phenylallyl)-1H-pyrrole-2-car-
boxylate (8bc).7 Yield: brown oil, 37.5 mg, 0.125 mmol, 67%.
Chromatography: ethyl acetate/petroleum ether 10:90.
Methyl 2-((1H-Indol-1-yl)(phenyl)methyl)acrylate (8bf).12c Yield:
colorless solid, 86.2 mg, 0.285 mmol, 96%. Chromatography: ethyl
acetate/petroleum ether 10:90.
Methyl 2-((5-Nitro-1H-indol-1-yl)(phenyl)methyl)acrylate (8bg).7
Yield: brown solid, 49.3 mg, 0.147 mmol, 77%. Chromatography:
ethyl acetate/petroleum ether 15:85.
Methyl 2-((4-Cyano-1H-indol-1-yl)(phenyl)methyl)acrylate
(8bh).7 Yield: colorless oil, 7.8 mg, 0.025 mmol, 93%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85.
Methyl 2-((5-Bromo-1H-indol-1-yl)(phenyl)methyl)acrylate
(8bi).12c Yield: colorless oil, 60.7 mg, 0.163 mmol, 90%.
Chromatography: ethyl acetate/petroleum ether 15:85.
Methyl 2-((5-Methoxy-1H-indol-1-yl)(phenyl)methyl)acrylate
(8bj).7 Yield: colorless solid, 74.0 mg, 0.22 mmol, 88%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85.
Methyl 2-((2-Methyl-1H-indol-1-yl)(phenyl)methyl)acrylate
(8bk).7 Yield: colorless oil, 37.6 mg, 0.123 mmol, 47%. Chromatog-
raphy: ethyl acetate/petroleum ether 5:95.
Methyl 2-((9H-Carbazol-9-yl)(phenyl)methyl)acrylate (8bl).7
Yield: colorless solid, 52.4 mg, 0.15 mmol, 82%. Chromatography:
ethyl acetate/petroleum ether 10:90.
Benzyl 2-((5-Bromo-1H-indol-1-yl)methyl)acrylate (8ai). Yield:
colorless solid, 23.7 mg, 0.064 mmol, 89%. Chromatography: ethyl
acetate/petroleum ether 10:90 1H NMR (400 MHz, CDCl3) δ 7.78
(d, J = 1.8 Hz, 1H), 7.39 (dd, J = 5.0, 3.3 Hz, 5H), 7.32−7.25 (m,
1H), 7.20−7.09 (m, 2H), 6.54−6.46 (m, 1H), 6.33 (s, 1H), 5.25 (s,
2H), 5.21 (s, 1H), 5.01 (s, 2H). 13C{1H} NMR (101 MHz, CDCl3) δ
165.2, 136.1, 135.4, 134.7, 130.3, 129.5, 128.7, 128.5, 128.3, 126.7,
124.7, 123.5, 113.0, 111.1, 101.6, 67.0, 47.0. HRMS [EI]: m/z
calculated for C19H16NO2Br [M]
+ 369.0365, found 369.0364. IR
(ATR): ν = 2928 (w), 1721 (s), 1466 (m), 1258 (vs), 1157 (vs), 736
(vs) cm−1.
Benzyl 2-((1H-Indol-1-yl)methyl)acrylate (8af). Yield: colorless
oil, 24.4 mg, 0.084 mmol, 69%. Chromatography: ethyl acetate/
petroleum ether 10:90 1H NMR (400 MHz, CDCl3) δ 7.77−7.67 (m,
1H), 7.41 (d, J = 3.4 Hz, 5H), 7.35−7.12 (m, 4H), 6.61−6.53 (m,
1H), 6.33 (s, 1H), 5.28 (s, 2H), 5.22 (s, 1H), 5.06 (s, 2H). 13C{1H}
NMR (101 MHz, CDCl3) δ 165.4, 136.4, 136.0, 135.6, 128.7, 128.6,
128.5, 128.4, 128.3, 126.6, 121.8, 121.0, 119.7, 109.6, 102.0, 66.9,
46.8. HRMS [ESI]: m/z calculated for C19H17NO2 [M]
+ 291.1259,
found 291.1253. IR (ATR): ν = 2951 (w), 1712 (s), 1462 (m), 1258
(vs), 1130 (s), 737 (vs) cm−1.
Benzyl 2-((2-Methyl-1H-indol-1-yl)methyl)acrylate (8ak). Yield:
colorless oil, 20.0 mg, 0.070 mmol, 69%. Chromatography: ethyl
acetate/petroleum ether 10:90 1H NMR (250 MHz, CDCl3) δ 7.63−
7.56 (m, 1H), 7.50−7.40 (m, 5H), 7.25−7.04 (m, 3H), 6.40−6.32
(m, 1H), 6.26 (s, 1H), 5.33 (s, 2H), 5.00 (t, J = 2.0 Hz, 2H), 4.87 (d,
J = 2.1 Hz, 1H), 2.40 (s, 3H).). 13C{1H} NMR (101 MHz, CDCl3) δ
165.5, 136.7, 136.4, 136.1, 135.6, 128.7, 128.5, 128.3, 128.2, 125.6,
120.9, 119.8, 119.7, 109.0, 100.7, 66.9, 43.3, 12.4. HRMS [ESI]: m/z
calculated for C20H19NO2 [M]
+ 305.1416, found 305.1416. IR
(ATR): ν = 1708 (s), 1454 (m), 1369 (m), 1292 (vs), 1130 (s),
737 (vs) cm−1.
Methyl 1-(2-(Methoxycarbonyl)-1-(4-(trifluoromethyl)phenyl)-
allyl)-1H-pyrrole-2-carboxylate (8kc).7 Yield: colorless oil, 26.6 mg,
0.072 mmol, 72%. Chromatography: diethyl ether/petroleum ether
20:80.
Methyl 4-(1-(1H-Indol-1-yl)-2-(methoxycarbonyl)allyl)benzoate
(8if).7 Yield: colorless solid, 74.0 mg, 0.22 mmol, 88%. Chromatog-
raphy: ethyl acetate/petroleum ether 20:80.
Methyl 2-((5-Bromo-1H-indol-1-yl)(2-fluorophenyl)methyl)-
acrylate (8wi).7 Yield: colorless oil, 30.5 mg, 0.08 mmol, 44%.
Chromatography: diethyl ether/petroleum ether 10:90.
Methyl 2-((9H-Carbazol-9-yl)(4-cyanophenyl)methyl)acrylate
(8jl).7 Yield: colorless solid, 81.2 mg, 0.22 mmol, 82%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85.
Methyl 2-((4-Chlorophenyl)(3-cyano-1H-indol-1-yl)methyl)-
acrylate (8om).7 Yield: wax, 65.0 mg, 0.19 mmol, 77%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85
Methyl 2-((5-Bromo-1H-indol-1-yl)(2-bromophenyl)methyl)-
acrylate (8xi).7 Yield: colorless oil, 58.0 mg, 0.13 mmol, 84%.
Chromatography: diethyl ether/petroleum ether 10:90
General Procedure for Enantioselective Allylation of N-
Heterocycles. To a flask N-silyl heterocycle (0.1 mmol) and
(DHQD)2PHAL (7.8 mg, 10 mol %) were added successively, and
the flask was then evacuated and refilled with nitrogen. This
procedure was repeated three times. Dry PhCF3 (0.5 mL), dissolving
MBH fluorides (0.2 mmol), was then added. The reaction mixture
was stirred at room temperature. After stirring for 40 h or the
completion of the reaction (monitored by TLC), the mixture was
concentrated and purified by flash column chromatography with ethyl
acetate in petroleum ether to afford the corresponding product. NMR
data were compared with the racemic material. The ratio of
enantiomers was determined by HPLC on chiral stationary phase.
General Procedure Hydrogenation of Substitution Prod-
ucts. The substrate (1 equiv) was dissolved in MeOH (1 mL) and
degassed with nitrogen for 5 min. Pd/C (10 mol %) was added, and
hydrogen was bubbled through the mixture until observed to be
completed (by GC-MS). The reaction mixture was filtered on a plug
of silica eluting with ethyl acetate if not stated differently.
Methyl 2-Methyl-3-phenyl-3-(1H-pyrrol-1-yl)propanoate (9ba).
Yield: colorless solid, 166 mg, 0.68 mmol, >99%. Mixture of
diastereomers. 1H NMR (250 MHz, CDCl3) δ 7.45−7.22 (m, 5H),
6.79 (m, 2H), 6.22−6.08 (m, 2H), 5.21 (m, 1H), 3.62 (s, 3H
(major)), 3.62 (s, 3H (minor)) 3.55−3.40 (m, 1H), 1.16 (m,
3H).13C{1H} NMR (63 MHz, CDCl3) δ 175.7, 175.4, 140.3, 139.5,
129.8, 129.6, 129.1, 129.0, 128.3, 127.9, 120.6, 120.3, 109.4, 109.2,
67.2, 66.6, 53.0, 52.8, 46.0, 45.8, 16.9, 165. HRMS [ESI]: m/z
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calculated for C15H17NNaO2 [M + Na]
+ 266.1157, found 266.1161.
IR (ATR): ν  = 2935 (w), 1728 (vs), 1454 (m), 1261 (m), 1092 (m),
725 (vs); 702 (vs) cm−1.
Methyl 3-(3,5-Dimethylphenyl)-2-methyl-3-(1H-pyrrol-1-yl)-
propanoate (9ea). Yield: colorless solid, 24.3 mg, 0.09 mmol,
>99%. Mixture of diastereomers. 1H NMR (400 MHz, CDCl3) δ 6.96
(m, 3H), 6.78 (m, 2H), 6.17 (m, 2H (minor)), 6.11 (m, 2H (major)),
5.12 (m, 1H), 3.59 (s, 3H, (major)), 3.52−3.40 (s, 3H (minor)), 2.31
(m, 6H), 1.13 (m, 3H).13C{1H} NMR (101 MHz, CDCl3) δ 175.0,
174.5, 139.2, 138.38, 138.37, 138.1, 129.9, 129.8, 125.2, 124.8, 119.7,
119.4, 108.4, 108.1, 66.4, 65.6, 52.0, 51.8, 45.0, 44.9, 21.4, 16.1, 15.6,
15.5. HRMS [ESI]: m/z calculated for C17H21NO2 [M]
+ 271.1567,
found 271.1570. IR (ATR): ν  = 3951 (w), 1753 (vs), 1458 (m), 1265
(m), 1165 (m), 718 (vs), 698 (s) cm−1.
Methyl 2-Methyl-5-phenyl-3-(1H-pyrrol-1-yl)pentanoate (9ua).
Yield: colorless oil, 22 mg, 0.08 mmol. Mixture of diastereomers. 1H
NMR (400 MHz, CDCl3) δ 7.38−7.26 (m, 2H), 7.27−7.18 (m, 2H),
7.17−7.06 (m, 2H), 6.70 (m, 2H), 6.23 (t, 2H (minor)), 6.19 (t, 2H
(major)), 4.1 (m, 1H (major)), 4.05 (m, 1H (minor)), 3.72 (s, 1H
(minor)), 3.54 (3H (major)), 2.88 (1H), 2.52−2.34 (2H), 2.30−1.98
(2H), 1.23 (3H (major)), 0.94 (3H (minor)). 13C{1H} NMR (101
MHz, CDCl3) δ 175.0, 174.5, 141.02, 140.97, 128.5, 128.4, 126.1,
126.0, 119.5, 119.4, 108.3, 108.0, 61.5, 61.4, 51.9, 51.8, 46.7, 46.5,
35.9, 33.8, 32.2, 32.0, 14.6, 14.4. HRMS [EI]: m/z calculated for
C17H21NO2 [M]
+ 271.1567, found 271.1568. IR (ATR): ν  = 2951
(w), 1732 (s), 1265 (m), 1161 (m), 721 (vs), 698 (vs) cm−1.
Methyl 3-Cyclohexyl-2-methyl-3-(1H-pyrrol-1-yl)propanoate
(9ta). Yield: colorless oil, 59 mg, 0.237 mmol. Mixture of
diastereomers. 1H NMR (400 MHz, CDCl3) δ 6.61 (m, 2H), 6.12
(m, 2H), 3.99 (dd, J = 8.6, 7.0 Hz, 1H (minor)), 3.89 (dd, J = 8.2, 6.6
Hz, 01H (major)), 3.71 (s, 3H (minor)), 3.57 (s, 3H (major)), 3.22−
2.95 (m, 1H), 1.89 (dddd, J = 11.7, 8.7, 6.5, 3.3 Hz, 1H), 1.82−1.44
(m, 6H), 1.22 (d, J = 7.0 Hz, 3H), 1.18−1.07 (m, 2H (major)), 1.01
(d, J = 7.0 Hz, 2H(minor)), 0.96−0.77 (m, 1H). 13C{1H} NMR (101
MHz, CDCl3) δ 175.3, 174.7, 120.8, 120.6, 107.5, 107.1, 67.4, 66.8,
51.9, 51.7, 42.5, 42.0, 41.2, 39.4, 30.9, 30.6, 28.7, 28.0, 26.3, 26.24,
26.21, 26.17, 26.12, 15.0, 13.49. HRMS [EI]: m/z calculated for
C15H23NO2 [M]
+ 249.1729, found 249.1724. IR (ATR): ν  = 2973
(m), 2855 (m), 1735 (s), 1261 (m), 1165 (m), 721 (vs) cm−1.
Methyl 3-(4-Methoxyphenyl)-2-methyl-3-(1H-pyrrol-1-yl)-
propanoate (9fa). Yield: colorless oil, 20.2 mg, 0.074 mmol. Mixture
of diastereomers. 1H NMR (400 MHz, CDCl3) δ 7.37−7.23 (m, 2H),
6.99−6.82 (m, 2H), 6.76 (m, 2H), 6.16 (m, 2H (minor)), 6.11 (m,
2H (major)), 5.16 (m, 1H), 3.80 (m, 3H), 3.60 (s, 3H (major)), 3.56
(s, 3H (minor)), 3.43 (m, 1H), 1.14 (m, 3H). 13C{1H} NMR (101
MHz, CDCl3) δ 174.9, 174.5, 159.4, 159.2, 131.7, 130.8, 129.9, 128.6,
128.2, 119.5, 119.3, 114.2, 114.0, 113.8, 108.5, 108.2, 65.7, 65.1, 55.3,
55.2, 52.1, 51.9, 45.3, 45.1, 29.7, 16.0, 15.6. HRMS [EI]: m/z
calculated for C16H19NO3 [M]
+ 273.1359, found 273.1355. IR
(ATR): ν  = 2951 (w), 1735 (s), 1512 (s), 1250 (m), 1165 (s),
723 (vs), 629 (s) cm−1.
Methyl (syn)-2-Methyl-3-(naphthalen-2-yl)-3-(1H-pyrrol-1-yl)-
propanoate (syn-9sa). Yield: colorless solid, 47.4 mg, 0.162 mmol,
41%. 1H NMR (400 MHz, CDCl3) δ 7.86−7.79 (m, 3H), 7.58−7.42
(m, 3H), 6.84 (t, J = 2.2 Hz, 2H), 6.20 (t, J = 2.1 Hz, 2H), 5.39 (d, J
= 11.0 Hz, 1H), 3.67−3.59 (m, 1H), 3.55 (s, 3H), 1.23 (d, J = 6.9 Hz,
3H). 13C{1H} NMR (101 MHz, CDCl3) δ 174.5, 136.8, 133.2, 133.0,
128.7, 128.2, 127.6, 126.3, 126.3, 125.6, 125.3, 119.8, 108.7, 65.6,
52.0, 44.9, 15.7. HRMS [EI]: m/z calculated for C19H19NO2 [M]
+
293.1410, found 293.1414. IR (ATR): ν  = 2935 (w), 1720 (vs), 1357
(m), 1269 (m), 1177 (m), 725 (vs), 383 (vs) cm−1.
Methyl (anti)-2-Methyl-3-(naphthalen-2-yl)-3-(1H-pyrrol-1-yl)-
propanoate (anti-9sa). Yield: colorless solid, 25.0 mg, 0.085 mmol,
21%. 1H NMR (400 MHz, CDCl3) δ 7.92−7.78 (m, 4H), 7.55−7.49
(m, 2H), 7.44 (dd, J = 8.5, 1.8 Hz, 1H), 6.86 (t, J = 2.2 Hz, 2H), 6.14
(t, J = 2.2 Hz, 2H), 5.40 (d, J = 11.2 Hz, 1H), 3.65 (s, 3H), 3.62−3.54
(m, 1H), 1.17 (d, J = 7.0 Hz, 3H). 13C{1H} NMR (101 MHz,
0CDCl3) δ 174.9, 136.0, 133.2, 133.1, 129.0, 128.03, 128.02, 127.7,
126.8, 126.5, 126.4, 124.6, 119.5, 108.4, 66.4, 52.2, 44.8, 16.1. HRMS
[EI]: m/z calculated for C19H19NO2 [M]
+ 293.1410, found 293.1413.
IR (ATR): ν  = 2936 (w), 1728 (s), 1258 (m), 1161 (m), 725 (vs),
687 (m) cm−1.
Methyl 3-(4-Fluorophenyl)-2-methyl-3-(1H-pyrrol-1-yl)-
propanoate (9na). Yield: colorless oil, 18.9 mg, 0.07 mmol. Mixture
of diastereomers. 1H NMR (400 MHz,CDCl3) δ 7.32 (m, 2H), 7.14−
6.96 (m, 2H), 6.76 (m, 2H), 6.18 (m, 2H), 5.19 (m, 1H), 3.61 (s, 3H
(major)), 3.56 (s, 3H (minor)), 3.42 (m, 1H), 1.13 (m, 3H).
13C{1H} NMR (101 MHz, CDCl3) δ 174.6, 174.3, 162.4 (d, J =
247.4 Hz), 134.6, 134.6, 129.0 (d, J = 8.3 Hz), 128,7 (d, J = 8.2 Hz),
119.5, 119.3, 115.8 (d, J = 21.4 Hz), 115.6 (d, J = 21.6 Hz), 108.8,
108.5, 65.5, 65.0, 52.2, 52.0, 45.2, 45.0, 16.0. 19F NMR (377 MHz,
CDCl3) δ −113.74, −114.01. HRMS [EI]: m/z calculated for
C15H16NFO2 [M]
+ 261.1160, found 261.1162. IR (ATR): ν  = 2951
(w), 1753 (s), 1512 (s), 1265 (m), 1161 (s), 721 (vs), 623 (s) cm−1.
Methyl 3-(4-Trifluoromethyl)-2-methyl-3-(1H-pyrrol-1-yl)-
propanoate (9ka). Yield: colorless oil, 46.5 mg, 0.15 mmol. Mixture
of diastereomers. 1H NMR (250 MHz, CDCl3) δ 7.62 (m, 2H), 7.46
(m, 2H), 6.78 (m, 2H), 6.18 (m, 2H), 5.28 (m, 1H), 3.64 (s, 3H
(major)), 3.58 (s, 3H (minor)), 3.55−3.39 (m, 1H), 1.17 (m, 3H).
13C{1H} NMR (63 MHz, CDCl3) δ 175.2, 175.0, 143.6, 131.4 (q,
JC−F = 32.4 Hz) 128.6, 128.3, 126.8 (q, JC−F = 3.8 Hz), 120.5, 120.3,
110.0, 109.7, 66.6, 66.0, 53.2, 53.0, 45.7, 45.5, 16.8, 16.4. 19F NMR
(377 MHz, CDCl3) δ −62.72. HRMS [EI]: m/z calculated for
C16H16NF3O2 [M]
+ 311.1128, found 311.1131. IR (ATR): ν  = 2954
(w), 1736 (s), 1250 (m), 1323 (vs), 1165 (s), 1068 (vs) cm−1.
Methyl 4-(3-Methoxy-2-methyl-3-oxo-1-(1H-pyrrol-1-yl)propyl)-
benzoate (9ia). Yield: colorless solid, 45 mg, 0.15 mmol, >99%.
Mixture of diastereomers. 1H NMR (400 MHz, CDCl3) δ 8.02−7.86
(m, 2H), 7.38−7.26 (m, 2H), 6.66 (m, 2H), 6.07 (m, 2H (minor)),
6.02 (m, 2H (major)), 5.15 (m, 1H), 3.81 (m, 3H), 3.51 (s, 3H
(major)), 3.44 (s, 3H (minor)), 3.36 (m, 1H) 1.07 (2H (minor)),
1.02 (2H (major)). 13C{1H} NMR (101 MHz, CDCl3) δ 174.4,
174.1, 166.5, 166.5, 144.3, 143.6, 130.2, 130.1, 130.0, 129.9, 127.4,
127.0, 119.6, 119.4, 108.9, 108.7, 65.8, 65.3, 52.2, 52.1, 52.0, 44.9,
44.6, 15.9, 15.5. HRMS [ESI]: m/z calculated for C17H19NO4 [M]
+
301.1317 found 301.1314. IR (ATR): ν  = 2951 (w), 1720 (vs), 1435
(m), 1276 (vs), 1168 (m), 725 (m) cm−1.
Methyl 3-(4-Cyanophenyl)-2-methyl-3-(1H-pyrrol-1-yl)-
propanoate (9ja). Yield: colorless oil, 41.2 mg, 0.153 mmol. Mixture
of diastereomers. 1H NMR (250 MHz, CDCl3) δ 7.65 (m, 2H), 7.44
(m, 2H), 6.75 (m, 2H), 6.27−6.08 (m, 2H), 5.39−5.18 (m, 1H), 3.63
(s, 3H (major)), 3.58 (s, 3H (minor)), 3.44 (m, 1H), 1.17 (3H).
13C{1H} NMR (63 MHz, CDCl3) δ 175.0, 174.9, 145.5, 144.7, 133.7,
133.5, 128.9, 128.6, 120.5, 120.3, 119.2, 113.2, 113.0, 110.2, 110.0,
66.5, 66.0, 53.2, 53.1, 45.6, 45.3, 30.6, 16.8, 16.4. HRMS [EI]: m/z
calculated for C16H16N2O2 [M]
+ 268.1206, found 268.1208. IR
(ATR): ν  = 2955 (w), 2230 (w), 1732 (s), 1269 (m), 1168 (m), 721
(vs) cm−1.
General Procedure for Intramolecular Friedel−Craft Acyla-
tion. Under nitrogen, the substrate (1 equiv) was dissolved in
CH2Cl2 (0.1M) and BBr3 (1.05 equiv) was added slowly. The
reaction was monitored by TLC and, when judged completed, poured
into sat. NaHCO3 solution. The organic phase was separated, and the
aqueous phase was extracted twice with CH2Cl2. The combined
organic phases were dried over Na2SO4 and, after evaporation,
subjected to column chromatography to yield the desired compound.
(2S,3R)-2-Methyl-3-phenyl-2,3-dihydro-1H-pyrrolizin-1-one
(trans-7ba). Yield: colorless oil, 74.9 mg, 0.35 mmol, 53%.
Chromatography: ethyl acetate/petroleum ether 15:85. 1H NMR
(250 MHz, CDCl3) δ 7.46−7.37 (m, 3H), 7.26−7.17 (m, 2H), 6.82
(d, J = 2.1 Hz, 2H), 6.56 (dd, J = 3.8, 2.5 Hz, 1H), 5.02 (d, J = 4.8 Hz,
1H), 2.98 (qd, J = 7.4, 4.8 Hz, 1H), 1.44 (d, J = 7.4 Hz, 3H).
13C{1H} NMR (63 MHz, CDCl3) δ 192.0, 140.3, 133.7, 130.2, 129.6,
127.3, 123.2, 118.1, 108.9, 67.5, 57.1, 15.1. HRMS [ESI]: m/z
calculated for C14H13NNaO [M + Na]
+ 234.0894, found 234.0896. IR
(ATR): ν  = 2966 (w), 1693 (vs), 1523 (m), 1454 (m), 1307 (s), 736
(vs), 798 (vs) cm−1.
(2S,3S)-2-Methyl-3-phenyl-2,3-dihydro-1H-pyrrolizin-1-one (cis-
7ba). Yield: colorless solid, 13.0 mg, 0.06 mmol, 10%. Chromatog-
raphy: ethyl acetate/petroleum ether 15:85. 1H NMR (400 MHz,
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CDCl3) δ 7.34 (dd, J = 5.8, 1.6 Hz, 3H), 6.92 (dd, J = 2.3, 1.1 Hz,
1H), 6.85 (dd, J = 3.8, 1.2 Hz, 3H), 6.61 (dd, J = 4.0, 2.3 Hz, 1H),
5.72 (d, J = 8.0 Hz, 1H), 3.50 (p, J = 7.7 Hz, 1H), 0.86 (d, J = 7.6 Hz,
3H). 13C{1H} NMR (63 MHz, CDCl3) δ 191.6, 138.3, 132.7, 128.8,
128.4, 126.9, 122.8, 117.2, 107.5, 62.6, 50.5, 12.1. IR (ATR): ν  =
2970 (w), 2018 (w), 1693 (vs), 1524 (m), 1369 (m), 1307 (m), 741
(s), 698 (s) in cm−1.
(2S,3R)-3-(3,5-Dimethylphenyl)-2-methyl-2,3-dihydro-1H-pyrro-
lizin-1-one (trans-7ea). Yield: colorless oil, 11.3 mg, 0.047 mmol,
53%. Chromatography: ethyl acetate/petroleum ether 15:85. 1H
NMR (250 MHz, CDCl3) δ 7.03 (s, 1H), 6.91−6.77 (m, 4H), 6.58
(dd, J = 3.7, 2.6 Hz, 1H), 4.94 (d, J = 4.8 Hz, 1H), 2.99 (qd, J = 7.4,
4.8 Hz, 1H), 2.34 (s, 6H), 1.44 (d, J = 7.4 Hz, 3H). 13C{1H} NMR
(63 MHz, CDCl3) δ 186.9, 134.9, 134.5, 128.3, 125.9, 119.8, 117.9,
112.6, 103.5, 62.2, 51.7, 16.9, 9.8. HRMS [ESI]: m/z calculated for
C16H18NO [M + H]
+ 240.1383, found 240.1338. IR (ATR): ν  = 2924
(w), 1697 (vs), 1527 (m), 1369 (m), 1307 (m), 848 (m), 741 (vs)
cm−1. This compound was subjected to the conventional self-
disproportionation of enantiomers (SDE) test described in the
literature.20 We did not observe significant SDE for this compound,
and there were no indications of significant SDE with other pyrrolizin-
1-one and N-allyl pyrroles reported here.
trans-2-Methyl-3-phenethyl-2,3-dihydro-1H-pyrrolizin-1-one
(trans-7ua). Yield: colorless solid, 7.5 mg, 0.040 mmol, 55% (brsm).
Chromatography: ethyl acetate/petroleum ether 10:90. 1H NMR
(400 MHz, CDCl3) δ 7.34 (dd, J = 8.0, 6.6 Hz, 2H), 7.30−7.20 (m,
3H), 7.05 (dd, J = 2.3, 1.0 Hz, 1H), 6.76 (dd, J = 4.0, 1.0 Hz, 1H),
6.56 (dd, J = 4.0, 2.3 Hz, 1H), 4.15 (dt, J = 8.1, 4.2 Hz, 1H), 2.87 (qd,
J = 7.4, 3.9 Hz, 1H), 2.82−2.66 (m, 2H), 2.46−2.30 (m, 1H), 2.24−
2.05 (m, 1H), 1.42 (d, J = 7.4 Hz, 3H).13C{1H} NMR (101 MHz,
CDCl3) δ 191.9, 140.4, 132.2, 128.7, 128.2, 126.4, 121.5, 116.9, 107.8,
62.1, 51.7, 37.2, 31.4, 15.9. HRMS [EI]: m/z calculated for
C16H17NO [M]
+ 239.1305, found 239.1303. IR (ATR): ν  = 2928
(w), 1693 (vs), 1523 (vs), 1307 (s), 736 (vs) cm−1.
trans-3-Cyclohexyl-2-methyl-2,3-dihydro-1H-pyrrolizin-1-one
(trans-7ta). Yield: colorless oil, 24.6 mg, 0.113 mmol, 62%.
Chromatography: ethyl acetate/petroleum ether 10:90. 1H NMR
(300 MHz, CDCl3) δ 7.01 (s, 1H), 6.70 (d, J = 4.0 Hz, 1H), 6.52 (dd,
J = 4.0, 2.3 Hz, 1H), 4.00 (t, J = 3.8 Hz, 2H), 2.85 (qd, J = 7.5, 3.3 Hz,
2H), 1.99−1.63 (m, 4H), 1.35 (d, J = 7.5 Hz, 3H), 1.31−1.14 (3H)
1.12−0.97 (m, 3H), 0.87 (m, 2H). 13C{1H} NMR (75 MHz, CDCl3)
δ 192.6, 132.4, 122.0, 116.61, 107.3, 67.4, 48.1, 42.4, 29.7, 28.9, 26.8,
26.3, 26.1, 25.9, 17.0. HRMS [EI]: m/z calculated for C14H19NO
[M]+ 217.1467, found 217.1463. IR (ATR): ν  = 2824 (m), 2855 (m),
1693 (vs), 1527 (m), 1369 (m), 1307 (m), 733 (vs) cm−1.
trans-3-(4-Methoxyphenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-
1-one (trans-7fa). Yield: colorless oil, 5.0 mg, 0.023 mmol, 32%.
Chromatography: ethyl acetate/petroleum ether 30:70. 1H NMR
(600 MHz, CDCl3) δ 7.05 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz,
2H), 6.73 (dd, J = 3.9, 1.1 Hz, 1H), 6.71 (dd, J = 2.4, 1.0 Hz, 1H),
6.46 (dd, J = 3.9, 2.3 Hz, 1H), 4.87 (d, J = 5.0 Hz, 1H), 3.75 (s, 3H),
2.88 (qd, J = 7.4, 5.0 Hz, 1H), 1.33 (d, J = 7.4 Hz, 3H). 13C{1H}
NMR (151 MHz, CDCl3) δ 191.3, 159.9, 132.7, 131.2, 127.8, 122.1,
117.1, 114.6, 107.9, 66.2, 56.2, 55.4, 14.0. HRMS [EI]: m/z calculated
for C15H15NO2 [M]
+ 241.1097, found 241.1095. IR (ATR): ν  = 2931
(w), 1693 (vs), 1512 (vs), 1249 (vs), 1030 (m), 736 (s), 613 (m)
cm−1.
trans-2-Methyl-3-(naphthalen-2-yl)-2,3-dihydro-1H-pyrrolizin-1-
one (trans-7sa). Yield: colorless solid, 4.8 mg, 0.018 mmol, 24%
(brsm). Chromatography: ethyl acetate/petroleum ether 15:85. 1H
NMR (400 MHz, CDCl3) δ 7.95−7.84 (m, 3H), 7.75 (d, J = 1.7 Hz,
1H), 7.63−7.50 (m, 2H), 7.22 (dd, J = 8.5, 1.9 Hz, 1H), 6.89 (dd, J =
3.9, 1.1 Hz, 1H), 6.84 (dd, J = 2.3, 1.1 Hz, 1H), 6.60 (dd, J = 4.0, 2.3
Hz, 1H), 5.19 (d, J = 4.9 Hz, 1H), 3.10 (qd, J = 7.4, 4.9 Hz, 1H), 1.49
(d, J = 7.4 Hz, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 191.1,
136.5, 133.3, 133.2, 129.6, 127.9, 127.9, 126.8, 126.8, 126.1, 123.4,
122.3, 117.3, 108.1, 66.9, 56.0, 14.2. HRMS [EI]: m/z calculated for
C18H15NO [M]
+ 261.1148, found 261.1152. IR (ATR): ν  = 2928
(w), 1693 (m), 1527 (m), 1572 (m), 1366 (m), 1308 (s), 736 (vs)
cm−1.
trans-3-(4-Fluorophenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-
one (trans-7na). Yield: colorless solid, 9.4 mg, 0.041 mmol, 53%.
Chromatography: ethyl acetate/petroleum ether 20:80. 1H NMR
(400 MHz, CDCl3) δ 7.19 (m 2H), 7.11 (m2H), 6.84 (dd, J = 4.0, 1.1
Hz, 1H), 6.82−6.79 (m, 1H), 6.58 (dd, J = 4.0, 2.3 Hz, 1H), 5.01 (d, J
= 4.8 Hz, 1H), 2.95 (qd, J = 7.4, 4.9 Hz, 1H), 1.44 (d, J = 7.4 Hz,
3H). 13C{1H} NMR (101 MHz, CDCl3) δ 190.8, 162.8 (d, JC−F =
247.9 Hz), 135.2 (d, JC−F = 3.1 Hz), 132.7, 128.2 (d, JC−F = 8.4 Hz),
122.1, 117.3, 116.3 (d, JC−F = 21.7 Hz), 108.1, 66.0, 56.2, 14.2. HRMS
[EI]: m/z calculated for C14H12NFO [M]
+ 229.0897, found 229.0899.
IR (ATR): ν  = 2931 (w), 1705 (s), 1512 (m), 1288 (m), 1010 (m),
829 (vs), 775 (s) cm−1.
cis-3-(4-Fluorophenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-
one (cis-7na). Yield: colorless solid, 1.2 mg, 0.005 mmol, 7%.
Chromatography: ethyl acetate/petroleum ether 20:80. 1H NMR
(300 MHz, CDCl3) δ 7.03 (m, 2H), 6.90 (m, 1H), 6.89−6.77 (m,
2H), 6.60 (dd, J = 4.0, 2.3 Hz, 1H), 5.71 (d, J = 8.0 Hz, 1H), 3.48 (p,
J = 7.7 Hz, 1H), 0.85 (d, J = 7.6 Hz, 3H). 19F NMR (377 MHz,
CDCl3) δ −113.37. HRMS [EI]: m/z calculated for C14H12NFO
[M]+ 229.0897, found 229.0900.
trans-3-(4-Trifluormethylphenyl)-2-methyl-2,3-dihydro-1H-pyr-
rolizin-1-one (trans-7ka). Yield: colorless solid, 12.2 mg, 0.044
mmol, 30%. Chromatography: ethyl acetate/petroleum ether 15:85.
1H NMR (250 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 2H), 7.33 (d, J =
8.1 Hz, 2H), 6.89−6.86 (m, 1H), 6.83 (dd, J = 2.4, 1.0 Hz, 1H), 6.61
(dd, J = 3.9, 2.4 Hz, 1H), 5.11 (d, J = 4.8 Hz, 1H), 2.97 (qd, J = 7.4,
4.8 Hz, 1H), 1.48 (d, J = 7.4 Hz, 3H). 13C{1H} NMR (63 MHz,
CDCl3) δ 191.2, 144.4, 133.7, 132.0 (q, JC−F = 32.5 Hz), 127.6, 127.2
(q, JC−F = 3.76 Hz), 124.7 (q, JC−F = 272 Hz), 118.5, 109.3, 67.0, 57.1,
15.2. 19F NMR (377 MHz, CDCl3) δ −62.72. HRMS [EI]: m/z
calculated for C15H12NF3O [M]
+ 279.0866, found 279.0862. IR
(ATR): ν  = 2970 (w), 1697 (m), 1528 (vs), 1312 (vs), 1065 (vs),
1018 (m), 734 (m) cm−1.
trans-3-(4-Cyanophenyl)-2-methyl-2,3-dihydro-1H-pyrrolizin-1-
one (trans-7ia). Yield: colorless solid, 7.2 mg, 0.030 mmol, 22%
(brsm). Chromatography: ethyl acetate/petroleum ether 20:80. 1H
NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.3 Hz, 1H), 7.30 (d, J = 8.4
Hz, 2H), 6.86 (dd, J = 4.0, 1.1 Hz, 1H), 6.82 (dd, J = 2.4, 1.0 Hz,
1H), 6.61 (dd, J = 4.0, 2.4 Hz, 1H), 5.10 (d, J = 4.7 Hz, 1H), 2.92
(qd, J = 7.4, 4.7 Hz, 1H), 1.47 (d, J = 7.4 Hz, 3H). 13C{1H} NMR
(101 MHz, CDCl3) δ 189.9, 144.8, 133.2, 132.7, 127.0, 122.1, 118.1,
117.9, 112.8, 108.5, 66.0, 56.1, 14.5. HRMS [EI]: m/z calculated for
C15H12N2O [M]
+ 236.0944, found 236.0945. IR (ATR): ν  = 2927
(w), 1701 (vs), 1458 (m), 1369 (m), 1281 (vs), 744 (m) cm−1.
trans-Methyl 4-(trans)-2-Methyl-1-oxo-2,3-dihydro-1H-pyrroli-
zin-3-yl)benzoate (trans-7ja). Yield: colorless solid, 16.9 mg, 0.063
mmol, 46% (brsm). Chromatography: ethyl acetate/petroleum ether
20:80. 1H NMR (600 MHz, CDCl3) δ 8.07−7.96 (m, 2H), 7.17 (d, J
= 8.3 Hz, 2H), 6.76 (d, J = 4.0 Hz, 1H), 6.73 (d, J = 1.3 Hz, 1H), 6.50
(dd, J = 4.0, 2.3 Hz, 1H), 5.00 (d, J = 4.8 Hz, 1H), 3.86 (s, 3H), 2.87
(qd, J = 7.4, 4.8 Hz, 1H), 1.37 (d, J = 7.4 Hz, 3H). 13C{1H} NMR
(151 MHz, CDCl3) δ 190.5, 166.4, 144.4, 132.7, 130.6, 130.6, 126.3,
122.2, 117.5, 108.3, 66.2, 56.1, 52.3, 14.4. HRMS [EI]: m/z calculated
for C16H15NO3 [M]
+ 269.1052, found 269.1053.
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Bellstedt, and Dr. Nico Ueberschaar for their support with
HPLC, NMR, and MS analysis, respectively. The help of
Constanze Schultz, Lea Klepsch, and Hannah Zeihe in the
synthesis of starting materials is greatly appreciated.
■ REFERENCES
(1) (a) Liddell, J. R. Pyrrolizidine alkaloids. Nat. Prod. Rep. 2002, 19,
773. (b) Robertson, J.; Stevens, K. Pyrrolizidine alkaloids. Nat. Prod.
Rep. 2014, 31, 1721. (c) Gouda, A. M.; Abdelazeem, A. H. An
integrated overview on pyrrolizines as potential anti-inflammatory,
analgesic and antipyretic agents. Eur. J. Med. Chem. 2016, 114, 257.
(d) Robertson, J.; Stevens, K. Pyrrolizidine alkaloids: occurrence,
biology, and chemical synthesis. Nat. Prod. Rep. 2017, 34, 62.
(2) (a) Usuki, H.; Toyo-oka, M.; Kanzaki, H.; Okuda, T.; Nitoda, T.
Pochonicine, a polyhydroxylated pyrrolizidine alkaloid from fungus
Pochonia suchlasporia var. suchlasporia TAMA 87 as a potent β-N-
acetylglucosaminidase inhibitor. Bioorg. Med. Chem. 2009, 17, 7248.
(b) Kitamura, Y.; Koshino, H.; Nakamura, T.; Tsuchida, A.; Nitoda,
T.; Kanzaki, H.; Matsuoka, K.; Takahashi, S. Total synthesis of the
proposed structure for pochonicine and determination of its absolute
configuration. Tetrahedron Lett. 2013, 54, 1456. (c) Zhu, J.-S.;
Nakagawa, S.; Chen, W.; Adachi, I.; Jia, Y.-M.; Hu, X.-G.; Fleet, G.
W.; Wilson, F. X.; Nitoda, T.; Horne, G. Synthesis of eight
stereoisomers of pochonicine: nanomolar inhibition of β-N-
acetylhexosaminidases. J. Org. Chem. 2013, 78, 10298.
(3) (a) Tries, S.; Laufer, S. The pharmacological profile of ML3000:
A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase
and 5-lipoxygenase. Inflammopharmacology 2001, 9, 113. (b) Paredes,
Y.; Massicotte, F.; Pelletier, J. P.; Martel-Pelletier, J.; Laufer, S.;
Lajeunesse, D. Study of the role of leukotriene B4 in abnormal
function of human subchondral osteoarthritis osteoblasts: Effects of
cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum.
2002, 46, 1804. (c) Fischer, L.; Hornig, M.; Pergola, C.; Meindl, N.;
Franke, L.; Tanrikulu, Y.; Dodt, G.; Schneider, G.; Steinhilber, D.;
Werz, O. The molecular mechanism of the inhibition by licofelone of
the biosynthesis of 5-lipoxygenase products. Br. J. Pharmacol. 2007,
152, 471. (d) Koeberle, A.; Siemoneit, U.; Bühring, U.; Northoff, H.;
Laufer, S.; Albrecht, W.; Werz, O. Licofelone suppresses prostaglandin
E2 formation by interference with the inducible microsomal
prostaglandin E2 synthase-1. J. Pharmacol. Exp. Ther. 2008, 326, 975.
(4) (a) Campbell, S.; Comer, M.; Derbyshire, P.; Despinoy, X. M.;
Sommerville, C. Synthesis of pyrrolizin-3-ones by flash vacuum
pyrolysis of pyrrol-2-ylmethylidene Meldrum’s acid derivatives and 3-
(pyrrol-2-yl) propenoic esters. J. Chem. Soc., Perkin Trans. 1 1997, 1,
2195. (b) Pinho e Melo, T. M.; Soares, M. I.; Gonsalves, A. M. d. A.
R.; Paixao, J. A.; Beja, A. M.; Silva, M. R. N-Vinyl-and C-Vinylpyrroles
from Azafulvenium Methides. Flash Vacuum Pyrolysis Route to 5-
Oxo-5 H-pyrrolizines and 1-Azabenzo [f] azulenes. J. Org. Chem.
2005, 70, 6629. (c) Boussard, M.-F.; Truche, S.; Rousseau-Rojas, A.;
Briss, S.; Descamps, S.; Droual, M.; Wierzbicki, M.; Ferry, G.;
Audinot, V.; Delagrange, P. New ligands at the melatonin binding site
MT3. Eur. J. Med. Chem. 2006, 41, 306. (d) Unaleroglu, C.; Yazici, A.
Gadolinium triflate catalyzed alkylation of pyrroles: efficient synthesis
of 3-oxo-2, 3-dihydro-1H-pyrrolizine derivatives. Tetrahedron 2007,
63, 5608. (e) Kirk, N. S.; Bezos, A.; Willis, A. C.; Sudta, P.;
Suksamrarn, S.; Parish, C. R.; Ranson, M.; Kelso, M. J. Synthesis and
preliminary evaluation of 5, 7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as
angiogenesis inhibitors. Bioorg. Med. Chem. Lett. 2016, 26, 1813.
(f) Simic, M.; Tasic, G.; Jovanovic, P.; Petkovic, M.; Savic, V.
Preparation of pyrrolizinone derivatives via sequential transformations
of cyclic allyl imides: synthesis of quinolactacide and marinamide.
Org. Biomol. Chem. 2018, 16, 2125.
(5) Jourdan, J. P.; Since, M.; El Kihel, L.; Lecoutey, C.; Corvaisier,
S.; Legay, R.; Sopkova-́de Oliveira Santos, J.; Cresteil, T.; Malzert-
Freón, A.; Rochais, C. Benzylphenylpyrrolizinones with Anti-amyloid
and Radical Scavenging Effects, Potentially Useful in Alzheimer’s
Disease Treatment. ChemMedChem 2017, 12, 913.
(6) (a) Sonnet, P.; Dallemagne, P.; Guillon, J.; Enguehard, C.;
Stiebing, S.; Tanguy, J.; Bureau, R.; Rault, S.; Auvray, P. c.; Moslemi,
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Abstract The use of latent nucleophiles, which are molecules that are
not nucleophilic but can be activated to act as a nucleophile at an op-
portune time during the reaction, expands the scope of Lewis base cat-
alyzed reactions. Here, we provide an overview of the concept and
show examples of applications to N- and C-centered nucleophiles in al-
lylic substitutions. N- and C-silyl compounds are superior latent
(pro)nucleophiles in Lewis base catalyzed reactions with allylic fluorides
in which the formation of the strong Si–F bond serves as the driving
force for the reactions. The latent (pro)nucleophiles ensure high regio-
selectivity in these reactions and enable enantioselective transforma-
tions of Morita–Baylis–Hillman adducts by the use of common chiral
Lewis base catalysts.
1 Introduction
2 Substitution of MBH Carbonates
3 The Concept of Latent (Pro)Nucleophiles
4 Enantioselective Allylation of N-Heterocycles
5 Enantioselective Phosphonyldifluoromethylation of Allylic Fluo-
rides
6 Conclusion
Key words Lewis base catalysis, enantioselective catalysis, organoca-
talysis, latent nucleophiles, latent pronucleophiles, allylic substitutions
1 Introduction
Enantioselective organocatalysis is still considered an
emerging technology ‘that will change our world’ according
to IUPAC.1 The main reason for this is its potential to make
synthetic organic chemistry more sustainable. Consequent-
ly, the goals in the field of enantioselective organocatalysis
are grouped around the development of (i) new catalysts
that maintain their efficacy with lower catalysts loading,2
(ii) efficient heterogeneous or immobilized organocatalysts
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tion,3 and (iii) more diverse ways to utilize the green and
sustainable raw materials.4 That said, the spotlight in any
discipline remains universally focused on pushing the
boundaries of what is possible and, in organic synthesis
specifically, discovering new types of reactivity. Lewis base
catalysis offers ample opportunity for such improvements,
which can be illustrated with Lewis base catalyzed allylic
substitutions. These reactions have been most often stud-
ied with Morita–Baylis–Hillman (MBH) adducts, derivatives
of MBH allylic alcohols.5 MBH alcohols can be prepared via
the perfectly atom economical Lewis base catalyzed reac-
tion of a suitable Michael acceptor and an aldehyde. Their
synthesis in the solid phase eliminates solvent waste and
makes MBH alcohols prime examples of green synthetic
products.6
It is not surprising that MBH alcohols became suitable
substrates for allylic substitution upon transformation of
the hydroxy into a better leaving group such as an ester.7
Such substrates will undergo a substitution reaction with
good nucleophiles to produce either the product of direct
SN2 substitution or the product of SN2′ substitution that
proceeds with transposition of the double bond, although
the underlying mechanism is unlikely to be a simple SN2 or
an SN2′ reaction (Scheme 1a). If such reactions are to be cat-
alyzed by a Lewis base catalyst and be regioselective, the
catalyst must be more nucleophilic than the nucleophilic
reaction partner and must show preference for formation of
a bond with one of the carbons of the allylic system. If this
is not the case, the reaction may proceed without involve-
ment of the catalyst and may lead to the formation of mix-
tures of SN2 and SN2′ products (Scheme 1a).8 It is apparent
that when a chiral Lewis base catalyst is used and the reac-
tion proceeds without involvement of the catalyst, the reac-
tions do not result in enantioselective formation of the
products.
2 Substitution of MBH Carbonates
A common strategy to overcome the problems in Lewis
base catalyzed allylic substitutions of MBH adducts
emerged through a switch of the electrophiles from MBH
esters to MBH carbonates.9 Lewis base catalysts such as
DABCO attack the Michael acceptor in the MBH carbonate
and trigger elimination of the carbonate via the E1cB mech-
anism (Scheme 1b). Loss of CO2 turns the carbonate into an
alcoholate. tert-Butoxide, a bulky base that is not strongly
nucleophilic, is formed when MBH Boc-carbonates are
used. The base will readily deprotonate any sufficiently
acidic X-H and generate an anionic nucleophile. This nucle-
ophile may attack the activated electrophile III′ and engage
in a regioselective reaction that is also enantioselective
when a chiral catalyst is a part of the activated electrophile
III′.
Scheme 1  An overview of (a) regioselectivity issues, (b) sequential ac-
tivation mechanism, and (c) enantioselectivity, chemoselectivity and 
reaction scope for Lewis base catalyzed substitutions of MBH carbon-
ates.
This kind of sequential activation of the electrophile by
the Lewis base catalyst and the nucleophile by the leaving
group produced during activation of the electrophile en-
sures that the activated nucleophile is produced only when
the activated electrophile is already present in the reaction
mixture. If the reaction between the two activated species
proceeds selectively, then the regio- and enantioselectivity
observed in such reactions is high. This strategy has been
utilized to introduce various types of Nu-H nucleophiles,10
but they all have one limitation: the need for an acidic Nu-
H that can be deprotonated by the tert-butoxide (Scheme
1c). Reactions with phthalimide, for example, proceed suc-
cessfully, but other less acidic N-centered nucleophiles are
not suitable for reactions with MBH carbonates. The re-
quirement for an acidic N-H or C-H is a severely limiting
factor for N- and C-centered nucleophiles.11
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quential activation that is not dependent on acid/base equi-
librium between the leaving group and the nucleophile but
rather on a thermodynamically favorable formation of a
strong Si–F bond, which also usually proceeds with high
rates. This method enabled allylation of trifluoromethyl,
(tetrazolyl)methyl and alkynyl nucleophiles carrying a
trimethylsilyl group (Scheme 2).12 A highly ordered ternary
transition state that features silyl assistance in C–F bond
cleavage and intramolecular delivery of the nucleophile has
been proposed for these reactions, but the reactions could
also proceed via an intermediate silicon ate complex that
fragments into trimethylsilylfluoride and the anionic nucle-
ophile. A range of other similar mechanistic scenarios can
also be envisioned.
Scheme 2  Novel mode of nucleophile activation via Si–F bond formation
Since the proposed silicon ate intermediate features
multiple carbon substituents, a question arises: which of
these substituents will be transferred as a nucleophile? Our
hypothesis was that it is the least basic group that will be
transferred as the nucleophile because it should also be the
best at stabilizing the negative charge. We consequently re-
alized the potential this mode of activation has for address-
ing several specific limitations in the use of N-centered nu-
cleophiles in Lewis base catalysis and allowing the develop-
ment of a truly general approach to Lewis base catalyzed N-
allylation. This hypothesis was a foundation of the concept
of latent nucleophiles in Lewis base catalysis.
3 The Concept of Latent (Pro)Nucleophiles
Latent nucleophiles are derivatives of nucleophilic mol-
ecules that are not markedly nucleophilic but can be acti-
vated to act as a nucleophile under specific conditions or
with a specific stimulus.13 These should be distinguished
from latent pronucleophiles, which are molecular species
that are not nucleophilic in nature but can be transformed
into a strong nucleophile by a specific stimulus or a chemi-
cal reaction.14 As a rule, the parent molecule from which
the pronucleophile is derived is not (or not markedly) nuc-
leophilic.
Latent nucleophiles do not compete with the Lewis base
catalyst. If activation of the latent nucleophile depends on
the activation of the electrophile by mediacy of the leaving
group, the resulting sequential activation allows for tempo-
ral control over formation of the activated nucleophile. The
activated nucleophile, which could compete with the cata-
lyst, is produced only when the activated electrophile is al-
ready present in the mixture; this allows the fast and selec-
tive reaction of the two activated intermediates to outcom-
pete other possible pathways (Scheme 3).
Scheme 3  The concept of latent nucleophiles and the interdependent 
sequential activation of electrophile and nucleophile in Lewis base ca-
talysis
Applying this concept to Lewis base catalyzed N-allyla-
tion, we envisioned N-trialkylsilyl compounds as latent nu-
cleophiles. A bulky silyl group reduces the nucleophilicity
of the nitrogen and makes the molecule less nucleophilic
than the corresponding N-H compound.15 A fluoride leaving
group is a suitable nucleophile activator and a mediator in
the sequential activation of the reaction partners, which
makes allyl fluorides suitable electrophiles. Finally, the rea-
son why this concept is best suited for N-centered nucleop-
hiles is the fact that, by virtue of being less basic than any of
the alkyl groups of the trialkylsilyl, it will always be the N-
centered nucleophile that is transferred from the proposed
ate intermediate derived from the N-trialkylsilyl com-
pound. Through synergy of these three effects, this strategy
may accommodate virtually any N-centered nucleophile.
4 Enantioselective Allylation of N-Heterocycles
The proof of principle study was the development of a
general protocol for enantioselective N-allylation of pyr-
roles and related heterocycles with MBH fluorides using si-
lylated heterocycles as latent nucleophiles. Pyrroles and in-
doles have been used in similar reactions with allylic car-
bonates, but these studies highlighted the need for
electron-withdrawing substituents on the nucleophile that
renders N-H more acidic and/or the need for stoichiometric
amounts of Lewis base.16 N-TBS-pyrroles, indoles and car-
bazoles were selected as latent nucleophiles in reactions
with MBH fluorides. The reactions proceed with high rates
and excellent efficiencies when DABCO is used as a catalyst
with 5 mol% loading. In many cases, catalyst loading can be
further reduced to 1 mol%. The reactions feature truly broad
scope both for the electrophile and the latent nucleophile
(Scheme 4a–c). They are not overly sensitive to steric hin-
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M. Lange et al. SynpactsSyn lettdrance in the vicinity of the reactive centers nor to elec-
tronic effects of the substituents in the starting materials
(electronically matched and mismatched substrates yield
the desired products with similar yields). Finally, the reac-
tions are highly regioselective, affording only SN2 substitu-
tion products.
A series of crossover experiments revealed that the free
anionic nucleophiles are likely produced in the course of
the reaction (Scheme 4d). Furthermore, it was demonstrat-
ed that activation of the electrophile by the Lewis base cat-
alysts (and further sequential activation) is instrumental
for the success of these reactions. If only the nucleophile is
activated17 by a catalytic amount of exogenous fluoride
ions, the reactions are autocatalytic, the regioselectivity is
reversed and only the product of SN2′ substitution is ob-
served (Scheme 4e).
Using chiral cinchona alkaloid based catalysts such as
(DHQD)2PHAL in trifluorotoluene renders these reactions
enantioselective. The diminished nucleophilicity of the chi-
ral catalysts compared to DABCO results in significantly
longer reactions times and highlights the need for the latent
nucleophile to be truly latent. Despite the longer reaction
times, the products are again isolated without regioselec-
tivity issues (only SN2 products observed). The products are
isolated with good enantiomeric ratios (87:13 for 6v′ to
99:1 for 6ac′; Scheme 5a and b) despite the slight drop in
yields attributed to longer reaction times. Reflecting the re-
sults of the reactions with DABCO, steric and electronic
properties of the reaction partners do not hinder the de-
sired N-allylation reactions and focused optimization can
be conducted to improve the efficacy of the reactions with
specific pairs of reactants.13
The reactions with chiral Lewis bases are kinetic resolu-
tions of the racemic allylic fluorides and the yields are high-
est when the fluoride is used in double the stoichiometric
quantity. The allylic fluoride remaining at the end of the re-
actions is enantioenriched. Reactions of the two enantio-
mers of allylic fluoride are enantioconvergent and, based on
qualitative observations, they proceed at different rates. Ab-
solute configuration of the products is consistent with pre-
viously reported data for reactions using (DHQD)2PHAL.10,12
The new Lewis base catalyzed enantioselective allyla-
tions of pyrrole-derived latent nucleophiles have already
found application in the first enantioselective synthesis of
pyrrolizin-1-ones (Scheme 5c). These compounds exhibit
anti-amyloid properties, making them potentially useful for
the treatment of Alzheimer’s disease but have not been
prepared in enantioenriched form yet.18 Starting from the
N-allylated pyrrole, a short and straightforward syntheses
of pyrrolizin-1-ones includes hydrogenation of the double
bond, which gives statistical mixtures of the syn and anti
products in excellent yields, and the subsequent Friedel–
Crafts type intramolecular acylation using BBr3.19 The cy-
clization furnishes the corresponding pyrrolizinones in a
Scheme 4  (a–c) Reaction scope and (d, e) mechanistic studies for N-
allylation
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M. Lange et al. SynpactsSyn letthighly diastereoselective manner favoring the trans product
(typically >25:1) while maintaining the enantiomeric ratios
of the starting material. The origin of the diastereoselectivi-
ty in these reactions is facile epimerization at the -carbon
to the carbonyl, which is thermodynamically driven.
5 Enantioselective Phosphonyldifluoro-
methylation of Allylic Fluorides using a Latent 
Pronucleophile
The concept of latent nucleophiles applied to C-centered
nucleophiles is better described as the concept of latent
pronucleophiles. The latency is not necessarily imposed on
the C-centered nucleophiles by a capping group like with
the bulky silyl group in the case of N-centered nucleo-
philes.20 Our first ventures in this direction were the at-
tempts to carry out enantioselective allylation of the difluo-
romethyl anion that would arise from the difluoromethyl-
trimethylsilane latent pronucleophile, which met with
failure. This suggested that it is only the stabilized C-cen-
tered nucleophiles that would be suitable pronucleophiles.
The difluoromethyl group is an oxygen bioisostere and a
lipophilic hydrogen-bond donor commonly used by medici-
nal chemists as a substitute for hydroxyl groups in lead op-
timization.21 Replacing the ester oxygen in a phosphate
with a difluoromethyl group creates a bioisostere of phos-
phates that are of interest as potential inhibitor of kinases
and enzymes involved in signaling through phosphoryla-
tion.22 Intrigued by the need to introduce phosphonyldiflu-
oromethyl group in drug-like molecules and driven by the
desire to stabilize the difluoromethyl anion with additional
substituents (and phosphonate fits the bill very well), we
focused on diethyl (difluoro(trimethylsilyl)methyl)-phos-
phonate 8 as a latent pronucleophile in Lewis base cata-
lyzed allylation (Scheme 6).14
Scheme 6  Scope for enantioselective allylation of difluoromethyl 
phosphonates.
The reactions of this unusual latent pronucleophile with
allylic fluorides required an excess of the reagent to drive
full conversion when DABCO was used as a catalyst. The ki-
netic resolution scenario discussed in the previous section
usually requires an excess of the fluoride to drive full con-
version of the latent nucleophile. Seemingly reconciling the
Scheme 5  (a, b) Reaction scope for the enantioselective N-allylation 
and (c) application for medicinal chemistry and the synthesis of pyr-
rolizinones. a Overall yield.
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M. Lange et al. SynpactsSyn letttwo requirements, we focused on optimization of reactions
that use equimolar quantities of the two reactants. The op-
timized conditions involve (DHQD)2PHAL (10 mol%) as the
catalyst in a mixture of dioxane and THF (5:1) at 0 °C
(Scheme 6). The reactions are kinetic resolutions that,
when stopped at around 50% conversion of the fluoride,
give the products with enantiomeric ratios ranging from
90:10 for (S)-9c to 98:2 for (S)-9a typically with good iso-
lated yields (30% up to 55%). Analysis of the remaining fluo-
ride starting materials shows excellent enantiomeric ratios,
often higher than 99:1. The recovered enantioenriched al-
lylic fluoride can be easily transformed into the other enan-
tiomer of the product by using the pseudoenantiomer of
(DHQD)2PHAL, (DHQ)2PHAL with similar yields and stereo-
selectivity. These reactions are the first examples of enantio-
selective phosphonyldifluoromethylation and they allowed
a short investigation of the consequent transformations of
the difluoromethylphosphonates. Such transformations
proved to be significantly more stereoselective than related
reactions with N-allyl-pyrroles due to the conformational
preferences imposed by the difluoromethyl group.
6 Conclusion
The concept of latent nucleophiles and pronucleophiles
is a powerful strategy to expand the nucleophile scope in
Lewis base catalyzed reactions. The concept is based on
three cornerstones: (i) the use of a capping group to impose
latency and lower the nucleophilicity of the nucleophilic re-
action partner, (ii) sequential activation of electrophile and
the nucleophile where activation of the latter is dependent
on the activation of the former and (iii) selectivity in gener-
ating the stabilized anionic nucleophiles. Although other
types of latent (pro)nucleophiles are envisioned, N-silyl and
C-silyl compounds have already been used as latent
(pro)nucleophiles in Lewis base catalyzed allylic substitu-
tions of allylic fluorides. In addition to expansion of the nu-
cleophile scope in Lewis base catalyzed reactions, latent nu-
cleophiles are instrumental in ensuring high regioselectivi-
ties and are an enabling factor in enantioselective
transformations that use chiral Lewis base catalysts. The
concept should not be limited to Lewis base catalysis and
will likely prove to be a general strategy that is useful in
other areas of organic chemistry. Numerous applications of
this concept in transition-metal-catalyzed processes can be
envisioned, and recent reports23 are an indication of its
broader potential.
Funding Information
Financial support from Carl-Zeiss Foundation (Carl-Zeiss-Stiftung en-
dowed professorship to I.V.), Friedrich Schiller University Jena and
State of Thuringia (fellowship to M.L.) is gratefully acknowledged.Carl-Zeis-Stiftung ()
Acknowledgment
The authors would like to express their gratitude to Constanze Schul-
tz, Philipp Schüler and Suresh Kumar for support in carrying out the
projects described in this article. We are grateful for numerous help-
ful discussions with Prof. Hans-Dieter Arndt and we thank Dr. Nico
Ueberschaar and Dr. Peter Bellstedt for their help and support with
MS and NMR analysis.
References
(1) Gomollón-Bel, F. Chem. Int. 2019, 41, 12.
(2) (a) Trost, B. M.; Brindle, C. S. Chem. Soc. Rev. 2010, 39, 1600.
(b) Ooi, T. ACS Catal. 2015, 5, 6980. (c) List, B. Acc. Chem. Res.
2004, 37, 548. (d) Rodríguez, B.; Rantanen, T.; Bolm, C. Angew.
Chem. Int. Ed. 2006, 45, 6924. (e) Huy, P. H. Eur. J. Org. Chem.
2020, 10.
(3) Lee, J.-W.; Mayer-Gall, T.; Opwis, K.; Song, C. E.; Gutmann, J. S.;
List, B. Science 2013, 341, 1225.
(4) Meninno, S. ChemSusChem 2020, 13, 439.
(5) (a) Kim, J. N.; Lee, H. J.; Gong, J. H. Tetrahedron Lett. 2002, 43,
9141. (b) Shafiq, Z.; Liu, L.; Liu, Z.; Wang, D.; Chen, Y.-J. Org. Lett.
2007, 9, 2525. (c) Wang, F.; Li, S.; Qu, M.; Zhao, M.-X.; Liu, L.-J.;
Shi, M. Chem. Commun. 2011, 47, 12813. (d) Li, Z.; Frings, M.; Yu,
H.; Raabe, G.; Bolm, C. Org. Lett. 2018, 20, 7367.
(6) Basavaiah, D.; Rao, A. J.; Satyanarayana, T. Chem. Rev. 2003, 103,
811.
(7) (a) Basavaiah, D.; Kumaragurubaran, N.; Sharada, D. S.; Reddy, R.
M. Tetrahedron 2001, 57, 8167. (b) Yao, L.; Wang, C.-J. Adv. Synth.
Catal. 2015, 357, 384. (c) Zhong, N.-J.; Wang, Y.-Z.; Cheng, L.;
Wang, D.; Liu, L. Org. Biomol. Chem. 2018, 16, 5214.
(8) Baidya, M.; Remennikov, G. Y.; Mayer, P.; Mayr, H. Chem. Eur. J.
2010, 16, 1365.
(9) (a) Du, Y.; Han, X.; Lu, X. Tetrahedron Lett. 2004, 45, 4967.
(b) Wu, L.; Zhang, Q.-R.; Huang, J.-R.; Li, Y.; Su, F.; Dong, L. Tetra-
hedron 2017, 73, 3966.
(10) (a) Cui, H.-L.; Feng, X.; Peng, J.; Lei, J.; Jiang, K.; Chen, Y.-C.
Angew. Chem. Int. Ed. 2009, 48, 5737. (b) Zhuang, Z.; Pan, F.; Fu,
J.-G.; Chen, J.-M.; Liao, W.-W. Org. Lett. 2011, 13, 6164.
(c) Huang, L.; Wei, Y.; Shi, M. Org. Biomol. Chem. 2012, 10, 1396.
(d) Lin, A.; Mao, H.; Zhu, X.; Ge, H.; Tan, R.; Zhu, C.; Cheng, Y.
Adv. Synth. Catal. 2011, 353, 3301. (e) Zhao, S.; Jin, L.; Chen, Z.-
L.; Rui, X.; He, J.-Y.; Xia, R.; Chen, K.; Chen, X.-X.; Yin, Z.-J.; Chen,
X. RSC Adv. 2019, 9, 11585. (f) Feng, X.; Yuan, Y.-Q.; Cui, H.-L.;
Jiang, K.; Chen, Y.-C. Org. Biomol. Chem. 2009, 7, 3660.
(11) (a) Kamlar, M.; Císařová, I.; Hybelbauerová, S.; Veselý, J. Eur. J.
Org. Chem. 2017, 1926. (b) Formánek, B.; Šimek, M.; Kamlar, M.;
Císařová, I.; Veselý, J. Synthesis 2019, 51, 907. (c) Zi, Y.; Lange,
M.; Schüler, P.; Krieck, S.; Westerhausen, M.; Vilotijevic, I.
Synlett 2020, 31, 575. (d) van Steenis, D. J. V. C.; Marcelli, T.; Lutz,
M.; Spek, A. L.; van Maarseveen, J. H.; Hiemstra, H. Adv. Synth.
Catal. 2007, 349, 281.
(12) (a) Nishimine, T.; Fukushi, K.; Shibata, N.; Taira, H.; Tokunaga,
E.; Yamano, A.; Shiro, M.; Shibata, N. Angew. Chem. Int. Ed. 2013,
53, 517. (b) Okusu, S.; Okazaki, H.; Tokunaga, E.; Soloshonok, V.
A.; Shibata, N. Angew. Chem. Int. Ed. 2016, 55, 6744.
(c) Nishimine, T.; Taira, H.; Mori, S.; Matsubara, O.; Tokunaga,
E.; Akiyama, H.; Soloshonok, V. A.; Shibata, N. Chem. Commun.
2017, 53, 1128.
(13) Zi, Y.; Lange, M.; Schultz, C.; Vilotijevic, I. Angew. Chem. Int. Ed.
2019, 58, 10727.
(14) Zi, Y.; Lange, M.; Vilotijevic, I. Chem. Commun. 2020, 56, 5689.© 2020. Thieme. All rights reserved. Synlett 2020, 31, A–G
G
M. Lange et al. SynpactsSyn lett(15) (a) Lakhdar, S.; Westermaier, M.; Terrier, F.; Goumont, R.;
Boubaker, T.; Ofial, A. R.; Mayr, H. J. Org. Chem. 2006, 71, 9088.
(b) Nigst, T. A.; Westermaier, M.; Ofial, A. R.; Mayr, H. Eur. J. Org.
Chem. 2008, 2369.
(16) (a) Ge, S. Q.; Hua, Y. Y.; Xia, M. Ultrason. Sonochem. 2009, 16,
743. (b) Kwon, S.-H.; Cho, C.-W. Bull. Korean Chem. Soc. 2008, 29,
1835.
(17) Hosomi, A.; Shirahata, A.; Sakurai, H. Tetrahedron Lett. 1978,
3043.
(18) Jourdan, J.-P.; Since, M.; El Kihel, L.; Lecoutey, C.; Corvaisier, S.;
Legay, R.; Sopková-de Oliveira Santos, J.; Cresteil, T.; Malzert-
Fréon, A.; Rochais, C.; Dallemagne, P. ChemMedChem 2017, 12,
913.
(19) Lange, M.; Zi, Y.; Vilotijevic, I. J. Org. Chem. 2020, 85, 1259.
(20) There will be examples where latency related to the presence of
the silyl group is relevant in reaction development, which is
why term ‘latent pronucleophile’ is more accurate than the
simple term ‘pronucleophile’. These examples are not described
here and go beyond the scope of the current discussion.
(21) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc.
Rev. 2008, 37, 320.
(22) (a) Bialy, L.; Waldmann, H. Angew. Chem. Int. Ed. 2005, 44, 3814.
(b) Hoffmann, W.; Langenhan, J.; Huhmann, S.; Moschner, J.;
Chang, R.; Accorsi, M.; Seo, J.; Rademann, J.; Meijer, G.; Koksch,
B.; Bowers, M. T.; von Helden, G.; Pagel, K. Angew. Chem. Int. Ed.
2019, 58, 8216. (c) Mandal, P. K.; Gao, F.; Lu, Z.; Ren, Z.; Ramesh,
R.; Birtwistle, J. S.; Kaluarachchi, K. K.; Chen, X.; Bast, R. C. Jr.;
Liao, W. S. J. Med. Chem. 2011, 54, 3549. (d) Bouwman, S.; Orru,
R. V.; Ruijter, E. Org. Biomol. Chem. 2015, 13, 1317.
(23) Trost, B. M.; Gholami, H.; Zell, D. J. Am. Chem. Soc. 2019, 141,
11446.© 2020. Thieme. All rights reserved. Synlett 2020, 31, A–G
 
        
 
 
 
 
 
 
Publication    P5 
Enantioselective Lewis base catalyzed phosphonyldifluoromethylation of allylic 
fluorides using a C-silyl latent pronucleophile 
 
 
Y. Zi, M. Lange, I. Vilotijevic, 
Chem. Commun. 2020, 56, 5689-5692. 
 
 
Reproduced by permission of The Royal Society of Chemistry, Copyright © 2020. 
 
The paper as well as the supporting information (free of charge) are available 
online under: DOI: 10.1039/D0CC01815E. 
 
 
 
 
 
 
 
 
 
 
This journal is©The Royal Society of Chemistry 2020 Chem. Commun.
Cite this:DOI: 10.1039/d0cc01815e
Enantioselective Lewis base catalyzed
phosphonyldifluoromethylation of allylic fluorides
using a C-silyl latent pronucleophile†
You Zi, Markus Lange and Ivan Vilotijevic *
The first enantioselective phosphonyldifluoromethylation is enabled
by the use of diethyl (difluoro(trimethylsilyl)-methyl)phosphonate
reagent as a latent pronucleophile in the Lewis base catalyzed sub-
stitution of allylic fluorides. The reaction proceeds as a kinetic resolu-
tion to produce both the difluoromethylphosphonate products and
the remaining fluorides in good yields and with high stereoselectivity.
The use of cinchona based alkaloid catalysts enables the facile synthesis
of both enantiomers of the difluoromethylphosphonate products.
The difluoromethyl group, an oxygen bioisostere and a lipophilic
hydrogen-bond donor, is commonly used in medicinal chemistry
as a replacement for hydroxyl groups that improves the properties
of biologically active molecules.1 In a similar vein, difluoromethyl-
phosphonate motifs (–CF2P(O)(OR)2) have emerged as metaboli-
cally stable bioisosteres of phosphates.2 They are surprisingly
resistant to hydrolysis and are therefore bioavailable unlike the
typical phosphate analogues. The phosphonic acids mimic the
tetrahedral transition state in the hydrolysis of peptides, which
may also be the basis for the biological activity of numerous
difluoromethylphosphonate containing enzyme inhibitors.3 Pio-
neering examples include protein tyrosine phosphatase (PTP)
inhibitors (A, Scheme 1),4 STAT3 phosphorylation inhibitors (B),5
mimics of sugar phosphates (C)6 and analogues of phosphoenol-
pyruvate (D).7 The resulting demand for difluoromethylphos-
phonates has inspired the development of strategies to introduce
this structural motif into drug like molecules (Scheme 1b).8 These
include nucleophilic additions and substitutions with the difluoro-
methylphosphonate anion with suitable electrophiles,9 additions
of the difluoromethylphosphonate radical to p-systems,10 and the
transition metal catalyzed coupling reactions for the synthesis of
aryldifluoromethylphosphonates.11 Despite the abundance of
naturally occurring chiral organophosphates, the stereoselective
methods to prepare difluoromethylphosphonates featuring an
adjacent stereogenic center are currently limited to substrate
controlled diastereoselective reactions.9c,9g A catalyst controlled
enantioselective method to introduce difluoromethylphospho-
nates while creating and controlling the configuration of an
adjacent stereogenic center would be an enabling factor for further
studies of this important bioisostere.12 With this in mind, we set
off to develop amethod to produce such chiral bioisosteres of alkyl
or allyl phosphates in an enantioselective fashion.
Scheme 1 (a) Examples of biologically active difluoromethylphos-
phonates. (b) Comparison of this work with the previous methods for
phosphonyldifluoromethylation and the use of latent (pro)nucleophiles in
Lewis base catalysis.
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Allylic substitutions have long served as a powerful tool for
stereoselective synthesis both in transition metal and Lewis
base catalyzed reactions, the latter being considered an impor-
tant part of the green chemistry toolbox.13 The most common
Lewis base catalyzed allylic substitutions utilize Morita–Baylis–
Hillman adducts as electrophiles,13c,d but the scope of these
reactions for N- and C-centered nucleophiles is limited.14
To address these challenges, we introduced the concept of
latent nucleophiles, molecules that are not nucleophilic them-
selves but can be activated to act as nucleophiles in Lewis base
catalyzed reactions.15 C- and N-trialkylsilyl latent (pro)nucleo-
philes16 undergo enantioselective Lewis base catalyzed allyla-
tion with allylic fluorides (Scheme 1b).15,17 In these reactions,
the formation of the activated nucleophile depends on the
decomposition of the silicate intermediate formed by nucleo-
philic addition of the fluoride to the silyl group of the latent
pronucleophiles.15a,17a,18 We hypothesized that this strategy
could be generally applicable to a variety of stabilized C-nucleo-
philes and useful in addressing specific synthetic problems.
Here, we report that (difluoro(trimethylsilyl)methyl)phos-
phonates serve as versatile latent pronucleophiles in Lewis base
catalyzed substitutions of allylic fluorides and enable the develop-
ment of the first enantioselective method to introduce the
(diethoxyphosphoryl)difluoromethyl group, while controlling the
configuration of the adjacent stereogenic center.
The feasibility of our approach was evaluated using com-
mercially available diethyl (difluoro(trimethylsilyl)methyl)-
phosphonate 2 in the DABCO catalyzed allylic substitution of
allylic fluoride 1a, derived from the Morita–Baylis–Hillman
alcohol adduct of acrylic ester and benzaldehyde (Scheme 2a).
Good yields in this reaction were achieved only if an excess of
the latent pronucleophile 2 was used to increase the conversion
of the fluoride to the corresponding (difluoromethyl)phos-
phonate 3a. Accordingly, the initial optimization efforts using
chiral Lewis base catalysts were made with superstoichiometric
quantities of 2. In the presence of (DHQD)2PHAL catalyst, most
reactions proceeded with good enantioselectivity but, despite
the use of an excess of the reagent, yields for the desired
allylation product remained close to but below 50%. This was
indicative of a kinetic resolution scenario,17a where one of the
enantiomers of allylic fluoride readily reacts with the chiral
catalyst while the other enantiomer remains unchanged.
To reconcile the need for superstoichiometric quantities of
the reagent that would increase conversion rates and the
requirement for a higher concentration of the fluoride that
could drive kinetic resolution to completion with respect to the
reagent, further optimization studies were focused on reactions
using equimolar quantities of allylic fluoride and the reagent
(Scheme 2b). The variables in reaction condition screening
included: the identity of the chiral catalyst, catalyst loading,
reaction solvent, temperature and concentration (for details of
optimization studies, please see the supporting information).
In a 5 : 1 mixture of dioxane and THF at 0 1C with 10 mol%
(DHQD)2PHAL catalyst, the reactions of 1a and 2 proceeded to
close to 50% conversion after 51 hours and afforded the
allylation product 3a in 47% yield and 98 : 2 ratio of enantio-
mers (Scheme 2b).
Closely monitoring the reaction progress showed that the
ratio of enantiomers in the product remained nearly constant
throughout the reaction, but that of the allylic fluoride steadily
increased with time/conversion (Scheme 2b).
Upon optimization of the reaction conditions, the reaction
scope for allylic fluorides was evaluated (Scheme 3). The low
reaction rates allowed for close monitoring of the kinetic
resolution reactions by NMR and/or HPLC on a chiral stationary
phase. The reactions were allowed to run until there were no
further changes in the er values of the remaining allylic fluoride or
when it reached a level equal to or higher than 99 : 1. A range of
esters, including methyl, ethyl, n-butyl, benzyl and t-butyl esters
(1a–1e), were investigated and converted to the corresponding
products S-3a–3e in good yields (34–47%) with good enantioselec-
tivity (95 : 5 to 98 : 2 er). The presence of electron withdrawing
groups in allylic fluorides 1g–1l noticeably increased the reaction
rates and the (difluoromethyl)phosphonate products S-3g–3l were
isolated in both good yields (38–55%) and enantioselectivities
(90 : 10 to 96 : 4 er). Allylic fluorides featuring halogen substi-
tuents, 1m–1p, were also well tolerated under the optimal
conditions, and all gave the products S-3m–3p in good yields
(42–49%,) with excellent degrees of stereocontrol (95 : 5 to 97 :3 er).
The reactions with allylic fluorides bearing electron rich aromatic
substituents 1q–1u were subsequently carried out. These uniformly
required a longer time to reach half-conversion but ultimately led to
satisfactory outcomes with yields between 30% and 45% and
enantiomeric ratios between 94 :6 and 97 :3. Installing alkyl instead
of aryl substituents lowered the reaction rates to synthetically
impractical levels (3f). In most reactions, the enantiomeric ratio
for the remaining ally fluorides R-1 was 99 :1 er or higher. The
absolute configuration of the products was assigned by analogy to
similar reactions using (DHQD)2PHAL.
Switching the catalyst to the (DHQD)2PHAL pseudoenantiomer,
(DHQ)2PHAL, unsurprisingly resulted in the preferential formation
of the other enantiomer although with slightly lower stereo-
selectivity (4 : 96 er for R-3a and 8 : 92 for R-3i, unoptimized results,
Scheme 4). Furthermore, the enantioenriched allylic fluoride R-1i
(499 :1 er) recovered from the (DHQD)2PHAL catalyzed reactionsScheme 2 Early optimization studies and the kinetic resolution of 1a.
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could be used as a starting material to produce R-3i with the same
stereoselectivity and in 80% yield in the presence of (DHQ)2PHAL.
In addition to serving as a bioisostere of phosphates,
difluoromethylphosphonate strongly influences the conforma-
tional preferences of the product, which can be exploited to
control stereoselectivity in the subsequent transformation. For
example, simple hydrogenation of analogues containing N-hetero-
cycles instead of the difluoromethylphosphonate proceeds with low
diastereoselectivity (1.4 : 1),15b while the same reactions of difluoro-
methylphosphonate analogues afford only the syn diastereomer of
6 in a nearly quantitative yield of 96% (Scheme 5a).
The effects of the fluorine atoms and the phosphonate on
the stability of the activated nucleophile were briefly explored
by examining the DABCO-catalyzed reactions of allylic fluoride 1a
with the related latent pronucleophiles: TMS-difluoromethane 7
and the diethyl (1-(trimethylsilyl)ethyl)phosphonate 8 (Scheme 5b).
7 failed to react with the allylic fluoride while the phosphonate
containing alkylsilane 8 afforded the desired product 9 although in
low yields (unoptimized results). This indicates that the formation
and decomposition of the silicate intermediate may be the deter-
mining factor for the outcome of the reaction.
In conclusion, the first enantioselective method to introduce
a phosphate bioisostere, –CF2P(O)(OR)2, has been developed
by using diethyl (difluoro(trimethylsilyl)methyl)phosphonate
reagent 2 as a latent pronucleophile in the Lewis base catalyzed
substitution of allylic fluorides. The reactions proceed as the
kinetic resolution of the racemic fluorides, which affords both
the difluoromethylphosphonate product and the recovered
allylic fluoride in good yields and with high enantiomeric ratios.
The reactions are operationally simple, use commercially available
Scheme 3 Enantioselective (DHQD)2PHAL catalyzed allylic substitution
of allylic fluorides 1 using 2 as the latent pronucleophile. The selectivity
factor19 (s) was based on recovered 1.
Scheme 4 Comparative test with (DHQ)2PHAL instead of (DHQD)2PHAL
and reaction with enantioenriched allylic fluoride.
Scheme 5 Diastereoselective hydrogenation of S-3q and influence
of the difluoromethylphosphonate on the stereochemical outcome.
Attempted reactions of 1a with related latent pronucleophiles.
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reagents and catalysts and transform readily available Morita–
Baylis–Hillman fluorides to the stable difluoromethylphospho-
nates. Both enantiomers of the product can be readily accessed
and they are amenable to further stereoselective transforma-
tions owing to the conformational effects of the difluoromethyl-
phosphonate.
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Chem. Rev., 2008, 108, 2796; (b) Q. Cheng, H.-F. Tu, C. Zheng,
J.-P. Qu, G. Helmchen and S.-L. You, Chem. Rev., 2018, 119, 1855;
(c) G. N. Ma, J. J. Jiang, M. Shi and Y. Wei, Chem. Commun., 2009,
5496; (d) Y. Wei and M. Shi, Chem. Rev., 2013, 113, 6659.
14 (a) B. M. Trost and C.-J. Li, J. Am. Chem. Soc., 1994, 116, 3167;
(b) D. Virieux, A.-F. Guillouzic and H.-J. Cristau, Tetrahedron, 2006,
62, 3710; (c) C. K. Pei, X. C. Zhang and M. Shi, Eur. J. Org. Chem.,
2011, 4479; (d) L. Zhu, H. Hu, L. Qi, Y. Zheng and W. Zhong,
Eur. J. Org. Chem., 2016, 2139.
15 (a) Y. Zi, M. Lange, C. Schultz and I. Vilotijevic, Angew. Chem., Int. Ed.,
2019, 58, 10727; (b) M. Lange, Y. Zi and I. Vilotijevic, J. Org. Chem., 2020,
85, 1259; (c) Y. Zi, M. Lange, P. Schüler, S. Krieck, M. Westerhausen and
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Lewis-base-catalysed selective reductions of
ynones with a mild hydride donor†
F. Schömberg, Y. Zi and I. Vilotijevic *
Ynones are efficiently reduced with a mild hydride donor in the
presence of a catalytic amount of nucleophilic phosphines. The
reactions are selective 1,2-reductions that give propargyl alcohols
in yields of up to 96%. It is proposed that success in these reactions
depends on the activation of ynones by a Lewis base catalyst.
A protic additive plays a key role in suppressing the undesired
reaction pathways and accelerating the 1,2-reductions.
Propargylic alcohols are a common moiety in natural products
and biologically active molecules,1 and they serve as versatile
intermediates in organic synthesis.2 Secondary propargylic alcohols
can be prepared via 1,2-reduction of ynones that are easily
accessible, i.e. via addition of alkynyl nucleophiles to various
carbonyl compounds.3 Reductions of carbonyl compounds,
including ynones, and the chemoselectivity of these reactions
have been the subjects of investigation for many decades.4
Recent efforts have focused on the use of mild reducing agents,
mild hydride donors, with an overall goal of developing more
selective transformations.5
Easy to handle, mild hydride donors such as pinacolborane
(pinBH) are ideal reductants for applications in the small scale
preparation of compound libraries where the scope and gene-
rality are of high importance. The low reactivity of pinBH pre-
vents its direct use as a reducing agent and enables its use in
catalytic processes.6 The common strategies to increase the
reactivity of such mild hydride donors, illustrated in Scheme 1,
are to rely on transition metal mediated activation,7 Brønsted
or Lewis acid activation of the substrate,8 and/or activation
of borane with a suitable Lewis base.9 Inspired by reductions
catalysed by frustrated Lewis pairs,10 and the surge of interest in
metal-free catalysts for reductions,8,11 we speculated that (i) a
suitable Lewis basemay be used to activate the carbonyl substrate,
instead of activating borane, and increase its reactivity towards
mild hydride donors such as pinBH (Scheme 1d) and that
(ii) different carbonyl compounds could be chemoselectively
reduced based on their contrasting reactivities with Lewis bases.
To test both of our hypotheses, we focused on reactions of
pinBH with ynone 5a and simple ketones (acetophenone and
cyclohexanone) in the presence of a Lewis base catalyst. The
choice of a catalyst and a reaction solvent in the initial experi-
ments was governed with the intent to activate the carbonyl
compound while avoiding activation of borane through creation
of a Lewis adduct. Simple nucleophilic phosphines were chosen
as catalysts because they do not form stable adducts with
pinBH.12 Dichloromethane, 1,2-dichloroethane and toluene were
Scheme 1 Catalytic reduction of carbonyl compounds with mild-hydride-
donor boranes.
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used as solvents to avoid activation of pinBH through the for-
mation of Lewis adducts with solvent molecules. In the presence
of catalytic amounts of tributylphosphine (20 mol%), ynone 5a
readily reacted with pinBH while acetophenone and cyclohexa-
none remained unaffected after prolonged exposure to the reac-
tion conditions. In the absence of phosphine catalysts, pinBH
does not reduce the ynone 5a. These experiments seemingly
corroborated the initial hypotheses showing (i) the effectiveness
of phosphine catalysts in reductions of ynones with pinBH and
(ii) that phosphines do not promote reduction of ketones which
opened the door for the development of chemoselective catalytic
reactions.
The product mixture isolated in the reaction of ynone 5a
highlighted the issues with reaction regioselectivity. The well-
established modes of reactivity including 1,2- and 1,4-reductions
with possible overreduction pathways, alkyne hydroboration, and
dimerization or oligomerization of ynones could easily lead to the
formation of a variety of different products. The major products
in the reduction of ynone 5a, however, were the products of
1,2- and 1,4-reductions, 6a and 1. The products of overreduction
(allylic alcohol derived from 1) and ynone dimerization were
observed in minor quantities.
Further optimization of the reaction conditions revealed that
protic additives suppress the major side reactions: 1,4-reduction
and dimerization/oligomerization of ynones (Table 1). The
increase in the selectivity and isolated yields of propargylic
alcohol 6a correlates with the increased amount of tert-butanol
in the reaction milieu (Table S1, ESI† document). When
1.5 equivalents of tert-butanol were present in the mixture,
products of 1,4-reduction and dimerization/oligomerization
were not observed and the propargylic alcohol 6a was the only
product isolated upon aqueous work up. Furthermore, in the
presence of the tert-butanol additive, catalyst loading could be
reduced to as low as 1 mol% for tributylphosphine without
affecting the yield. Only 1.1 equivalents of pinBH were suffi-
cient to effect the complete consumption of the starting ynone.
In the absence of phosphine, tert-butanol does not catalyse the
1,2-reduction reaction: reduction product 6a was not observed
after 6 hours in the presence of 2 equiv. of pinBH and 2 equiv.
of alcohol.
A set of commercially available and easy to handle alkyl- and
arylphosphines was tested as Lewis base catalysts in the reduc-
tions of ynones (for detailed results see Table S2, ESI† document).
Triphenylphosphine and diphenylmethylphosphine provided the
desired products in acceptable yields but required longer reaction
times and failed to drive the complete consumption of ynone
after 24 hours. Trialkylphosphines proved to be more efficient
catalysts with tributyl- and trimethylphosphine both effecting
the full conversion of ynones within 10 minutes with desired
products isolated in high yields. In contrast, bulky trialkyl-
phosphines, tri-t-butylphosphine and tricyclohexylphosphine,
showed decreased activity which highlighted the importance of
nucleophilicity of the phosphine catalyst for a successful reac-
tion outcome.
Upon optimizing the reaction conditions for the reduction
of 5a, the substrate scope for the 1,2-reductions of ynones was
evaluated with special attention to the identity of the a0 and
g substituents in the ynones. Urgency to evaluate various com-
binations of alkyl and aryl substituents was brought on by the
previous reports which map an extremely divergent reactivity
network in phosphine catalysed reaction of ynones or ynoates
under similar reaction conditions.13
Gratifyingly, substrates with either alkyl or aryl groups in
a0 and g positions were equally reactive as 5a, all providing the
products of 1,2-reductions in good yields (Scheme 2, compounds
6a, 6b, 6d, 6e and 6f). A similar reactivity was observed even
when a tertiary carbon centre was present in a0 or g positions of
the ynone. However, quaternary carbon centres in these posi-
tions significantly decrease the rates of the reduction reactions
making them less practical (Scheme 2, compounds 6c and 6g).
Further inspection of the substrate scope has shown that
both electron rich and electron poor ynones are efficiently
reduced under the optimized conditions (6h, 6i, 6j and 6k).
A selection of substrates containing various heterocycles such
as furan, thiophene, both protected and non-protected indoles
and protected aniline all tolerated the mild reaction conditions
well and produced the corresponding propargyl alcohols in
good yields (Scheme 2, compounds 6j–6o). It is worth noting
that under optimized conditions, acetophenone and cyclo-
hexanone do not react even after longer periods of time similar
to our initial experiments. Other reducible groups are also not
affected under optimized conditions as illustrated by substrates
6h, 6j, 6k, 6o, 6p and 6q which contain nitro, carbamate, amide,
ester and nitrile groups respectively.
A closer inspection of the substrate scope clearly matched
the expectations arising from our initial hypothesis. The sub-
strates with electron withdrawing substituents that should
render the ynone more electrophilic were reduced significantly
faster than the corresponding substrates that carry electron
donor groups (i.e. compound 6h vs. 6a vs. 6i, Scheme 2). These
observations are consistent with simple hydride delivery to
carbonyl substrates. Knowing that phosphine does not react
Table 1 Effects of additives on reaction selectivity and isolated yield of the
1,2-reduction product
Entry Additive (1.5 equiv.) Time Yield of 6aa (%)
1 AcOH 120 min (Trace)
2 DABCO 16 h 0
3 NEt3 16 h (18)
4 t-BuOK 10 min (Trace)
5 H2O 10 min 86 (86)
6 MeOH 60 min 61
7 EtOH 60 min 64
8 i-PrOH 10 min 94
9 t-BuOH 10 min 87 (89)
a Isolated yield of 6a. Numbers in brackets designate yields determined
by 1H NMR spectroscopy of crude product mixtures after quenching at a
designated time point using triphenylmethane as the standard.
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with tert-butanol or pinBH,12 we propose that the observed rate
acceleration is also a consequence of a higher rate of 1,4-addition
of the phosphine catalyst to ynones. In the presence of protic
additives, the resulting zwitterionic intermediate would get pro-
tonated to produce the corresponding vinylphosphonium salts.14
Quenching of the enolate intermediate initially produced by
conjugate addition of phosphine is believed to play a key role in
suppressing the oligomerization of ynones which occurs rapidly
in the absence of an additive or borane and in suppressing the
1,4-reduction pathways.
After establishing that a tertiary carbon centre in the a0 position
does not deter the reactivity of ynones (Scheme 2, entries 6b and 6d),
diastereoselectivity of the reductions was briefly examined with
ynones 5r, 5s and 5t (Scheme 3).15 The reactions of 5r produced a
1.8 :1 mixture of diastereomers 6ra and 6rbwith a combined yield of
96%. Reductions of 5s and 5t which feature a phenyl and a benzyl
ether substituent in a0 positions, respectively, also proceeded with
moderate diastereoselectivity producing a 2.1 :1 mixture of 6sa and
6sb and a 1.5 :1 mixture of 6ta and 6tb (anti diastereomer favoured
in both cases). The observed low diastereoselectivity in these reac-
tions may be a consequence of the low selectivity in the formation of
E- and Z-vinylphosphonium intermediates and suggests that the
coordination of borane followed by intramolecular hydride delivery
is not the dominant pathway.
Finally, the scalability of the developed transformation was
tested. Reduction of 5a on a gram-scale proceeds efficiently
without deterioration of the isolated yield.
In conclusion, we have developed a phosphine catalysed chemo-
selective 1,2-reduction of ynones using pinBH as a mild hydride
donor. The key control element in these reactions is the presence
of a protic additive, tert-butanol, which plays a role in suppressing
1,4-reduction and ynone dimerization pathways and in increasing
the reaction rates of the 1,2-reduction presumably through the
activation of pinBH. The efficiency of this transformation has been
demonstrated on a number of structurally diverse ynones with high
yields observed for 1,2-reductions of both electron rich and electron
poor ynones carrying either aryl or alkyl substituents. The reactions
appear to be selective for ynones indicating that activation of the
carbonyl substrate, and not the reductant, by the phosphine
catalyst plays a critical role. The detailed mechanistic aspects of
this process will be the subject of future investigations.
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trans-Hydroboration vs. 1,2-reduction: divergent
reactivity of ynones and ynoates in Lewis-base-
catalyzed reactions with pinacolborane†
You Zi,a Fritz Schömberg,a Fabian Seifert,a Helmar Görlsb and Ivan Vilotijevic *a
Ynones and ynoates react with pinacolborane in a divergent manner in the presence of nucleophilic
phosphine catalysts. Ynones are transformed to the corresponding propargyl alcohols in good yields with
high regio- and chemoselectivity. Ynoates undergo highly regio- and stereoselective trans-hydroboration
to produce E-vinylboronates. Impressive divergence in reactivity of ynones and ynoates can be traced
back to the mechanistic aspects of 1,2-reduction and trans-hydroboration. A comparative analysis of the
two pathways paints a complex picture in which different reaction rates control selectivity in these see-
mingly unrelated processes and explains how sufficiently acidic protons in the reaction mixtures can be
used to steer the selectivity in different directions.
Introduction
Neutral boron hydrides are among the most versatile reagents
in organic synthesis most commonly used as stoichiometric
reductants1 and as reagents for hydroboration of unsaturated
compounds.2 Both Lewis acidic (boron atom) and nucleophilic
(hydride) properties, and therefore the reactivity of boranes,
can be tuned over an unusually wide range by controlling the
identity of substituents on neutral boron hydrides, and the
identity of the activating Lewis base in Lewis adducts that
involve boranes.3 Among neutral boron hydrides, pinacolbor-
ane has emerged as a commonly used mild reagent for
reduction and hydroboration reactions.4 Relatively low reactiv-
ity of pinacolborane towards alkenes and alkynes has made it
an ideal reaction partner in catalytic reactions where catalyzed
pathways easily outcompete non-catalyzed pathways and back-
ground reactions.5 Activation of pinacolborane in these cata-
lytic reactions has been achieved by transition metals,2f,5d,g
Lewis bases1i,6 and Lewis or Brønsted acids.1e,g,h
A large body of work in the past decade has established
that small molecules can be activated by frustrated Lewis pair
catalysts.7 These Lewis pairs are often structurally complex,
expensive and not easily accessible. Simple trialkyl- and triaryl-
phosphines do not form stable Lewis adducts with pinacol-
borane.6 Intrigued by the finding that these simple to handle,
cheap and easily accessible reagents constitute a non-tra-
ditional frustrated Lewis pair,8 we set off to explore the reac-
tions of quintessential substrates in Lewis base catalysis,
α,β-unsubstituted carbonyl compounds, with pinacolborane in
the presence of phosphines as Lewis base catalysts.
If only the main reaction pathways, reduction and hydro-
boration, are considered, simple ynones could easily be trans-
formed to upwards of twenty distinct products (Scheme 1).4
These products would arise via 1,2-, 1,4- and over-reduction
pathways, syn- and trans-hydroboration,9 and various combi-
nations of these pathways. The possibility of dimerization and
Scheme 1 Selectivity issues in reactions of ynones/ynoates with pinacol-
borane and outline of the selective transformations presented here:
1,2-reduction of ynones and trans-hydroboration of ynoates.
†Electronic supplementary information (ESI) available: Detailed experimental
procedures and characterization data for new compounds. CCDC 1845339 for
12k (excluding structure factors). For ESI and crystallographic data in CIF or
other electronic format see DOI: 10.1039/c8ob01343h
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Friedrich Schiller University Jena, Humboldtstr. 10, 07743 Jena, Germany.
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oligomerization of ynone promoted by Lewis base further
expands the landscape of possible products. Defying this
complex network of reaction outcomes, we have recently
reported that in the presence of an appropriate Lewis base
catalyst and stoichiometric amount of protic additive, pinacol-
borane effects clean 1,2-reduction of ynones.6 Here, we
describe the chemoselectivity studies for the 1,2-reductions of
ynones, present the organocatalyzed regio- and stereoselective
trans-hydroboration reactions of ynoates, and report on the
divergent reactivity of ynones and ynoates with pinacolborane
in the presence of nucleophilic phosphine catalysts. A detailed
analysis and comparison of the two pathways informs the
means to control selectivity in related transformations.
Results and discussion
When ynone 1a in dichloromethane was treated with pinBH in
the presence of catalytic amount of tributylphosphine
(20 mol%), major products isolated from the reaction mixture
were propargylic alcohol 2a, enone 3 and allylic alcohol 4
together with a complex mixture of oligomers of 1a
(Scheme 2A). We have previously described that protic addi-
tives, water and simple alcohols, help steer the selectivity
towards products of 1,2-reduction (Scheme 2B).6 They acceler-
ate the 1,2-reduction pathway and suppress 1,4-reduction and
dimerization/oligomerization pathways.
Our previous studies have established that 5 mol% of PBu3
and only 1.1 equivalents of pinBH in the presence of 1.5
equivalents of tBuOH in dichloromethane are sufficient to
efficiently reduce a series of structurally diverse ynones to the
corresponding propargyl alcohols (Scheme 3).6 Both alkyl and
aryl groups are tolerated in α′ and γ positions of the ynone
(entries 2a, 2b, 2c, 2d and 2e). Electron rich and electron poor
ynones are reduced with equal efficiency (2f and 2g). Various
ynones containing O-, S- and N-heterocyclic motifs are also
efficiently reduced to the corresponding alcohols (2h, 2i and
2j). When tertiary carbon center was present in α′ position of
the ynone, yields of propargylic alcohols remained high (2b,
2k, 2l and 2m). Low diastereoselectivity observed in reactions
that produce 2k, 2l and 2m and apparent similarities between
the substrates that feature a potential directing group in α′
position (O atom in 2l and 2m may coordinate to the borane
and direct the delivery of the hydride) and those with non-
coordinating substituents were indicative of the direct inter-
molecular delivery of the hydride to both π-faces of the
carbonyl group. Finally, we have observed that quaternary
carbon centers in α′ and γ positions reduce reaction rates sig-
nificantly (2n and 2o).
We have determined that simple aldehydes, ketones, esters,
amides, carboxylic acids, alkenes, alkynes, aryl bromides and
aryl iodides do not react with pinacolborane under the opti-
mized reaction conditions with significant reaction rates. A
study aimed at evaluating robustness of the method via typical
competition experiments, however, led to several interesting
discoveries.10 We performed reactions using equimolar mix-
tures of ynone 1a and simple substrates carrying various redu-
cible functional groups (Scheme 4). When ketone 5 was used
in the competition experiments with 1a, partial reduction to
the corresponding alcohol 7 was observed, although in low
yield. In contrast, ketone 6 was not reduced under these con-
ditions in competition experiments.
These results prompted a more detailed look into chemo-
selectivity of 1,2-reduction reactions. We designed and carried
out a series of intramolecular competition experiments start-
Scheme 2 Lewis base catalyzed reduction of ynones with pinacolbor-
ane – the influence of protic additive on selectivity.
Scheme 3 Evaluation of the reaction scope for phosphine catalyzed
1,2-reduction of ynones with pinBH.6 Isolated yields are shown.
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ing from compounds that feature an ynone and other groups
prone to reduction (Scheme 5). These studies better mimicked
the potential applications of chemoselective reductions in syn-
thesis, and clearly demonstrated the chemoselective 1,2-
reduction of ynones in the presence of carbamates (entries 2p
and 2r), amides (2q), nitro compounds (2f ), esters (2s), nitriles
(2t), alkenes (2v) and ketones (2u, 2w and 2y). With substrates
that feature both a ketone and an ynone, the corresponding
diol was observed only in minor quantities. Reduction of
benzylic aldehydes, regrettably, appeared to be faster than
reductions of ynones under these conditions (2x).
Optimized conditions for 1,2-reduction of ynones do not
affect reduction of simple ketones which suggested that, for
the reaction to occur, pinacolborane must be activated by a
Lewis base stronger than the carbonyl oxygen. This raised
questions about the identity of the Lewis base that could co-
ordinate to pinacolborane and increase the hydride donor
ability of the resulting complex. Ynones and ynoates undergo
conjugate addition of phosphines to produce enolate-type
intermediates (i, Scheme 6A).11 Addition of the Lewis base
catalyst renders the ynone more nucleophilic and increases the
Lewis basicity of oxygen atom in the intermediate. It was
expected that this nucleophilic intermediate will interact
with pinacolborane to produce ii. It was also apparent that i
may act as a Brønsted base and deprotonate another molecule
of the ynone or, if present in the mixture, a molecule of
alcohol additive. The resulting enolate iv or tert-butoxide ion
could interact with pinacolborane to produce adducts v and vi
respectively.
Intermediate iii could be more prone to reduction than the
starting ynone owing to its cationic character. This type of
vinylphosphonium salts has been observed in the reaction
mixtures by in situ NMR experiments.6 Different product distri-
bution in reactions with and without a protic additive
suggested that the identity of the reductant (ii or v vs. vi) and
the species that is reduced (1 or iii) determine the reaction
selectivity.
Initial mechanistic proposal involved addition of the phos-
phine catalyst to ynone followed by protonation of the result-
ing enolate by the protic additive to produce vinylphospho-
nium salt iii and tert-butoxide ion (Scheme 6C, cycle A). tert-
Butoxide could then coordinate to pinBH to produce activated
hydride vi which could, in turn, selectively reduce the carbonyl
of vinylphosphonium salt to form allylic alcoholate viii.1i
Proton transfer followed by elimination of the phosphine from
intermediate ix could produce the propargyl alcohol and close
the catalytic cycle. In this mechanistic scenario, direct
reduction of vinylphosphonium salt explains the high selecti-
vity for 1,2-reduction. The conjugate addition of the hydride
on vinylphosphonium salt which would lead to 1,4-reduction
is hindered by the sterically demanding phosphonium ion.
A simple experiment where potassium tert-butoxide was
used as a catalyst instead of the phosphine, suggested that the
active catalyst in the system may be the tert-butoxide ion
(Scheme 6B). A series of labelling experiments using deute-
rated tert-butanol (tBuOD) and deuterated pinacolborane
(pinBD) established that carbinol proton in propargyl alcohol
can be traced back exclusively to the hydride of pinacolborane
(Scheme 6B). Any deuterium incorporated from deuterated
alcohol additive proved to be exchangeable under standard
aqueous work-up conditions. These results also support a
simpler mechanistic proposal where activated hydride source,
intermediate vi, simply reduces the starting ynone directly and
generates yet another alcoholate that could directly activate
pinBH or deprotonate the protic additive to regenerate tert-but-
oxide ion (Scheme 6C, cycle B). While cycle A and cycle B
depicted in Scheme 6C may operate in parallel, it is clear that
activation of hydride source via alcoholate ions is required in
the 1,2-reductions of ynones with pinBH.
Scheme 4 Competition experiments to test chemoselectivity and
robustness in phosphine catalyzed 1,2-reduction of ynones with
pinacolborane.
Scheme 5 Evaluation of chemoselectivity in phosphine catalyzed 1,2-
reduction of ynones by pinacolborane. Isolated yields are shown.
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With a better understanding of the role of the protic addi-
tive in the reductions of ynones, reactions without the additive
were brought back to the focal point. In absence of protic addi-
tive, the role of oxygen-centered Lewis base that activates
pinacolborane can be fulfilled by the enolate ions (i or iv,
Scheme 6A). To prevent formation of enolate of type iv, we
focused on the reactions of ynone 1c which lacks acidic
protons in α′ and γ position (Table 1). In the presence of protic
additive, 1c is cleanly reduced to the corresponding propargyl
alcohol 2c in 87% yield (entry 1). Without the protic additive,
only trace amounts of propargyl alcohol 2c were detected in
the reaction mixture after 4 hours at room temperature
(entry 2). More forcing conditions, in refluxing dichloroethane
resulted only in 1,4-reduction to enone 9 (entry 3). When the
reaction was performed in THF at elevated temperature, main
product, isolated in 56% yield, was enone 9 along with a
product of hydroboration 10 which was isolated in 23% yield
(entry 4).
Knowing that the rates of hydroboration are much lower in
absence of phosphine and that in absence of protic additive
activation of borane by a Lewis base is unlikely,12 we sought to
test if this pathway could serve as a foundation for the develop-
ment of a general method for phosphine catalyzed hydrobora-
tion of alkynes. Since ynones with acidic protons in α′ or γ
Scheme 6 A) Possible pathways to activate pinacolborane by a Lewis base in phosphine catalysed reactions of ynones. (B) Labelling and product
studies of 1,2-reduction of ynones. (C) Proposed mechanisms for the phosphine/tert-butoxide catalyzed 1,2-reduction of ynones to propargyl alco-
hols (R = tBu).
Table 1 Phosphine-catalyzed reactions of ynone 1c with
pinacolboranea
Entry Conditions 2c 9 10
1 DCM, rt, tBuOH (1.5 equiv.) 87% — —
2 DCM, rt <3% — —
3 DCE, reflux — 77%b —
4 THF, reflux <3% 56%b 23%b
aNMR yields based on crude mixtures with triphenylmethane as the
internal standard. b Isolated yields.
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positions react predominantly via reductive pathways, to sim-
plify the complex network of possible reaction outcomes, we
turned our attention to aryl ynoates as surrogates of diaryl
ynones.
We were pleased to discover that ethyl phenylpropiolate 11a
undergoes hydroboration in the presence of pinacolborane
and catalytic amounts of tributylphosphine (Scheme 7).13
Since ynoates are less prone to reduction, replacing the ynone
with an ynoate reduced the rates of reduction reactions allow-
ing for the vinylboronate to be isolated as the sole product.
Initial assumption that the product of hydroboration 12a is of
Z-configuration was contradicted by the comparison to the
spectral data for Z-vinylboronate obtained under previously
reported conditions.14 This suggested that 12a is an E-olefin
that could arise from a trans-selective hydroboration or a more
common syn-hydroboration followed by isomerization.
Very few examples of trans-selective hydroboration of
alkynes have been reported to date and they uniformly rely on
transition metal catalysts to confer selectivity to the
system.13,15 Pioneering work by Fürstner where cationic ruthe-
nium(II) catalysts promote trans-hydroboration remains the
only general method to perform this challenging transform-
ation on internal alkynes.16 Recent reports also describe
pyridyl- and alkene-directed trans-hydroboration of internal
conjugated alkynes.17 These methods are, however, not suit-
able for electron poor alkynes and cannot be applied to trans-
hydroboration of ynones or ynoates.
While the anti-difunctionalizations of ynoates reported by
Ohmiya and Sawamura support the feasibility of trans-hydro-
boration,18 the unusual outcome of this experiment called for
a high scrutiny of the product structure. NOESY spectra of 12a
showed a cross peak between the vinylic and aryl hydrogens
suggesting that they are on the same side of the double bond.
Vinylboronate 12k prepared from methyl 3-(4-bromophenyl)
propiolate could be crystalized and crystallographic data
obtained from single crystal measurement served as a proof of
structure for E-vinylboronates (Scheme 7). No other products
were observed in significant quantities in reactions of 11a,
including the Z-vinylboronate, the product of syn-
hydroboration.
Optimization of solvent showed that reactions at room
temperature performed best in halogenated solvents, dichloro-
methane and dichloroethane (Table 2, entries 1 and 4). Diethyl
ether and tetrahydrofuran showed lower rates and generally
lower yields for the vinylboronate 12a. With the additional
concern that ethers may activate borane for the more conven-
tional syn-hydroboration and result in deterioration of stereo-
selectivity, the chlorinated solvents were chosen as optimal.
Hydroboration of 11a at increased temperature (Table 2, entry 5)
afforded the product 12a in comparable yields to the reactions
at room temperature and the increase in reaction rates was
apparent.
High yields of 12a were obtained even with stoichiometric
amount of pinacolborane. With slightly higher amount of
borane (1.3 equiv.) there was no increase in yield and the use
of 1.1 equivalents of pinacolborane was deemed optimal.
While the use of methylpentanediolborane (4,4,6-trimethyl-
1,3,2-dioxaborinane) resulted in diminished yields of trans-
hydroboration product (68% NMR yield, Scheme 8A, entry
12f ), catecholborane and 9-BBN both failed to give any of the
desired products.
Comparison of various Lewis base catalysts in the trans-
hydroboration of ynoates demonstrated that identity of the
Lewis base and it’s nucleophilicity play crucial roles. Both O-
and N-centered Lewis bases failed to catalyze the trans-hydro-
boration presumably because they form stable Lewis adducts
with pinacolborane. In catalytic quantities, these also failed
to sufficiently activate the borane for any other reaction
pathway and no consumption of starting material was
observed after 4 hours at room temperature (Table 3). Less
nucleophilic phosphines, triarylphosphines and bulky trialk-
ylphosphines failed to catalyze the reaction (Table 3, entries 5
and 6). More nucleophilic phosphines, such as methyl-
diphenylphosphine, afforded the reaction product in 12%
yield with lower E/Z selectivity (Table 3 entry 4). Nucleophilic
trialkylphosphines afforded the product of trans-hydrobora-
tion in high yields and excellent selectivity (>99 : 1) for the
E-product (Table 3, entries 1 and 2). Catalyst loading with tri-
methyl- and tributylphosphines could be reduced to 2 mol%
Scheme 7 Initial experiments on phosphine catalyzed trans-hydro-
boration of ynoate 11a and the crystal structure analysis of p-bromo
derivative 12k as the proof of E-configuration of the double bond in
vinylboronate products.
Table 2 Optimization of the solvent for phosphine catalyzed trans-
hydroboration of ynoate 11a
Entry Cat. Sol. T (°C) t (h) NMR yielda (%)
1 PBu3 DCM rt 4 92 (83% isolated)
2 PBu3 Et2O rt 4 45
3 PBu3 THF rt 4 66
4 PBu3 DCE rt 4 93
5 PBu3 DCE Reflux 2 94
6 PBu3 PhMe rt 4 64
aNMR yields based on triphenylmethane as the internal standard.
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without deterioration of reaction yield in reactions of 11a
(Table 3, entry 3).
Under the optimized conditions a range of aryl ynoates are
efficiently transformed to the corresponding vinylboronates
(Scheme 8A). Both electron rich and electron poor substrates
were processed including substrates that feature other reduci-
ble groups (12a–12l). Electron poor ynoates showed generally
lower reaction rates which prompted further optimization of
the conditions (12m–12o). Switching the solvent to dichloro-
ethane allowed for the reactions to be heated to reflux tem-
perature which significantly increased the reaction rates and,
in some cases, resulted in higher yields compared to the reac-
tions performed at room temperature. E/Z selectivity remained
high across the board for ynoates 12a–12n (>99 : 1, determined
by 1H NMR).
Because of low rates and low conversion of starting
material, lower yields were observed with electron poor sub-
strates (Scheme 8A, 12m, 12n) and substrates that feature ortho
substituents on the aryl ring (12e and 12h). Even in these
cases, yields based on recovered starting material remained
high. Substrates with strongly electron withdrawing substitu-
ents (11o and 11p, precursors of 12o and 12p), however, failed
to react under the optimized conditions. More forcing con-
ditions including higher catalyst loadings and prolonged
heating time in reactions of 11p resulted in 1,4-reduction
(14%) and over-reduction to the corresponding saturated
ester (11%).
To demonstrate the utility of the trans-hydroboration in syn-
thesis, we have tested scalability of the method and demon-
strated that the reactions work with equal efficiency on a
Scheme 8 (A) trans-Hydrobration of ynonates. Conditions: 11 (0.3 mmol), pinBH (0.33 mmol), PBu3 (5 mol%), DCM, rt, or DCE, reflux.
aNMR yields
with Ph3CH as the internal standard and isolated yields (in brackets) for reactions in DCM at rt.
bNMR yields and isolated yields (in brackets) for reac-
tions in DCE at reflux. c4,4,6-Trimethyl-1,3,2-dioxaborinane was used instead of pinacol borane. (B) E-Vinylboronates used in Suzuki coupling reac-
tions. (C) Labeling and product studies of trans-hydroboration of ynoates.
Paper Organic & Biomolecular Chemistry
6346 | Org. Biomol. Chem., 2018, 16, 6341–6349 This journal is © The Royal Society of Chemistry 2018
View Article Online
1.0 gram scale with 12a isolated in 87% yield. As an illustration
of versatility of E-vinylboronates as synthetic intermediates,
Suzuki coupling was carried out with 12a to prepare enoates
13 and 14 with a stereodefined trisubstituted double bond
(Scheme 8B, the yields are not optimized). Comparison of the
data for 14 to the previously reported data for same material
served as additional indirect evidence of the E-configuration of
vinylboronate 12a.19
Despite the acidic protons in γ-position, alkyl ynoates 11q
and 11r (precursors of 12q and 12r, Scheme 8A), surprisingly,
also underwent trans-hydroboration. Although the yields and
E/Z selectivity were lower than with the corresponding aryl
ynoates (in refluxing DCE E/Z ratios for 12q = 83 : 17 and for
12r = 86 : 14), these results prompted a closer look at how sen-
sitive to protic additives these reactions really are. A series of
experiments demonstrated that the reaction outcome, in this
case too,6 is a function of the concentration of protic additive
(Table 1, ESI†). tBuOH suppresses the trans-hydroboration in a
concentration dependent manner. Enoate 15 (shown in
Scheme 8C), the product of 1,4-reduction, was observed in
minor quantities when protic additive was present. A separate
experiment confirmed that 12a doesn’t react to produce enoate
15 under the reaction conditions suggesting that 15 is pro-
duced via direct 1,4-reduction of ynoate 11a and not via pro-
teodeborylation of 12a.
To exclude the possibility that a photochemical isomeriza-
tion is responsible for the stereochemical outcome of the reac-
tions,20 a test reaction was performed in the dark. Identical
outcome of the reaction carried out in absence of light
suggested that photochemical isomerization of alkene does
not occur.
When pinBD was used, complete incorporation of the deu-
terium label in α position of the vinylboronate 12aD was
observed (Scheme 8C), suggesting that the trans-addition of
hydrogen and boron are a consequence of unique mechanistic
features of the process rather than a combination of more con-
ventional pathways.
Based on the labeling studies, dependence of reactivity on
structure of the starting material, influence of protic groups on
reaction outcome and qualitative observations about effects of
concentration on reaction rates, we propose that the mecha-
nism of the reaction involves an intramolecular hydride trans-
fer step in intermediate xi that results in formation of a phos-
phorus ylide xii (Scheme 9). In contrast to ynoate 11a, enoate
15 does not react under the optimized conditions (Scheme 8C)
because the enone derived intermediate analogous to xi
cannot undergo intramolecular hydride transfer to produce a
phosphorus ylide. The hydride must be delivered to the same
side of the C1–C2 π-system as the boronate resulting in a
Z-configured allylic phosphorous ylid intermediate xii. Allylic
anion resonance enables isomerization of the double bond to
the E-configured intermediate xiii which, unlike xii, can
undergo intramolecular transfer of the boronate to C3 position
via intermediate xiv. E1cb elimination of phosphine from xv
completes the catalytic cycle, forms the product and regener-
ates the phosphine catalyst. E-Configuration of the final
product is determined by the interaction between the boronate
and carbonyl oxygen. If this interaction is broken, the resulting
intermediate could eliminate the phosphine to produce either
E- or Z-vinylboronate and deterioration of selectivity would be
observed. This could be the case when elimination of phos-
phine is slow and other Lewis bases are present in the reaction
mixture.
A comparison of the reduction reactions of ynones and
ynoates under the described conditions leads to several inter-
esting observations about the role of phosphine catalyst and
the rates of the competing reduction pathways. The role of
phosphine in these reactions can be to (i) generate a stronger
Table 3 Optimization of the catalysts for phosphine catalyzed trans-
hydroboration of ynoate 11a
Entry Catalyst Loading t (h) NMR Yielda (%)
1 PMe3 5 mol% 4 90
2 PBu3 5 mol% 4 92 (83% isolated)
3 PBu3 2 mol% 8 88
4 PMePh2 5 mol% 4 12 (E/Z = 82 : 18)
5 PPh3 5 mol% 4 No reaction
6 P(t-Bu)3 5 mol% 4 No reaction
7 DABCO 5 mol% 4 No reaction
8 DBU 5 mol% 4 No reaction
9 N-Methyl pyrrolidine 5 mol% 4 No reaction
10 tBuOK 5 mol% 4 No reaction
11 None — 24 No reaction
a Triphenylmethane was used as the internal standard.
Scheme 9 Proposed mechanism of the phosphine catalyzed trans-
hydroboration of ynoates.
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base (O-centered Lewis base) which further modifies down-
stream pathways by influencing the reactivity of pinacolborane,
(ii) modify the reactivity of the unsaturated carbonyl com-
pound by making it more prone to reduction and (iii) modu-
late the character of the α-carbon (formal umpolung from a
typically nucleophilic to an electrophilic center) and allow for
hydride delivery to form a phosphorus ylide (as described in
intermediate xi). Since ynones are more electrophilic than
corresponding ynoates, the direct reduction of carbonyl
compounds with Lewis-base activated pinacolborane
occurs faster than the trans-hydroboration which is in turn
faster than either 1,4-reduction, syn-hydroboration or direct
reduction by borane. With less electrophilic ynoates, direct
reduction of the carbonyl is outcompeted by the trans-
hydroboration and 1,4-reduction. These features enable
ynones to be transformed to propargyl alcohols, and ynoates
to be transformed to vinylboronates in high yields and with
excellent selectivities.
Conclusions
Trialkylphosphines and pinacolborane constitute a non-tra-
ditional frustrated Lewis pair which allows for dual activation
of alkynyl carbonyl compounds. A careful selection of reactive
partners: ynones or ynoates, and a suitable combination of the
borane reductant, phosphine catalyst and protic additives can
lead to selective transformation: reduction of the carbonyl and
hydroboration of the alkyne as the major pathways.
Ynones are efficiently reduced with pinacolborane to
produce propargyl alcohols in high yields when a nucleophilic
phosphine catalyst and protic additive are present in the
mixture. In absence of acidic protons, 1,2-reduction pathways
for ynones are outcompeted by 1,4-reduction and hydrobora-
tion pathways.
Ynoates undergo regio- and stereoselective trans-hydro-
boration with pinacolborane in the presence of nucleophilic
phosphine catalysts to produce E-vinylboronates in good
yields. Unique mechanistic features of the process allow for
unusual stereoselectivity in the reactions. An umpolung of
reactivity of the α carbon in ynoates enables intramolecular
delivery of the hydride which produces phosphorus ylide
nucleophile that effects the transfer of pinacolboronate
from the carbonyl oxygen to the β carbon of the ynoate. The
reactions are to a certain extent tolerant of protic additives
and allow trans-hydroboration of both aryl and alkyl
ynoates.
Both 1,2-reductions of ynones and trans-hydroboration of
ynoates produce versatile synthetic intermediates in high
yields and with excellent selectivity. The divergent outcomes in
reactions of ynones and ynoates with pinacolborane in the
presence of nucleophilic phosphines provide insight into com-
peting reaction pathways and their relative rates. With the
better understanding of these pathways, selectivity in related
reactions can be controlled by external factors, i.e. by protic
additives.
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ABSTRACT: Benzothiazoles undergo regioselective C2−H func-
tionalization with triphenylphosphine to form thiazol-2-yl-
triphenylphosphonium salts, and these phosphonium salts react
with a wide range of O- and N-centered nucleophiles to give the
corresponding ethers, amines, and C−N biaryls. The reactions
proceed under mild conditions and allow for the recovery of
triphenylphosphine at the end of the sequence. In the presence of
hydroxide, phosphonium salts undergo disproportionation, resulting in the reduction of the benzothiazole, which is useful for specific
C2 deuteration of benzothiazoles.
Phosphonium salts are commonly used in organic synthesisas reagents in Witting-type olefinations,1 catalysts in
phase-transfer catalysis and related transformations,2 solvents
in processes that rely on the use of ionic liquids,3 and catalytic
intermediates in Lewis-base-catalyzed reactions with phos-
phine catalysts.4 The breadth of their reactivity and the
electrophilic character of the phosphorus atom, in particular,
have driven the recent leaps in the development of synthetic
methods that feature pentavalent phosphorus intermediates
such as biphilic organophosphorus catalysis,5 contractive C−C
coupling via P(V) intermediates,6 and the redox-neutral
organocatalytic Mitsunobu reactions.7 Our interest in
phosphonium ions stems from reactions that use phosphines
as Lewis base catalysts with typical Michael acceptors, which,
in the presence of water and other protic additives, produce
vinylphosphonium intermediates (Scheme 1a).8 We hypothe-
sized that the distinctly different outcomes these reactions have
in the presence of alcohols (oxidation of C3 of the ynone)9
and water (reduction of C3)10 are the consequence of the
differences in the reactivity of the pentavalent phosphorus
intermediates generated in these processes. If this is also
reflected in the reactivity of arylphosphonium salts,11 the easily
accessible heteroarylphosphonium salts would become val-
uable intermediates in the regioselective functionalization of
heterocycles.
Thiazoles and benzothiazoles are the most common five-
membered aromatic N-heterocycles among the FDA-approved
pharmaceuticals,12 and they are present in numerous bio-
logically active molecules (Scheme 1b),13 are important
components of functional materials,14 and are common
intermediates in organic synthesis.15 Although they almost
always feature a heteroatom substituent at C2 in approved
pharmaceuticals, the direct C2−H functionalization of
benzothiazoles remains largely limited to metal-catalyzed
processes that proceed at elevated temperatures, often as
high as 130 °C (Scheme 1c).16 A metal-free pathway for the
C2−H functionalization of benzothiazoles under mild
conditions would be a valuable addition to medicinal chemistry
toolbox and an enabling factor for rapid access to libraries of
small benzothiazole-containing molecules. In his seminal work
on the synthesis of benzothiazol-2-yl-triphenylphosphonium
triflate, Anders showed that the treatment of benzothiazole
with triphenylphosphine in the presence of triflic anhydride
and a base provides direct regioselective access to this salt.11
Here we demonstrate the generality of this process and show
that benzothiazol-2-yl-triphenylphosphonium salts react with a
wide range of O- and N-nucleophiles under mild conditions
and produce C2-substituted benzothiazoles (Scheme 1d). The
two-step sequence constitutes an efficient method for the C2−
H functionalization of benzothiazoles because the phosphine
can be recovered at the end of the sequence.
Encouraged by the early observations of Anders and the later
work of McNally on similar functionalization of pyridines,6,11
our optimization studies focused on the reactions of benzo-
[d]thiazol-2-yltriphenylphosphonium triflate salt 2a with
benzyl alcohol. Activation of the nucleophile with a suitable
base was required. Strong bases like sodium hydride and alkali
hexamethyldisilazide (HMDS) amides performed well, provid-
ing yields of up to 82%. (For details of the optimization
studies, see the SI.) The outcome depended on the quality of
the base used, and some reactions benefited from increasing
the amount of the nucleophile to 1.5 equiv, although a further
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increase had the inverse effect. The reactions proceeded with
high rates at room temperature in THF, with deprotonation of
alcohol usually performed at a low temperature prior to the
addition of the phosphonium triflate.
A range of alcohol nucleophiles were reactive with the
benzothiazol-2-yl-phosphonium salt 2a (Scheme 2). Primary
alcohols, including simple alkyl, benzylic, and propargylic
alcohols, all gave the desired ethers in a yield range of 42−99%
(4a−n). Even electron-poor alcohol proved efficient in a yield
of 84% (4e). Secondary (4i−k) and tertiary aliphatic alcohol
(4l) gave the desired ethers in 72−83% yields and
demonstrated that the reactions tolerate steric hindrance
close to the reactive centers. The reactions performed well
even in the more complex setting, when menthol and
cholesterol were used as the O-nucleophiles (4m and 4n).
Electron-rich phenols performed well in a yield range of 60−
99% (4o−t). When hydroquinone was used, the product of
monosubstitution was produced in 75% yield (4u). Phenols
with an extended conjugated system, a coumarin derivative,
and naphthalen-1-ol were also suitable reaction partners (4v
and 4w). Halogen-substituted phenols were well tolerated in a
yield range of 59−87% (4x−ab). Sterically more demanding
and electron-poor substrates gave slightly lower yields between
59 and 66% (4z−ac). The main side product was
triphenylphosphine, which could be recovered during
purification.
Encouraged by the good reactivity observed with O-
nucleophiles, the focus was shifted to N-nucleophiles (Scheme
3). NaHMDS performs significantly better than NaH with N-
nucleophiles. The initial attempts with primary amines and
anilines proved futile. Instead of the desired products, the
corresponding iminophosphoranes were isolated. Along with
this, secondary amines performed well, with 4ad−af obtained
in 61−81% yield. When acetanilide was used, the product of
amidation could not be isolated, but the product of amide
hydrolysis 4ag was isolated in yields of 30%. Switching to N-
methylbenzamide improved the overall yield to 81%, but a 1:2
mixture of the amide 4ah and the hydrolysis product 4ai was
obtained. A range of N-heterocycles was shown to be reactive
under the same conditions, affording good yields observed for
pyrroles and indoles regardless of their electronic properties
(4aj−ap, Scheme 3). Imidazoles and benzimidazoles were
equally reactive (4aq and 4as), but the yields were lowered by
the increasing steric demand of the nucleophile (4at and 4au).
Scheme 1. Bioactive C2-Substituted Benzothiazoles,
Previous Work on C2−H Functionalization of
Benzothiazoles, and Our Approach Using Phosphonium
Ions
Scheme 2. Scope of the Reaction for O-Nucleophiles
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Using pyrazole as the nucleophile resulted in the formation of
biaryl 4ar in a yield of 54%.
A set of benzothiazol-2-yl-phosphonium triflates carrying
both electron-donating and electron-withdrawing substituents
in positions five, six, and seven, 2a−j (Scheme 4, Step 1), was
prepared in a yield range of 24−87% following the method
described by Anders. (The mechanistic proposal for the
formation of the phosphonium salts is shown in Scheme 5a.) 4-
Methoxyphenol and 5-nitroindole were used to evaluate the
reactions with substituted salts. Both electron-rich and
electron-poor phosphonium salts performed well, giving the
products of etherification (4av−bd) and amination (4be−bj)
in good yields (Scheme 4, Step 2). No obvious trends for the
electronic effect of the substituents on benzothiazole could be
observed, suggesting the generality of this method. The studies
of scope also established the tolerance for ether, nitro, ester,
nitrile, ketone, alkene, alkyne, aryl halides, and other N-
heterocyclic substituents.
Aniline and other primary amines failed to produce any of
the desired amination products when used in reactions with
thiazol-2-yl-phosphonium salts. Instead, the reduced benzo-
thiazole was isolated alongside the iminophosphorane 5
derived from the amine nucleophile and triphenylphosphine
(Scheme 5b). It is reasonable to propose that the N−P bond is
formed through direct nucleophilic attack of the anilide anion
on the electrophilic phosphonium ion. This would produce the
aminophosphonium intermediate iv via nucleophilic substitu-
tion or the pentavalent phosphorus intermediate i via
nucleophilic addition to phosphorus. Under basic conditions,
i would be deprotonated to form ii, which would, in turn,
fragment to produce the iminophosphorane 5 and the
benzothiazolide anion iii.11b,17 Because both pathways involve
the formation of benzothiazolide iii, we hypothesized that the
use of water as the nucleophile (as hydroxide ion) would also
result in reduction of the benzothiazole and the formation of
phosphine oxide. Experiments using only a slight excess of
sodium deuteride demonstrated that this indeed is the case
(Scheme 5c). The specific C2 deuterium labeling with 97%
yield and >98% deuterium incorporation was observed for 6a.
The process appears general, as benzothiazoles with electron-
donating and -withdrawing substituents both undergo efficient
C2 labeling (6b and 6c).
The proposed direct nucleophilic attack of the nucleophiles
to the phosphorus atom in the phosphonium salt with both
primary amines and water suggests that this process could also
operate in the reactions that result in C2 functionalization of
benzothiazole. If the pentavalent phosphorus intermediate
similar to i is indeed on the reaction path, that would
necessitate a contractive C−O or C−N bond formation from
the same intermediate akin to reductive elimination. Another
possible mechanistic scenario is the simple aromatic
nucleophilic substitution reaction that would see nucleophilic
attack to the C2 position of the benzothiazole. Our current
studies are aiming to decipher the reaction mechanism and
determine the chemical competence of the proposed
Scheme 3. Scope of the Reaction for N-Nucleophiles Scheme 4. Reaction Scope for Substituted Benzothiazoles
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pentavalent phosphorus intermediates that have been observed
via in situ 31P NMR.18
In summary, we have developed an effective method for the
C2−H functionalization of benzothiazoles via thiazol-2-yl-
phosphonium intermediates that readily undergo reactions
with O- and N-nucleophiles under mild conditions. Reactions
are productive with a range of substituted benzothiazoles and
feature an unusually wide scope for nucleophiles including
alcohols, phenols, amines, amides, and N-heterocycles. The
resulting C2-subsituted benzothiazoles are structurally related
to many biologically active molecules, making this method
attractive for use in medicinal chemistry development.
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Selective C–H chalcogenation of thiazoles via
thiazol-2-yl-phosphonium salts†‡
You Zi, Konrad Wagner, Fritz Schömberg and Ivan Vilotijevic *
Thiazoles and benzothiazoles undergo regioselective C2–H chalcogenation via the sequence of thiazole
C2-functionalization with phosphines to produce phosphonium salts which in turn react with S- and Se-
centered nucleophiles to give products of C2–H chalcogenation and allow for recovery of the starting
phosphine. The atom economical sequence proceeds under mild conditions and features broad scope
for both the nucleophiles (electron-rich, electron-poor, sterically hindered thiols) and the various substi-
tuted benzothiazoles. The access to the substituted medicinally relevant C2-thio benzothiazoles also
enables stereoselectivity improvements in the modified Julia olefinations.
Introduction
Thiazoles and benzothiazoles are important constituents of
electronic materials,1 common intermediates in organic syn-
thesis,2 and a regular occurrence in natural products3 and bio-
logically active molecules.4 They are the most common aro-
matic 5-membered N-heterocycles among FDA approved phar-
maceuticals.5 The vast majority of these bioactive molecules
feature a heteroatom substituent at C2 which highlights the
need for methods to introduce such substituents and makes
these methods valuable tools in medicinal chemistry.
2-Thio-substituted (benzo)thiazoles, such as the wideband
microbicide TCMTB (A),6 cathepsin-D inhibitor (B),7 heat
shock protein 90 inhibitor (C)8 and PPAR receptor activator
(D),9 have attracted attention for their biological activities
(Scheme 1a). Other 2-thio-substituted (benzo)thiazoles are
common intermediates in organic synthesis where they are
used to construct double bonds via Julia olefination10 or as
substrates for transition metal-catalysed coupling reactions.11
While other strategies to prepare 2-thio-substituted thiazoles
exist,12 C2–H thiolation (and chalcogenation) is of particular
interest as a method for their direct functionalization. Despite
the apparent demand, the methods for C2–H thiolation of
thiazoles have thus far been limited to transition metal
mediated processes that (i) typically proceed under harsh con-
ditions at temperatures between 120 and 140 °C with long
reactions times,13,14 (ii) use stoichiometric amounts of tran-
sition metal salts and/or (iii) require the use of strong oxidants
(Scheme 1b).14 These features greatly limit the reaction scope
and prevent general application of such methods in more
complex settings common in medicinal chemistry. A recent
Scheme 1 (a) Examples of biologically active C2-thio benzothiazole
derivatives; (b) previous work for C2 thiolation of (benzo)thiazoles and
(c) our approach.
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report of photochemically promoted Cu-catalyzed chalcogena-
tion of thiazoles which proceeds at room temperature and
improves the functional group tolerance is an important
improvement in this field but it requires a specific photoche-
mical setup and is limited to synthesis of diaryl sulphides
(Scheme 1b).15 A general method for C2–H thiolation of thia-
zoles that proceeds under mild conditions with broad sub-
strates scope, uses readily available starting materials and
avoids the use of transition metals would provide a simple way
to create the C2–S bond of interest and generate libraries of
medicinally relevant C2-thio substituted thiazoles.
Early work of Anders demonstrated the ease of synthesis of
heteroaryl phosphonium salts by activating the corresponding
heterocycle with triflic anhydride and exposing the resulting
intermediate to a phosphine nucleophile.16 In our work on
phosphine promoted reactions of Michael acceptors that
proceed via vinylphosphonium intermediates,17 we found out
that such intermediates readily undergo reactions with hetero-
atom-centered nucleophiles which suggested that a two-step
sequence where regioselective formation of the phosphonium
salt and a subsequent reaction with suitable nucleophile
would constitute an efficient and selective C2–H functionali-
zation of (benzo)thiazoles.18 Recent work on the related reac-
tions with pyridinylphosphonium salts also supported the
feasibility of this approach.19 Here we show that such thiazol-
2-yl-phosphonium salts undergo highly efficient chalcogena-
tion with a broad range of thiols, thiophenols and a Se-cen-
tered nucleophile and produce a variety of C2-chalcogen sub-
stituted thiazoles in excellent yields (Scheme 1c).
Results and discussion
In our initial study, benzothiazole was selected as the model
system and converted to the corresponding benzo[d]thiazol-2-
yltriphenylphosphonium triflate salt (1a) which was then used
in reactions with 1-octanethiol. The reactions required nucleo-
phile activation by a base. Sodium hydride proved to be a suit-
able and atom economical solution for this. With slight excess
of the thiol, the reaction between 1-octanethiol and the benzo
[d]thiazol-2-yltriphenylphosphonium triflate yielded the
product 3a in excellent yield. The reactions proceeded with
high rates at room temperature in THF. The main side product
was the triphenylphosphine which could be recovered at the
end of the reaction making the entire process atom economi-
cal. The ease of preparation of benzo[d]thiazol-2-yltriphenyl-
phosphonium triflate and its favourable solubility profile
enabled the two-step sequence to be carried out in one pot
with removal of excess ammonium salt by precipitation of the
phosphonium salt and decanting between the steps. Although
typical reactions used 1.5 equivalents of the thiol and sodium
hydride, lower quantities (1.1 equiv.) were often sufficient to
achieve good yields for the desired products.
With fast turnaround in the optimization studies, the atten-
tion was focused on exploration of the reaction scope. Primary,
secondary, tertiary alkyl and benzylic thiols all produced the
desired thioethers in nearly quantitative yields (3a–3h,
Scheme 2). Thiophenols also gave the desired products in high
yields (3i–3u) with electron rich and electron poor thiophenols
showing comparable efficacy (3j–3r). The reactions appeared to
be tolerant of steric crowding in the vicinity of the S-centered
nucleophile with products 3c and 3l derived from t-BuSH and
Scheme 2 Thiolation of benzothiazole with different thiols. Conditions:
Phosphonium salt (0.2 mmol), pronucleophile (0.3 mmol), NaH
(0.3 mmol), THF (2 mL, 0.1 M), at 0 °C to room temperature. [a]
Conditions: Phosphonium salt (0.2 mmol), pronucleophile (0.15 mmol),
NaHMDS (0.3 mmol), THF (2 mL, 0.1 M), at −78 °C to room temperature.
[b] Conditions: Phosphonium salt (0.2 mmol), pronucleophile
(0.1 mmol), NaH (0.2 mmol), THF (2 mL, 0.1 M), at 0 °C to room
temperature.
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2,6-dimethylphoenylthiol produced in 99% and 93% yields
respectively. The double thioetherification to produce 3u pro-
ceeded with satisfactory yield as did the reactions with thiols
with extended conjugation and those containing other hetero-
cycles like pyridine (3s–3t).
To test the selectivity for S- and O-centered nucleophiles,
3-mercaptopropan-1-ol and 6-mercaptohexan-1-ol were tested
under optimized conditions. 6-Mercaptohexan-1-ol provided
the desired product 3v in 70% yield, while 3-mercaptopropan-
1-ol produced 3x in 45% yield alongside the product of double
functionalization of the mercaptoalcohol with two benzothia-
zoles in small quantities. Product 3w could be isolated in 33%
yield when 2 equiv. of phosphonium salt 1a were used in com-
bination with 2 equiv. of sodium hydride.
To test the feasibility of the same approach in construction
of C–Se bonds, benzo[d]thiazol-2-yltriphenylphosphonium tri-
flate was subjected to reaction with Se-centered nucleophile
generated by reduction of diphenyl diselenide with sodium
hydride to produce the 2-(phenylselanyl)thiazole 3y in yield of
77% (Scheme 3). Dimethyl diselenide gave the corresponding
methylselenide 3aa in 67% yield. Dibenzyl diselenide failed to
produce any of the desired product likely due to the high reac-
tivity of the resulting 2-(benzylselanyl)benzo[d]thiazole.
The scope for the benzothiazol-2-yl-phosphonium triflates
has been explored by employing various substituted salts that
were available via the method outlined by Anders.16 Salts
derived from substituted benzothiazoles carrying both elec-
tron-donating and electron-withdrawing substituents in posi-
tions 5, 6 and 7 have been examined. 1-Octanethiol was used
as a model nucleophile in these reactions to determine that
they all proceed with nearly quantitative yields regardless of
the electronic properties of the salt (Scheme 4). Ethers (3ad
and 3ae), aryl halides (3af–3ai), nitriles (3aj and 3ak), nitro
compounds (3al) were well tolerated in these reactions. In
addition to salts derived from benzothiazoles, that derived
from simple thiazole was also a competent substrate in this
reaction (3ab). Finally, a few diverse combinations of phos-
phonium salts and the thiols showed the generality of the
process (3am–3ar).
A series of control experiments was carried out to show that
the formation of the phosphonium salt is indeed necessary for
successful C–H functionalization. The direct use of
S-nucleophiles in combination with N-triflyl salts of benzothia-
zole, similar to the previously reported methods for C4-
functionalization of pyridines,20 failed to produce any of the
C2-sulfenylation products.
Having access to a variety of electronically different C2-thio
substituted benzothiazoles, piqued our curiosity about the
possibility of exploiting electronic effects of these substituents
to address selectivity issues in modified Julia olefination reac-
tions that otherwise proceed with lower selectivity. We hypoth-
esized that electronic effects of the substituents may change
the selectivity of the reactions by changing the nature of tran-
sition states in the selectivity determining addition of the
sulfone stabilized anion to the aldehyde or by changing the
kinetics of individual elementary steps during the olefination
reactions that may ultimately enable different equilibria to be
established.10 With this in mind, for our model study we
selected the typical modified Julia olefination substrate (3a)
and the two substituted starting materials, one featuring an
electron donating (3ad) and the other featuring electron with-
drawing group (3aj) (Scheme 5). The three sulfones were easily
accessed from the corresponding sulfides by mCPBA oxidation.
Applying the typical conditions for modified Julia olefination
with 4a resulted in a 3.2 : 1 mixture of Z-5 and E-5 favouring
the Z product. Under the same conditions, both 4ad and 4aj
gave the products 5 with higher selectivity (6.7 : 1 and 5.6 : 1,
respectively) while maintaining similar efficacy. Future studies
will be directed towards understanding and further establish-
ing the substituent effect in these reactions.
Scheme 3 Synthesis of selenides via reaction of phosphonium salt and
Se-centered nucleophiles. Conditions: Phosphonium salt (0.2 mmol),
PhSeSePh (0.3 mmol), NaH (0.6 mmol), THF (2 mL, 0.1 M), at 0 °C to
room temperature.
Scheme 4 Reaction scope for substituted thiazoles. Conditions:
Phosphonium salt (0.2 mmol), pronucleophile (0.3 mmol), NaH
(0.3 mmol), THF (2 mL, 0.1 M), at 0 °C to room temperature.
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Conclusions
In conclusion, the regioselective C2–H functionalization of
thiazoles with phosphines followed by the highly efficient base
promoted reaction with S-centered nucleophiles is an effective
way to produce C2-thio thiazole derivatives. The reactions
proceed under mild conditions, use simple starting materials
and feature broad scope that includes both alkyl thiols and
thiophenols. Electronic and steric factor do not significantly
change the high efficacy of reactions of phosphonium salts
with S- and Se-nucleophiles. The substituted C2-thio ben-
zothiazoles can be of use in organic synthesis to improve the
selectivity of the modified Julia olefination reactions.
Applications of this methodology to rapidly generate targeted
libraries of compounds for medicinal chemistry are
envisioned.
Experimental
General procedure for the thiolation of thiazole derivatives
NaH (0.3 mmol) was added to the pronucleophile (0.3 mmol)
in dry THF (0.1 M) under inert atmosphere at 0 °C. After stir-
ring for half an hour at room temperature, the phosphonium
salt18 (0.2 mmol) was added subsequently at 0 °C followed by
three quick vacuum/nitrogen refills. The reaction mixture was
warmed up to room temperature and quenched by addition of
a small amount of water when it completed. The crude
product was purified by column chromatography using ethyl
acetate in petroleum ether.
2-(Octylthio)benzo[d]thiazole (3a).21 Yield: 97%. 1H-NMR
(300 MHz, CDCl3) δ 7.99–7.82 (m, 1H), 7.82–7.70 (m, 1H), 7.42
(td, J = 8.2, 7.8, 1.2 Hz, 1H), 7.29 (td, J = 7.9, 1.1 Hz, 1H), 3.35
(t, J = 7.4 Hz, 2H), 1.83 (p, J = 7.3 Hz, 2H), 1.56–1.42 (m, 2H),
1.42–1.19 (m, 8H), 0.99–0.79 (m, 3H). 13C-NMR (75 MHz,
CDCl3) δ 167.41, 153.37, 135.15, 125.97, 124.07, 121.44, 120.89,
33.64, 31.80, 29.20, 29.15, 29.07, 28.79, 22.66, 14.12.
2-(Isopropylthio)benzo[d]thiazole (3b).22 Yield: 92%.
1H-NMR (300 MHz, CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H), 7.82–7.71
(m, 1H), 7.43 (ddd, J = 8.2, 7.3, 1.3 Hz, 1H), 7.30 (ddd, J = 8.4,
7.3, 1.2 Hz, 1H), 4.10 (hept, J = 6.8 Hz, 1H), 1.53 (s, 3H), 1.51
(s, 3H). 13C-NMR (75 MHz, CDCl3) δ 166.45, 153.42, 135.29,
125.97, 124.22, 121.61, 120.91, 39.47, 23.31.
2-(tert-Butylthio)benzo[d]thiazole (3c).23 Yield: 99%. 1H
NMR (300 MHz, CDCl3) δ 8.00 (ddd, J = 8.1, 1.3, 0.6 Hz, 1H),
7.81 (ddd, J = 7.9, 1.4, 0.6 Hz, 1H), 7.50–7.41 (m, 1H),
7.40–7.36 (m, 1H), 1.62 (s, 9H).
Butyl 3-(benzo[d]thiazol-2-ylthio)propanoate (3d). Yield:
21%. 1H NMR (300 MHz, chloroform-d ) δ 7.92–7.84 (m, 1H),
7.78–7.74 (m, 1H), 7.46–7.39 (m, 1H), 7.34–7.28 (m, 1H), 4.14
(t, J = 6.7 Hz, 2H), 3.62 (t, J = 7.0 Hz, 2H), 2.93 (t, J = 6.9 Hz,
2H), 1.69–1.57 (m, 2H), 1.48–1.31 (m, 2H), 0.94 (t, J = 7.4 Hz,
3H). 13C NMR (75 MHz, CDCl3) δ 171.64, 166.05, 153.14,
135.28, 126.03, 124.28, 121.53, 120.99, 64.81, 34.42, 30.59,
28.21, 19.12, 13.70. HRMS: [EI]: m/z calculated for
C14H17NO2S2 [M]
+ 295.0701, found 295.0701. IR (ATR): 2958,
1732, 1462, 1427, 1350, 1176, 999, 756 cm−1.
2-(Benzylthio)benzo[d]thiazole (3e).24 Yield: 96%. 1H-NMR
(300 MHz, CDCl3) δ 7.94 (dd, J = 8.2, 1.1 Hz, 1H), 7.76 (dd, J =
8.0, 1.2 Hz, 1H), 7.53–7.41 (m, 3H), 7.40–7.27 (m, 4H), 4.63 (s,
2H). 13C-NMR (75 MHz, CDCl3) δ 166.43, 153.17, 136.18,
135.34, 129.16, 128.73, 127.78, 126.08, 124.30, 121.57, 121.03,
37.72.
2-((4-Fluorobenzyl)thio)benzo[d]thiazole (3f ).25 Yield: 99%.
1H NMR (300 MHz, CDCl3) δ 7.98–7.86 (m, 1H), 7.81–7.74 (m,
1H), 7.49–7.39 (m, 3H), 7.36–7.28 (m, 1H), 7.10–6.95 (m, 2H),
4.59 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 166.02, 162.27 (d, J =
246.6 Hz), 153.07, 135.34, 132.13 (d, J = 3.3 Hz), 130.82 (d, J =
8.2 Hz), 128.52 (d, J = 12.2 Hz), 126.12, 124.39, 121.31 (d, J =
39.0 Hz), 115.60 (d, J = 21.6 Hz), 36.86.
2-((4-Methoxybenzyl)thio)benzo[d]thiazole (3g).26 Yield:
99%. 1H NMR (300 MHz, CDCl3) δ 7.97–7.89 (m, 1H),
7.79–7.73 (m, 1H), 7.48–7.37 (m, 3H), 7.35–7.27 (m, 1H),
6.91–6.85 (m, 2H), 4.58 (s, 2H), 3.80 (s, 3H). 13C NMR (75 MHz,
CDCl3) δ 166.61, 159.19, 153.18, 135.30, 130.37, 127.99, 126.06,
124.26, 121.53, 121.02, 114.12, 55.28, 37.34.
2-((1-Phenylethyl)thio)benzo[d]thiazole (3h).27 Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.97–7.89 (m, 1H), 7.79–7.71 (m,
1H), 7.54–7.48 (m, 2H), 7.43 (ddd, J = 8.3, 7.3, 1.3 Hz, 1H),
7.39–7.27 (m, 4H), 5.18 (q, J = 7.0 Hz, 1H), 1.87 (d, J = 7.0 Hz,
3H). 13C-NMR (75 MHz, CDCl3) δ 165.87, 153.20, 141.80,
135.43, 128.69, 127.78, 127.41, 126.01, 124.33, 121.71, 120.97,
47.58, 22.67.
2-(Phenylthio)benzo[d]thiazole (3i).23 Yield: 82%. 1H-NMR
(300 MHz, CDCl3) δ 7.90 (dt, J = 8.2, 0.9 Hz, 1H), 7.81–7.71 (m,
2H), 7.66 (dt, J = 7.8, 1.0 Hz, 1H), 7.57–7.45 (m, 3H), 7.42 (ddd,
J = 8.3, 7.3, 1.3 Hz, 1H), 7.33–7.23 (m, 1H). 13C-NMR (75 MHz,
CDCl3) δ 169.72, 153.93, 135.54, 135.39, 130.50, 129.94, 126.17,
124.33, 121.96, 120.80.
2-(p-Tolylthio)benzo[d]thiazole (3j).23 Yield: 99%. 1H-NMR
(300 MHz, CDCl3) δ 7.88 (dt, J = 8.2, 0.8 Hz, 1H), 7.67–7.61 (m,
3H), 7.41 (ddd, J = 8.3, 7.3, 1.3 Hz, 1H), 7.33–7.28 (m, 2H),
7.28–7.20 (m, 1H), 2.45 (s, 3H).
2-(m-Tolylthio)benzo[d]thiazole (3k).28 Yield: 94%. 1H-NMR
(300 MHz, CDCl3) δ 7.89 (dt, J = 8.2, 0.9 Hz, 1H), 7.66 (dt, J =
7.9, 0.9 Hz, 1H), 7.60–7.53 (m, 2H), 7.45–7.35 (m, 2H),
Scheme 5 Modified Julia olefination using differently substituted
sulfones.
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7.35–7.31 (m, 1H), 7.27 (ddd, J = 8.3, 7.3, 1.2 Hz, 1H), 2.42 (s,
3H). 13C-NMR (75 MHz, CDCl3) δ 170.10, 153.94, 139.99,
135.88, 135.53, 132.39, 131.32, 129.74, 129.56, 126.13, 124.27,
121.91, 120.77, 21.31.
2-((2,6-Dimethylphenyl)thio)benzo[d]thiazole (3l).29 Yield:
93%. 1H-NMR (300 MHz, CDCl3) δ 7.88 (dt, J = 8.2, 0.8 Hz, 1H),
7.67–7.57 (m, 1H), 7.44–7.33 (m, 2H), 7.30–7.21 (m, 3H), 2.56
(s, 6H).
2-((4-Methoxyphenyl)thio)benzo[d]thiazole (3m).30 Yield:
83%. 1H-NMR (300 MHz, CDCl3) δ 7.87 (ddd, J = 8.2, 1.2, 0.6
Hz, 1H), 7.71–7.61 (m, 3H), 7.40 (ddd, J = 8.3, 7.3, 1.3 Hz, 1H),
7.25 (ddd, J = 8.0, 7.3, 1.2 Hz, 1H), 7.05–6.97 (m, 2H), 3.88 (s,
3H). 13C-NMR (75 MHz, CDCl3) δ 171.93, 161.70, 154.18,
137.60, 135.40, 126.09, 124.06, 121.75, 120.75, 120.17, 115.51,
55.48.
2-((4-Fluorophenyl)thio)benzo[d]thiazole (3n).31 Yield: 77%.
1H-NMR (300 MHz, CDCl3) δ 7.89 (ddd, J = 8.1, 1.2, 0.6 Hz,
1H), 7.80–7.63 (m, 3H), 7.42 (ddd, J = 8.3, 7.3, 1.3 Hz, 1H),
7.35–7.09 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ 169.54, 164.20
(d, J = 252.2 Hz,), 153.92, 137.79 (d, J = 8.8 Hz), 135.44, 126.26,
125.09 (d, J = 3.6 Hz), 124.41, 121.97, 120.82, 117.25 (d, J = 22.2
Hz).
2-((2-Fluorophenyl)thio)benzo[d]thiazole (3o). Yield: 81%.
1H-NMR (300 MHz, CDCl3) δ 7.90 (dt, J = 8.1, 0.8 Hz, 1H), 7.75
(td, J = 7.7, 7.2, 1.9 Hz, 1H), 7.71–7.65 (m, 1H), 7.60–7.50 (m,
1H), 7.42 (ddd, J = 8.4, 7.3, 1.3 Hz, 1H), 7.32–7.22 (m, 3H).
13C-NMR (75 MHz, CDCl3) δ 167.40, 162.69 (d, J = 251.4 Hz),
153.80, 137.39, 135.62, 133.16 (d, J = 8.2 Hz), 126.23, 125.33 (d,
J = 4.1 Hz), 124.51, 122.10, 120.84, 117.25, 116.85 (d, J = 22.7
Hz). 19F NMR (377 MHz, CDCl3) δ −104.89. HRMS: [EI]: m/z
calculated for C13H8FNS2 [M]
+ 261.0082, found 261.0082. IR
(ATR): 3066, 1454, 1423, 1219, 1002, 817, 721 cm−1.
2-((4-Bromophenyl)thio)benzo[d]thiazole (3p).31 Yield: 91%.
1H-NMR (300 MHz, CDCl3) δ 7.93–7.86 (dt, J = 8.2, 0.9 Hz, 1H),
7.73–7.65 (m, 1H), 7.61–7.55 (m, 4H), 7.43 (ddd, J = 8.3, 7.3,
1.3 Hz, 1H), 7.30 (ddd, J = 8.3, 7.3, 1.2 Hz, 1H). 13C-NMR
(75 MHz, CDCl3) δ 168.07, 153.78, 136.56, 135.57, 133.13,
129.05, 126.31, 125.18, 124.59, 122.11, 120.88.
2-((3-(Trifluoromethyl)phenyl)thio)benzo[d]thiazole (3q).28
Yield: 91%. 1H-NMR (300 MHz, CDCl3) δ 8.05–7.99 (m, 1H),
7.97–7.89 (m, 2H), 7.79–7.69 (m, 2H), 7.61 (t, J = 7.8 Hz, 1H),
7.45 (ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.33 (ddd, J = 8.3, 7.3, 1.2
Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 166.70, 153.66, 137.92,
135.66, 132.26 (d, J = 32.9 Hz), 131.59, 131.34 (q, J = 3.7 Hz),
130.29, 126.88 (q, J = 3.7 Hz), 126.41, 124.83, 123.40 (d, J = 294
Hz), 122.29, 120.95.
2-((4-(Trifluoromethyl)phenyl)thio)benzo[d]thiazole (3r).31
Yield: 86%. 1H-NMR (300 MHz, CDCl3) δ 7.94 (dt, J = 8.2, 0.8
Hz, 1H), 7.87–7.79 (m, 2H), 7.77–7.66 (m, 3H), 7.46 (ddd, J =
8.3, 7.3, 1.3 Hz, 1H), 7.34 (ddd, J = 8.2, 7.3, 1.2 Hz, 1H).
13C-NMR (75 MHz, CDCl3) δ 165.77, 153.57, 135.83, 135.28,
134.12, 131.76 (q, J = 32 Hz), 126.57 (q, J = 3.7 Hz), 126.44,
124.99, 123.66 (q, J = 266 Hz), 122.41, 120.99.
2-(Pyridin-2-ylthio)benzo[d]thiazole (3s).32 Yield: 65%.
1H-NMR (300 MHz, CDCl3) δ 8.61 (ddd, J = 4.9, 1.9, 0.9 Hz,
1H), 8.00 (ddd, J = 8.1, 1.3, 0.7 Hz, 1H), 7.82 (ddd, J = 7.9, 1.4,
0.6 Hz, 1H), 7.68 (ddd, J = 8.0, 7.4, 1.9 Hz, 1H), 7.55 (dt, J = 8.0,
1.0 Hz, 1H), 7.47 (ddd, J = 8.2, 7.2, 1.4 Hz, 1H), 7.37 (ddd, J =
8.4, 7.2, 1.3 Hz, 1H), 7.24 (ddd, J = 7.4, 4.9, 1.2 Hz, 1H).
13C-NMR (75 MHz, CDCl3) δ 162.51, 154.74, 152.72, 149.95,
137.42, 136.26, 126.23, 125.10, 125.07, 122.57, 122.48, 121.01.
2-(Naphthalen-2-ylthio)benzo[d]thiazole (3t).21 Yield: 90%.
1H-NMR (300 MHz, CDCl3) δ 8.30 (d, J = 1.7 Hz, 1H), 7.98–7.85
(m, 4H), 7.74 (dd, J = 8.6, 1.8 Hz, 1H), 7.67–7.55 (m, 3H), 7.42
(ddd, J = 8.3, 7.2, 1.3 Hz, 1H), 7.27 (ddd, J = 8.1, 7.3, 1.2 Hz,
1H). 13C-NMR (75 MHz, CDCl3) δ 169.65, 153.94, 135.61,
135.52, 133.77, 133.74, 131.22, 129.77, 128.18, 127.91, 127.79,
127.04, 127.02, 126.20, 124.36, 121.99, 120.83.
Bis(4-(benzo[d]thiazol-2-ylthio)phenyl)sulfane (3u). Yield:
66%. 1H-NMR (300 MHz, CDCl3) δ 7.91 (dt, J = 8.2, 0.8 Hz, 2H),
7.74–7.66 (m, 6H), 7.49–7.40 (m, 6H), 7.31 (ddd, J = 8.3, 7.3,
1.2 Hz, 2H). 13C-NMR (75 MHz, CDCl3) δ 168.25, 153.77,
137.93, 135.66, 135.59, 131.97, 129.29, 126.32, 124.62, 122.12,
120.89. HRMS: [EI]: m/z calculated for C26H16N2S5 [M]
+
515.9917, found 515.9913. IR (ATR): 3063, 2924, 1570, 1454,
1423, 1385, 1092, 1076, 1007, 818, 748, 721 cm−1.
6-(Benzo[d]thiazol-2-ylthio)hexan-1-ol (3v). Yield: 70%.
1H-NMR (300 MHz, CDCl3) δ 7.80 (d, J = 7.8 Hz, 1H), 7.68 (dd,
J = 7.9, 0.6 Hz, 1H), 7.38–7.29 (m, 1H), 7.25–7.18 (m, 1H), 3.58
(t, J = 6.4 Hz, 2H), 3.28 (t, J = 6.0 Hz, 2H), 1.84–1.70 (m, 2H),
1.54–1.35 (m, 6H). 13C-NMR (75 MHz, CDCl3) δ 167.36, 153.24,
135.09, 126.04, 124.16, 121.42, 120.93, 62.79, 33.49, 32.52,
29.14, 28.48, 25.22. HRMS: [EI]: m/z calculated for C13H17NOS2
[M]+ 267.0752, found 267.0748. IR (ATR): 3282, 2927, 1647,
1539, 1458, 1307, 995, 756 cm−1.
2-((3-(Benzo[d]thiazol-2-yloxy)propyl)thio)benzo[d]thiazole (3w).
Yield: 33%. 1H-NMR (300 MHz, CDCl3) δ 7.76 (d, J = 7.7 Hz,
1H), 7.67 (d, J = 7.3 Hz, 1H), 7.62–7.53 (m, 2H), 7.36–7.25 (m,
2H), 7.24–7.13 (m, 2H), 4.67 (t, J = 6.0 Hz, 2H), 3.48 (t, J = 7.0
Hz, 2H), 2.42–2.29 (m, 2H). 13C-NMR (75 MHz, CDCl3) δ
172.63, 166.20, 153.20, 149.26, 135.24, 131.88, 126.02, 126.01,
124.27, 123.55, 121.53, 121.27, 120.96, 120.83, 69.94, 29.85,
28.76. HRMS: [EI]: m/z calculated for C10H12NOS2
+ [M-ben-
zothiazole + H]+ 226.0355, found 226.0360. IR (ATR): 2924,
1716, 1624, 1535, 1427, 1249, 1219, 995, 756 cm−1.
3-(Benzo[d]thiazol-2-ylthio)propan-1-ol (3x). Yield: 45%.
1H-NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 1H), 7.65 (d, J =
7.9 Hz, 1H), 7.38–7.29 (m, 1H), 7.25–7.18 (m, 1H), 3.68 (t, J = 5.9
Hz, 2H), 3.46 (t, J = 5.9 Hz, 2H), 1.95 (td, J = 11.1, 5.9 Hz, 2H).
13C-NMR (75 MHz, CDCl3) δ 168.91, 152.41, 135.02, 126.24, 124.49,
121.06, 121.02, 59.02, 33.11, 29.83. HRMS: [EI]: m/z calculated for
C10H11NOS2 [M]
+ 225.0282, found 225.0278. IR (ATR): 3294, 2927,
1535, 1458, 1423, 1238, 1049, 995, 756 cm−1.
2-(Phenylselanyl)benzo[d]thiazole (3y).23 Yield: 77%.
1H-NMR (300 MHz, CDCl3) δ 7.94 (dt, J = 8.2, 0.9 Hz, 1H),
7.89–7.80 (m, 2H), 7.72–7.67 (m, 1H), 7.55–7.38 (m, 4H),
7.32–7.24 (m, 1H).
2-(Methylselanyl)benzo[d]thiazole (3aa).33 Yield: 67%.
1H-NMR (300 MHz, CDCl3) δ 7.89–7.81 (m, 1H), 7.72 (dd, J =
8.0, 0.6 Hz, 1H), 7.39–7.29 (m, 1H), 7.27–7.19 (m, 1H), 2.62 (s,
3H). 13C-NMR (75 MHz, CDCl3) δ 160.08, 153.98, 136.26,
126.04, 124.20, 121.55, 120.93, 8.06.
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2-(Octylthio)thiazole (3ab). Yield: 93%. 1H-NMR (300 MHz,
CDCl3) δ 7.66 (d, J = 3.4 Hz, 1H), 7.20 (d, J = 3.4 Hz, 1H),
3.28–3.12 (m, 2H), 1.76 (p, J = 7.6, 7.2 Hz, 2H), 1.55–1.37 (m,
2H), 1.37–1.20 (m, 8H), 0.97–0.80 (m, 3H). 13C-NMR (75 MHz,
CDCl3) δ 166.32, 143.60, 119.45, 35.51, 32.68, 30.12, 30.03,
29.96, 29.66, 23.54, 15.00. HRMS [EI]: m/z calculated for
C11H19NS2 [M]
+ 229.0959, found 229.0959. IR (ATR): 2924,
2854, 1739, 1384, 1018, 864, 705 cm−1.
6-Methyl-2-(octylthio)benzo[d]thiazole (3ac). Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.3 Hz, 1H), 7.58–7.53
(m, 1H), 7.22 (dd, J = 8.2, 1.7 Hz, 1H), 3.33 (t, J = 6.0 Hz, 2H),
2.46 (s, 3H), 1.88–1.76 (m, 2H), 1.54–1.43 (m, 2H), 1.37–1.25
(m, 8H), 0.89 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ
166.04, 151.48, 135.31, 134.13, 127.41, 120.95, 120.76, 33.69,
31.79, 29.22, 29.13, 29.06, 28.78, 22.65, 21.40, 14.10. HRMS:
[EI]: m/z calculated for C16H23NS2 [M]
+ 293.1272, found
293.1265. IR (ATR): 2924, 2855, 1601, 1447, 1258, 1204, 1114,
1065, 995, 818 cm−1.
6-Ethoxy-2-(octylthio)benzo[d]thiazole (3ad). Yield: 86%.
1H-NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.9 Hz, 1H), 7.22 (d,
J = 2.5 Hz, 1H), 7.00 (dd, J = 8.9, 2.5 Hz, 1H), 4.07 (q, J = 7.0
Hz, 2H), 3.31 (t, J = 7.4 Hz, 2H), 1.81 (p, J = 7.3 Hz, 2H),
1.54–1.40 (m, 5H), 1.40–1.18 (m, 8H), 0.89 (t, J = 6.0 Hz, 3H).
13C-NMR (75 MHz, CDCl3) δ 156.28, 147.84, 136.47, 121.90,
115.16, 104.79, 64.09, 33.83, 31.79, 29.27, 29.13, 29.05, 28.77,
22.65, 14.84, 14.10. HRMS: [EI]: m/z calculated for C17H25NOS2
[M]+ 323.1378, found 323.1370. IR (ATR): 2924, 2855, 1601,
1447, 1258, 1204, 1115, 1065, 1038, 995, 937, 818 cm−1.
5-Methoxy-2-(octylthio)benzo[d]thiazole (3ae). Yield: 95%.
1H-NMR (300 MHz, CDCl3) δ 7.60 (d, J = 8.8 Hz, 1H), 7.40 (d,
J = 2.5 Hz, 1H), 6.94 (dd, J = 8.8, 2.5 Hz, 1H), 3.88 (s, 3H), 3.33
(t, J = 6.0 Hz, 2H), 1.82 (p, J = 7.2 Hz, 2H), 1.54–1.42 (m, 2H),
1.36–1.24 (m, 8H), 0.89 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz,
CDCl3) δ 168.60, 158.88, 154.57, 126.75, 121.07, 113.78, 104.47,
55.60, 33.69, 31.79, 29.15, 29.14, 29.06, 28.78, 22.65, 14.11.
HRMS: [EI]: m/z calculated for C16H23NOS2 [M]
+ 309.1221,
found 309.1216. IR (ATR): 2928, 2855, 1744, 1597, 1466, 1416,
1319, 1026, 810 cm−1.
6-Fluoro-2-(octylthio)benzo[d]thiazole (3af). Yield: 94%.
1H-NMR (300 MHz, CDCl3) δ 7.71 (dd, J = 8.9, 4.8 Hz, 1H), 7.35
(dd, J = 8.1, 2.6 Hz, 1H), 7.05 (td, J = 8.9, 2.6 Hz, 1H), 3.24 (t,
J = 7.4 Hz, 2H), 1.73 (p, J = 7.3 Hz, 2H), 1.46–1.33 (m, 2H),
1.32–1.16 (m, 8H), 0.80 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz,
CDCl3) δ 166.84 (d, J = 3.0 Hz), 159.75 (d, J = 244.6 Hz), 150.01
(d, J = 1.8 Hz), 136.09 (d, J = 11.1 Hz), 122.12 (d, J = 9.2 Hz),
114.26 (d, J = 24.5 Hz), 107.37 (d, J = 26.9 Hz), 33.70, 31.78,
29.18, 29.12, 29.04, 28.76, 22.64, 14.10. 19F NMR (377 MHz,
CDCl3) δ −117.55. HRMS: [EI]: m/z calculated for C15H20FNS2
[M]+ 297.1021, found 297.1020. IR (ATR): 2924, 2855, 1601,
1566, 1447, 1308, 1254, 1192, 995, 907, 810 cm−1.
6-Chloro-2-(octylthio)benzo[d]thiazole (3ag). Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.76 (d, J = 8.7 Hz, 1H), 7.73 (d,
J = 2.1 Hz, 1H), 7.37 (dd, J = 8.7, 2.1 Hz, 1H), 3.34 (t, J = 7.3 Hz,
2H), 1.83 (p, J = 7.3 Hz, 2H), 1.48 (p, J = 6.8 Hz, 2H), 1.37–1.25
(m, 8H), 0.89 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ
168.10, 151.93, 136.31, 129.89, 126.67, 122.02, 120.54, 33.68,
31.77, 29.13, 29.12, 29.03, 28.75, 22.64, 14.10. HRMS: [EI]: m/z
calculated for C15H20ClNS2 [M]
+ 313.0726, found 313.0726. IR
(ATR): 2920, 2855, 2191, 1431, 1300, 1261, 1196, 1103, 999,
814 cm−1.
5-Bromo-2-(octylthio)benzo[d]thiazole (3ah). Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.93 (d, J = 1.9 Hz, 1H), 7.51 (d,
J = 8.5 Hz, 1H), 7.31 (dd, J = 8.5, 1.9 Hz, 1H), 3.26 (t, J = 7.4 Hz,
2H), 1.74 (p, J = 7.3 Hz, 2H), 1.48–1.34 (m, 2H), 1.27–1.16 (m,
8H), 0.81 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ
169.49, 154.48, 133.95, 127.03, 124.31, 121.84, 119.61, 33.63,
31.78, 29.13, 29.13, 29.04, 28.77, 22.65, 14.10. HRMS: [EI]: m/z
calculated for C15H20BrNS2 [M]
+ 357.0221, found 357.0227. IR
(ATR): 2920, 2851, 1740, 1408, 1231, 1204, 1146, 1011, 891,
868 cm−1.
7-Bromo-2-(octylthio)benzo[d]thiazole (3ai). Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.71 (dd, J = 8.1, 1.0 Hz, 1H), 7.33
(dd, J = 7.8, 1.0 Hz, 1H), 7.23–7.17 (m, 1H), 3.26 (t, J = 7.4 Hz,
2H), 1.75 (p, J = 7.3 Hz, 2H), 1.47–1.35 (m, 2H), 1.30–1.15 (m,
8H), 0.84–0.78 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ 168.02,
153.20, 137.91, 127.19, 126.79, 120.10, 113.15, 33.71, 31.78,
29.12, 29.08, 29.03, 28.75, 22.64, 14.10. HRMS: [EI]: m/z calcu-
lated for C15H20BrNS2 [M]
+ 357.0221, found 357.0224. IR
(ATR): 2924, 2855, 1740, 1450, 1377, 999, 775 cm−1.
2-(Octylthio)benzo[d]thiazole-6-carbonitrile (3aj). Yield:
98%. 1H-NMR (300 MHz, CDCl3) δ 8.05 (d, J = 1.6 Hz, 1H), 7.88
(d, J = 8.4 Hz, 1H), 7.65 (dd, J = 8.4, 1.6 Hz, 1H), 3.37 (t, J = 7.3
Hz, 2H), 1.83 (p, J = 7.3 Hz, 2H), 1.56–1.41 (m, 2H), 1.41–1.17
(m, 8H), 0.96–0.82 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ
172.94, 155.70, 135.66, 129.51, 125.34, 121.82, 118.81, 107.27,
33.73, 31.76, 29.10, 29.10, 29.01, 28.74, 22.63, 14.10. HRMS:
[EI]: m/z calculated for C16H20N2S2 [M]
+ 304.1068, found
304.1068. IR (ATR): 2920, 2843, 2222, 1427, 1400, 1308, 1246,
1192, 1003, 826 cm−1.
2-(Octylthio)benzo[d]thiazole-5-carbonitrile (3ak). Yield:
99%. 1H-NMR (300 MHz, CDCl3) δ 8.12 (d, J = 1.5 Hz, 1H), 7.84
(d, J = 8.3 Hz, 1H), 7.52 (dd, J = 8.2, 1.6 Hz, 1H), 3.37 (t, J = 7.3
Hz, 2H), 1.83 (p, J = 7.3 Hz, 2H), 1.56–1.41 (m, 2H), 1.36–1.23
(m, 8H), 0.92–0.86 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ
170.83, 153.00, 140.20, 126.56, 125.07, 121.86, 118.85, 109.65,
33.66, 31.77, 29.12, 29.06, 29.02, 28.75, 22.64, 14.11. HRMS:
[EI]: m/z calculated for C16H20N2S2 [M]
+ 304.1068, found
304.1061. IR (ATR): 2924, 2855, 1744, 1431, 1412, 1018,
826 cm−1.
6-Nitro-2-(octylthio)benzo[d]thiazole (3al). Yield: 86%.
1H-NMR (300 MHz, CDCl3) δ 8.66 (d, J = 2.3 Hz, 1H), 8.29 (dd, J
= 9.0, 2.3 Hz, 1H), 7.89 (d, J = 9.0 Hz, 1H), 3.40 (t, J = 7.4 Hz,
2H), 1.85 (p, J = 7.4 Hz, 2H), 1.55–1.43 (m, 2H), 1.40–1.25 (m,
8H), 0.89 (t, J = 6.0 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ
174.64, 157.10, 143.96, 135.48, 121.84, 121.12, 117.30, 33.79,
31.76, 29.10, 29.01, 28.99, 28.75, 22.63, 14.09. HRMS: [EI]: m/z
calculated for C15H20N2O2S2 [M]
+ 324.0966, found 324.0966. IR
(ATR): 2924, 2851, 1512, 1327, 1265, 1118, 1049, 1003,
829 cm−1.
6-Ethoxy-2-(propylthio)benzo[d]thiazole (3am).34 Yield: 80%.
1H-NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.9 Hz, 1H), 7.22 (d,
J = 2.5 Hz, 1H), 7.00 (dd, J = 8.9, 2.5 Hz, 1H), 4.06 (q, J = 7.0
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Hz, 2H), 3.29 (t, J = 7.2 Hz, 2H), 1.85 (h, J = 7.3 Hz, 2H), 1.44 (t,
J = 7.0 Hz, 3H), 1.08 (t, J = 7.4 Hz, 3H). 13C-NMR (75 MHz,
CDCl3) δ 163.91, 156.29, 147.83, 136.47, 121.90, 115.17, 104.78,
64.09, 35.72, 22.76, 14.84, 13.38.
5-Methoxy-2-((4-methoxybenzyl)thio)benzo[d]thiazole (3an).26
Yield: 83%. 1H-NMR (300 MHz, CDCl3) δ 7.59 (d, J = 8.8 Hz,
1H), 7.43 (d, J = 2.5 Hz, 1H), 7.41–7.34 (m, 2H), 6.96 (dd, J =
8.8, 2.5 Hz, 1H), 6.91–6.83 (m, 2H), 4.55 (s, 2H), 3.89 (s, 3H),
3.80 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 167.72, 159.18,
158.94, 154.40, 130.33, 127.94, 126.92, 121.18, 114.11, 113.96,
104.57, 55.62, 55.28, 37.42.
2-(Benzylthio)-6-chlorobenzo[d]thiazole (3ao).35 Yield: 99%.
1H-NMR (300 MHz, CDCl3) δ 7.81 (d, J = 8.7 Hz, 1H), 7.72 (d,
J = 2.1 Hz, 1H), 7.51–7.44 (m, 2H), 7.41–7.30 (m, 4H), 4.61 (s,
2H).
5-Bromo-2-((4-methoxybenzyl)thio)benzo[d]thiazole (3ap).
Yield: 99%. 1H-NMR (300 MHz, CDCl3) δ 7.95 (d, J = 1.9 Hz,
1H), 7.50 (d, J = 8.5 Hz, 1H), 7.34–7.24 (m, 3H), 6.82–6.73 (m,
2H), 4.46 (s, 2H), 3.71 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ
168.63, 159.23, 154.27, 134.10, 130.37, 127.80, 127.20, 124.39,
121.94, 119.68, 114.13, 55.29, 37.30. HRMS: [EI]: m/z calculated
for C15H12BrNOS2 [M]
+ 515.9917, found 364.9544. IR (ATR):
2916, 1608, 1508, 1419, 1246, 1172, 1014, 829, 794 cm−1.
2-(p-Tolylthio)benzo[d]thiazole-6-carbonitrile (3aq). Yield:
99%. 1H-NMR (300 MHz, CDCl3) δ 7.95–7.92 (m, 1H), 7.89 (dd,
J = 8.5, 0.6 Hz, 1H), 7.69–7.59 (m, 3H), 7.39–7.31 (m, 2H), 2.47
(s, 3H). 13C-NMR (75 MHz, CDCl3) δ 177.96, 157.47, 142.93,
136.68, 132.03, 130.50, 126.12, 126.03, 123.19, 119.69, 108.25,
22.43. HRMS: [EI]: m/z calculated for C15H10N2S2 [M]
+
282.0285, found 282.0285. IR (ATR): 3089, 2229, 2739, 1431,
1381, 1006, 794 cm−1.
2-((4-Methoxybenzyl)thio)benzo[d]thiazole-5-carbonitrile (3ar).
Yield: 99%. 1H-NMR (300 MHz, CDCl3) δ 8.08 (d, J = 1.5 Hz,
1H), 7.76 (d, J = 8.2 Hz, 1H), 7.45 (dd, J = 8.3, 1.6 Hz, 1H),
7.35–7.24 (m, 2H), 6.84–6.75 (m, 2H), 4.51 (s, 2H), 3.72 (s, 3H).
13C-NMR (75 MHz, CDCl3) δ 169.98, 159.33, 152.82, 140.32,
130.40, 127.47, 126.71, 125.19, 121.96, 118.81, 114.18, 109.75,
55.30, 37.33. HRMS: [EI]: m/z calculated for C16H12N2OS2 [M]
+
312.0391, found 312.0391. IR (ATR): 2920, 2229, 1739, 1508,
1435, 1249, 1172, 1006, 813 cm−1.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
This work was supported by the Carl-Zeiss Foundation
(endowed professorship to I.V.) and Friedrich Schiller
University Jena. We thank Dr Peter Bellstedt, and Dr Nico
Ueberschaar for their support with NMR and MS analysis and
Dr Wenxue Huang for synthesis of starting materials.
Notes and references
1 (a) I. Osaka, K. Takimiya and R. D. McCullough, Adv.
Mater., 2010, 22, 4993; (b) Y. Lin, H. Fan, Y. Li and X. Zhan,
Adv. Mater., 2012, 24, 3087; (c) J. E. Klare, G. S. Tulevski,
K. Sugo, A. de Picciotto, K. A. White and C. Nuckolls, J. Am.
Chem. Soc., 2003, 125, 6030.
2 (a) G. Li, M. Arisawa and M. Yamaguchi, Chem. Commun.,
2014, 50, 4328; (b) M. Arisawa, T. Tazawa, S. Tanii,
K. Horiuchi and M. Yamaguchi, J. Org. Chem., 2017, 82,
804; (c) M. Yamaguchi, M. Arisawa, S. Tanii, T. Tougo and
K. Horiuchi, Synlett, 2017, 28, 1601; (d) R. Brückner and
A. Sorg, Synlett, 2005, 289; (e) A. R. de Lera, B. Vaz,
R. Alvarez and J. A. Souto, Synlett, 2005, 294.
3 D. Davyt and G. Serra, Mar. Drugs, 2010, 8, 2755.
4 (a) R. Van Ginckel, H. Bruwiere, P. Moelans, B. Janssen,
W. Floren, B. Van der Leede, J. Van Dun, G. Sanz, M. Venet
and L. Dillen, Br. J. Cancer, 2002, 86, 605; (b) D. Rakowitz,
B. Hennig, M. Nagano, S. Steger, L. Costantino and
B. Matuszczak, Arch. Pharm. Chem. Life Sci., 2005, 338, 411;
(c) J. Kočí, V. Klimešová, K. Waisser, J. Kaustová,
H.-M. Dahse and U. Möllmann, Bioorg. Med. Chem. Lett.,
2002, 12, 3275; (d) A. Naya, K. Kobayashi, M. Ishikawa,
K. Ohwaki, T. Saeki, K. Noguchi and N. Ohtake, Chem.
Pharm. Bull., 2003, 51, 697; (e) R. Paramashivappa, P. Phani
Kumar, P. V. Subba Rao and A. Srinivasa Rao, Bioorg. Med.
Chem. Lett., 2003, 13, 657; (f ) R. V. Kumar, K. R. Gopal and
K. V. S. R. S. Kumar, J. Heterocycl. Chem., 2005, 42, 1405;
(g) Y. G. Gu, M. Weitzberg, R. F. Clark, X. Xu, Q. Li,
T. Zhang, T. M. Hansen, G. Liu, Z. Xin, X. Wang, R. Wang,
T. McNally, H. Camp, B. A. Beutel and H. L. Sham, J. Med.
Chem., 2006, 49, 3770; (h) S. J. Kashyap, V. K. Garg,
P. K. Sharma, N. Kumar, R. Dudhe and J. K. Gupta, Med.
Chem. Res., 2011, 21, 2123; (i) E. Meltzer-Mats, G. Babai-
Shani, L. Pasternak, N. Uritsky, T. Getter, O. Viskind,
J. Eckel, E. Cerasi, H. Senderowitz, S. Sasson and
A. Gruzman, J. Med. Chem., 2013, 56, 5335.
5 E. Vitaku, D. T. Smith and J. T. Njardarson, J. Med. Chem.,
2014, 57, 10257.
6 M. A. Azam and B. Suresh, Sci. Pharm., 2012, 80, 789.
7 J. Dumas, D. Brittelli, J. Chen, B. Dixon, H. Mokdad,
G. König, R. Sibley, J. Witowsky and S. Wong, Bioorg. Med.
Chem. Lett., 1999, 9, 2531.
8 L. Zhang, J. Fan, K. Vu, K. Hong, J. Y. Le Brazidec, J. Shi,
M. Biamonte, D. J. Busch, R. E. Lough, R. Grecko, Y. Ran,
J. L. Sensintaffar, A. Kamal, K. Lundgren, F. J. Burrows,
R. Mansfield, G. A. Timony, E. H. Ulm, S. R. Kasibhatla and
M. F. Boehm, J. Med. Chem., 2006, 49, 5352.
9 W. Huang and G. F. Yang, Bioorg. Med. Chem., 2006, 14,
8280.
10 (a) P. R. Blakemore, J. Chem. Soc., Perkin Trans. 1, 2002,
2563; (b) J. B. Baudin, G. Hareau, S. A. Julia and O. Ruel,
Tetrahedron Lett., 1991, 32, 1175; (c) J. B. Baudin,
G. Hareau, S. A. Julia and O. Ruel, Bull. Soc. Chim. Fr.,
1993, 130, 336; (d) J. B. Baudin, G. Hareau, S. A. Julia,
R. Lorne and O. Ruel, Bull. Soc. Chim. Fr., 1993, 130, 856;
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2020 Org. Biomol. Chem.
Pu
bl
is
he
d 
on
 1
7 
Ju
ne
 2
02
0.
 D
ow
nl
oa
de
d 
by
 T
hu
er
in
ge
r U
ni
ve
rs
ita
ts
 L
an
de
sb
ib
lio
th
ek
 Je
na
 o
n 
7/
13
/2
02
0 
4:
47
:0
9 
PM
. 
View Article Online
(e) R. Bellingham, K. Jarowicki, P. Kocienski and
V. Martin, Synthesis, 1996, 285; (f ) A. B. Charette and
H. Lebel, J. Am. Chem. Soc., 1996, 118, 10327; (g) K. Ando,
T. Kobayashi and N. Uchida, Org. Lett., 2015, 17, 2554;
(h) P. R. Blakemore, D. K. H. Ho and W. M. Nap, Org.
Biomol. Chem., 2005, 3, 1365; (i) F. Billard, R. Robiette and
J. Pospíšil, J. Org. Chem., 2012, 77, 6358; ( j) D. Gueyrard,
R. Haddoub, A. Salem, N. S. Bacar and P. G. Goekjian,
Synlett, 2006, 520.
11 (a) A. Correa, M. Carril and C. Bolm, Angew. Chem., Int. Ed.,
2008, 47, 2880; (b) X. Ku, H. Huang, H. Jiang and H. Liu,
J. Comb. Chem., 2009, 11, 338; (c) P. F. Larsson, A. Correa,
M. Carril, P. O. Norrby and C. Bolm, Angew. Chem., Int. Ed.,
2009, 48, 5691; (d) Y. S. Feng, Y. Y. Li, L. Tang, W. Wu and
H. J. Xu, Tetrahedron Lett., 2010, 51, 2489; (e) Y. Yuan,
X. Wang and Y. Li, Synthesis, 2013, 45, 1247; (f ) X. Li,
T. Yuan, Y. Yang and J. Chen, Tetrahedron, 2014, 70, 9652;
(g) N. H. Cano, M. S. Ballari, A. G. Lopez and
A. N. Santiago, J. Agric. Food Chem., 2015, 63, 3681;
(h) B. Zhang, Y. Kang, L. Yang and X. Chen,
ChemistrySelect, 2016, 1, 1529; (i) C. Savarin, J. Srogl and
L. S. Liebeskind, Org. Lett., 2002, 4, 4309; ( j) H. J. Xu,
Y. Q. Zhao, T. Feng and Y. S. Feng, J. Org. Chem., 2012, 77,
2878; (k) J. Shanmugapriya, K. Rajaguru,
S. Muthusubramanian and N. Bhuvanesh, Eur. J. Org.
Chem., 2016, 1963; (l) J. H. Cheng, C. Ramesh, H. L. Kao,
Y. J. Wang, C. C. Chan and C. F. Lee, J. Org. Chem., 2012,
77, 10369; (m) I. M. Yonova, C. A. Osborne,
N. S. Morrissette and E. R. Jarvo, J. Org. Chem., 2014, 79,
1947.
12 (a) A. K. Ghosh and B. Zajc, J. Org. Chem., 2009, 74, 8531;
(b) T. Deligeorgiev, S. Kaloyanova, N. Lesev and
J. J. Vaquero, Ultrason. Sonochem., 2010, 17, 783;
(c) A. Duarte, W. Cunico, C. M. Pereira, A. F. Flores,
R. A. Freitag and G. M. Siqueira, Ultrason. Sonochem., 2010,
17, 281; (d) Z. Wang, Z. Chen and J. Sun, Angew. Chem., Int.
Ed., 2013, 52, 6685; (e) B. C. Duffy, K. T. Howard and
J. D. Chisholm, Tetrahedron Lett., 2015, 56, 3301;
(f ) K. C. Nicolaou, P. K. Sasmal, G. Rassias, M. V. Reddy,
K. H. Altmann, M. Wartmann, A. O’Brate and
P. Giannakakou, Angew. Chem., Int. Ed., 2003, 42, 3515;
(g) S. S. Badsara, C. C. Chan and C. F. Lee, Asian J. Org.
Chem., 2014, 3, 1197.
13 (a) A. R. Rosario, K. K. Casola, C. E. S. Oliveira and G. Zeni,
Adv. Synth. Catal., 2013, 355, 2960; (b) J. Rafique, S. Saba,
T. E. A. Frizon and A. L. Braga, ChemistrySelect, 2018, 3,
328.
14 (a) S. Ranjit, R. Lee, D. Heryadi, C. Shen, J. Wu, P. Zhang,
K. W. Huang and X. Liu, J. Org. Chem., 2011, 76, 8999;
(b) C. Dai, Z. Xu, F. Huang, Z. Yu and Y. F. Gao, J. Org.
Chem., 2012, 77, 4414; (c) A. X. Zhou, X. Y. Liu, K. Yang,
S.-C. Zhao and Y. M. Liang, Org. Biomol. Chem., 2011, 9,
5456; (d) T. Guo, X. N. Wei, Y. L. Zhu, H. Chen, S. L. Han
and Y. C. Ma, Synlett, 2018, 29, 1530.
15 P. Gandeepan, J. Mo and L. Ackermann, Chem. Commun.,
2017, 53, 5906.
16 (a) E. Anders and F. Markus, Tetrahedron Lett., 1987, 28,
2675; (b) E. Anders and F. Markus, Chem. Ber., 1989, 122,
113; (c) E. Anders and F. Markus, Chem. Ber., 1989, 122,
119.
17 (a) F. Schomberg, Y. Zi and I. Vilotijevic, Chem. Commun.,
2018, 54, 3266; (b) Y. Zi, F. Schomberg, F. Seifert, H. Gorls
and I. Vilotijevic, Org. Biomol. Chem., 2018, 16, 6341.
18 Y. Zi, F. Schömberg, K. Wagner and I. Vilotijevic, Org. Lett.,
2020, 22, 3407.
19 (a) M. C. Hilton, R. D. Dolewski and A. McNally, J. Am.
Chem. Soc., 2016, 138, 13806; (b) R. G. Anderson, B. M. Jett
and A. McNally, Angew. Chem., Int. Ed., 2018, 57, 12514;
(c) J. L. Koniarczyk, D. Hesk, A. Overgard, I. W. Davies and
A. McNally, J. Am. Chem. Soc., 2018, 140, 1990;
(d) R. D. Dolewski, M. C. Hilton and A. McNally, Synlett,
2018, 29, 8; (e) X. Zhang and A. McNally, Angew. Chem., Int.
Ed., 2017, 56, 9833; (f ) R. G. Anderson, B. M. Jett and
A. McNally, Tetrahedron, 2018, 74, 3129; (g) R. D. Dolewski,
P. J. Fricke and A. McNally, J. Am. Chem. Soc., 2018, 140,
8020; (h) C. Patel, M. Mohnike, M. C. Hilton and
A. McNally, Org. Lett., 2018, 20, 2607; (i) M. C. Hilton,
X. Zhang, B. T. Boyle, J. V. Alegre-Requena, R. S. Paton and
A. McNally, Science, 2018, 362, 799; ( j) B. T. Boyle,
M. C. Hilton and A. McNally, J. Am. Chem. Soc., 2019, 141,
15441; (k) J. L. Koniarczyk, J. W. Greenwood, J. V. Alegre-
Requena, R. S. Patonand and A. McNally, Angew. Chem., Int.
Ed., 2019, 58, 14882; (l) X. Zhang and A. McNally, ACS
Catal., 2019, 9, 4862.
20 E. J. Corey and Y. Tian, Org. Lett., 2005, 7, 5535.
21 S. Ranjit, R. Lee, D. Heryadi, C. Shen, J. Wu,
P. Zhang, K. W. Huang and X. Liu, J. Org. Chem., 2011, 76,
8999.
22 L. Shi, X. Liu, H. Zhang, Y. Jiang and D. Ma, J. Org. Chem.,
2011, 76, 4200.
23 A. R. Rosario, K. K. Casola, C. E. S. Oliveira and G. Zeni,
Adv. Synth. Catal., 2013, 355, 2960.
24 S. Murru, P. Mondal, R. Yella and B. K. Patel, Eur. J. Org.
Chem., 2009, 5406.
25 A. M. Romine, K. S. Yang, M. K. Karunananda, J. S. Chen
and K. M. Engle, ACS Catal., 2019, 9, 7626.
26 C. Miao, H. Zhuang, Y. Wen, F. Han, Q.-F. Yang, L. Yang,
Z. Li and C. Xia, Eur. J. Org. Chem., 2019, 3012.
27 M. A. Savolainen and J. Wu, Org. Lett., 2013, 15, 3802.
28 P. Gandeepan, J. Mo and L. Ackermann, Chem. Commun.,
2017, 53, 5906.
29 M. Sayah and M. G. Organ, Chem. – Eur. J., 2013, 19,
16196.
30 S. S. M. Bandaru, S. Bhilare, J. Cardozo, N. Chrysochos,
C. Schulzke, Y. S. Sanghvi, K. C. Gunturu and A. R. Kapdi,
J. Org. Chem., 2019, 84, 8921.
31 X. Liu, S. B. Zhang, H. Zhu and Z. B. Dong, J. Org. Chem.,
2018, 83, 11703.
32 C. Dai, Z. Xu, F. Huang, Z. Yu and Y. F. Gao, J. Org. Chem.,
2012, 77, 4414.
33 V. Alcolea, D. Plano, I. Encio, J. A. Palop, A. K. Sharma and
C. Sanmartin, Eur. J. Med. Chem., 2016, 123, 407.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2020
Pu
bl
is
he
d 
on
 1
7 
Ju
ne
 2
02
0.
 D
ow
nl
oa
de
d 
by
 T
hu
er
in
ge
r U
ni
ve
rs
ita
ts
 L
an
de
sb
ib
lio
th
ek
 Je
na
 o
n 
7/
13
/2
02
0 
4:
47
:0
9 
PM
. 
View Article Online
34 E. Meltzer-Mats, G. Babai-Shani, L. Pasternak, N. Uritsky,
T. Getter, O. Viskind, J. Eckel, E. Cerasi, H. Senderowitz,
S. Sasson and A. Gruzman, J. Med. Chem., 2013, 56,
5335.
35 C. Franchini, M. Muraglia, F. Corbo, M. A. Florio,
A. Di Mola, A. Rosato, R. Matucci, M. Nesi, F. van Bambeke
and C. Vitali, Arch. Pharm. Chem. Life Sci., 2009, 342,
605.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2020 Org. Biomol. Chem.
Pu
bl
is
he
d 
on
 1
7 
Ju
ne
 2
02
0.
 D
ow
nl
oa
de
d 
by
 T
hu
er
in
ge
r U
ni
ve
rs
ita
ts
 L
an
de
sb
ib
lio
th
ek
 Je
na
 o
n 
7/
13
/2
02
0 
4:
47
:0
9 
PM
. 
View Article Online
